data_2joo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2joo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.36 155.65 19.59 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.721 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 9.6 m -65.11 133.68 52.13 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.2 m -106.02 -28.65 10.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.003 0.43 . . . . 0.0 111.089 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.423 ' HB2' HE22 ' A' ' 11' ' ' GLN . 3.4 mm-40 -125.31 158.21 34.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.0 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -87.85 125.96 34.76 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 116.4 -5.74 19.2 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.064 -173.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.953 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -91.16 157.87 16.95 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.507 0.194 . . . . 0.0 110.917 176.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 14' ' ' CYS . 3.0 p30 -127.61 -59.26 1.22 Allowed 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 87.1 mt -60.64 59.5 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.482 1.114 . . . . 0.0 113.635 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.721 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -155.15 169.27 24.54 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.264 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.5 103.13 10.15 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.758 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 12.8 t -86.56 -72.87 0.48 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.617 0.723 . . . . 0.0 110.624 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -91.38 107.46 19.22 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.334 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.85 -82.41 0.01 OUTLIER Glycine 0 C--N 1.307 -1.038 0 O-C-N 124.694 1.246 . . . . 0.0 113.296 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.4 p -127.21 -3.16 6.3 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.534 0.334 . . . . 0.0 111.418 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -66.75 116.18 7.37 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.219 0.533 . . . . 0.0 111.27 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 t -88.68 93.83 4.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.871 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -63.37 145.79 54.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.803 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.87 -132.22 3.21 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.783 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -88.43 139.97 29.95 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.17 0.51 . . . . 0.0 110.525 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.29 -11.73 71.14 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.791 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -121.54 164.61 16.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.033 0.444 . . . . 0.0 110.286 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' O ' HG13 ' A' ' 40' ' ' VAL . 24.9 ttpp -150.67 124.91 9.42 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.734 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.758 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.6 t -89.62 135.82 33.39 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.947 0.403 . . . . 0.0 110.503 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -125.05 120.86 59.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.561 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.409 HD11 ' HB2' ' A' ' 6' ' ' CYS . 5.9 mp . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.573 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 35.3 tp60 . . . . . 0 CA--C 1.519 -0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 111.64 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 79.3 m -91.65 92.76 8.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.852 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 27' ' ' LYS . 6.2 p -89.57 155.72 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -88.23 132.26 34.44 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.459 0.647 . . . . 0.0 111.179 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.16 -128.09 1.65 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.09 117.62 13.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.223 0.535 . . . . 0.0 110.033 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -93.8 -146.64 20.5 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.596 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.712 HG21 ' HG3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -150.42 145.67 18.84 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.89 118.83 5.74 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.364 2.042 . . . . 0.0 110.969 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.953 ' HG3' HE21 ' A' ' 11' ' ' GLN . 15.9 tttt . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.097 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.525 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 2.5 p . . . . . 0 N--CA 1.441 -0.892 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.98 161.78 18.02 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.171 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 17.7 m -64.5 137.94 58.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.721 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 ' HG2' ' A' ' 8' ' ' GLU . 6.2 t -106.76 -16.73 14.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.2 0.524 . . . . 0.0 110.444 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.617 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 4.9 mm-40 -138.26 154.99 49.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.741 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -88.07 127.2 35.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.608 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.43 -6.68 31.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.617 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.16 157.28 18.34 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.9 p30 -129.23 -60.02 1.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.66 60.65 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.306 1.042 . . . . 0.0 113.511 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.78 169.76 23.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.005 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -81.26 112.49 18.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.769 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 36.4 t -98.12 -79.42 0.47 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.651 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.92 111.09 18.93 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.414 -172.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.17 -92.33 0.01 OUTLIER Glycine 0 C--N 1.297 -1.596 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.327 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 p -121.16 2.06 10.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.709 0.29 . . . . 0.0 111.343 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -68.09 125.72 27.25 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.534 0.683 . . . . 0.0 111.381 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.26 108.64 19.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.496 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.778 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -74.6 149.77 39.94 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.123 176.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.33 -149.35 5.09 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.571 -0.611 . . . . 0.0 111.571 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -87.33 133.01 33.76 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.04 -8.24 38.63 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -133.57 166.84 21.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.611 -0.795 . . . . 0.0 109.253 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 24.3 ttpp -149.41 117.9 6.52 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.769 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.0 t -89.39 125.53 35.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.206 0.527 . . . . 0.0 110.865 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.5 pt -121.07 124.18 71.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.851 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.292 179.085 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.733 0.301 . . . . 0.0 111.343 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.778 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 97.5 m -90.14 86.96 6.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.949 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.528 HG11 ' O ' ' A' ' 27' ' ' LYS . 3.2 p -88.02 165.89 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 p -88.97 132.22 34.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.67 0.748 . . . . 0.0 111.271 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.8 -140.39 6.4 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -138.82 111.31 7.55 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.536 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -86.5 -155.28 26.57 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.941 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.22 141.8 43.19 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.2 140.82 71.38 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.996 1.797 . . . . 0.0 109.931 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.531 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 42.0 tttt . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 120.706 0.289 . . . . 0.0 111.334 -169.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.42 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.11 144.41 26.51 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.751 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.3 m -60.2 132.3 53.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 m -111.37 -12.99 13.97 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.195 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.671 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 37.4 mt-10 -136.05 156.01 49.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.892 -172.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.8 m -89.24 118.8 29.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.117 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.62 1.41 24.47 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.779 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.68 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -92.93 158.9 15.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.6 p30 -134.31 -57.38 0.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 76.6 mt -63.26 59.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.103 0.877 . . . . 0.0 112.587 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.751 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -154.43 164.9 37.93 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.778 177.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.95 98.69 7.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.762 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 14.6 t -74.16 -77.83 0.11 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.435 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 28.2 tt0 -84.13 154.52 23.09 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 11.44 -89.75 0.0 OUTLIER Glycine 0 N--CA 1.471 1.023 0 O-C-N 125.003 1.439 . . . . 0.0 115.062 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.0 p -120.07 16.96 12.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.268 0.556 . . . . 0.0 111.074 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 24.2 m-80 -79.03 98.21 6.39 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.531 0.681 . . . . 0.0 110.578 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 40.7 t -88.43 98.04 7.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.933 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -78.71 160.22 27.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.149 -174.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -143.3 -136.95 3.22 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.042 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -87.8 133.77 33.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.201 0.524 . . . . 0.0 109.86 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.7 -8.76 51.5 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.287 -173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -125.99 164.06 21.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.444 -0.378 . . . . 0.0 110.12 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 43' ' ' GLU . 27.4 ttpp -148.23 120.43 8.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.745 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.762 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 10.4 t -88.84 136.96 32.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.856 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 pt -127.78 134.5 65.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.239 0.543 . . . . 0.0 110.28 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 mt . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.412 -179.53 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.724 HE21 ' HA ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.166 0.508 . . . . 0.0 111.666 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 89.4 m -92.02 97.95 11.26 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.135 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.472 HG11 ' O ' ' A' ' 27' ' ' LYS . 4.8 p -89.67 161.8 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.2 p -89.11 129.39 35.73 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.368 0.604 . . . . 0.0 111.58 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.87 -132.33 2.62 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.183 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.507 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 5.8 pt-20 -136.95 119.24 15.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.266 0.555 . . . . 0.0 110.756 175.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.86 -143.87 15.64 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.208 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.22 142.71 17.21 Favored Pre-proline 0 C--N 1.324 -0.514 0 C-N-CA 122.507 0.323 . . . . 0.0 110.399 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.495 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 32.0 Cg_exo -59.0 132.79 49.37 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.655 2.237 . . . . 0.0 111.159 174.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.68 ' HG3' HE21 ' A' ' 11' ' ' GLN . 1.8 ttpm? . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.77 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.511 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 5.5 p . . . . . 0 N--CA 1.444 -0.757 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.32 145.52 26.31 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 26.1 m -59.54 134.14 56.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.959 0.409 . . . . 0.0 110.941 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 m -110.61 -31.67 7.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.61 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.591 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 25.6 mp0 -115.1 152.52 32.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.717 -176.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 m -88.88 119.91 29.8 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.475 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 117.46 -5.85 16.89 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.999 -173.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.689 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.08 166.33 13.93 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' CYS . 8.6 p30 -135.62 -58.19 0.78 Allowed 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.75 60.56 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.119 0.887 . . . . 0.0 112.944 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -153.76 161.28 42.22 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.359 178.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -81.77 100.03 9.3 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 30.8 t -82.34 -74.93 0.32 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.843 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 2.0 tm-20 -78.38 148.16 33.8 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 10.02 -85.87 0.0 OUTLIER Glycine 0 N--CA 1.471 1.016 0 O-C-N 124.972 1.42 . . . . 0.0 115.372 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.9 p -119.81 5.36 10.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.967 0.413 . . . . 0.0 111.248 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.5 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -71.38 107.64 4.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.227 0.537 . . . . 0.0 110.502 -177.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.9 t -89.09 98.55 8.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.497 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.738 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -66.88 153.72 42.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.211 -178.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.71 -128.17 1.69 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.095 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.67 134.45 33.65 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.207 0.527 . . . . 0.0 109.956 -174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.66 0.63 66.62 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.644 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.412 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 51.9 m-80 -133.96 164.48 27.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.126 0.488 . . . . 0.0 110.794 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 25.0 ttpp -150.61 123.34 8.6 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.494 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 27.8 t -89.94 133.08 34.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.986 0.422 . . . . 0.0 110.6 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.69 112.42 33.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.431 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.569 178.104 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 33.1 tp60 . . . . . 0 CA--C 1.517 -0.302 0 CA-C-O 120.979 0.418 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.738 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 60.3 m -89.36 87.93 7.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.946 172.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.53 HG11 ' O ' ' A' ' 27' ' ' LYS . 3.9 p -89.23 159.31 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -88.9 130.62 35.39 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.258 0.551 . . . . 0.0 111.186 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.91 -134.83 3.3 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.5 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.517 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 8.8 pt-20 -133.8 113.86 12.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.099 0.476 . . . . 0.0 109.888 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -96.18 -149.75 26.02 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.523 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.39 142.47 26.68 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 122.568 0.347 . . . . 0.0 110.324 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.42 129.55 33.2 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.301 2.0 . . . . 0.0 110.851 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.689 ' HG3' HE21 ' A' ' 11' ' ' GLN . 15.2 tttt . . . . . 0 N--CA 1.446 -0.67 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.349 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.471 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.7 p . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.524 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 7.4 m-20 -87.72 149.53 24.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.774 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 25.9 m -61.45 134.75 57.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.858 0.361 . . . . 0.0 110.755 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -112.1 -20.85 11.78 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.265 0.555 . . . . 0.0 110.406 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -134.92 154.99 51.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.333 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -86.63 124.44 32.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.8 -10.05 16.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.663 -172.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.698 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.95 154.05 20.14 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.1 p30 -126.79 -61.85 1.16 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.4 mt -58.99 63.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.011 0.925 . . . . 0.0 113.05 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.774 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.15 162.32 41.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.871 177.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -78.37 87.84 4.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 13.9 t -61.3 -77.55 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.253 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 6.8 tp10 -82.56 164.91 20.53 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -8.41 -71.86 0.01 OUTLIER Glycine 0 N--CA 1.472 1.089 0 O-C-N 124.88 1.363 . . . . 0.0 115.269 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.4 p -127.67 4.38 6.11 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.697 -0.296 . . . . 0.0 111.392 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.513 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -78.8 110.64 14.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 110.737 -179.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 40.6 t -89.88 106.78 17.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.74 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.76 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -68.42 146.98 52.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.92 177.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.98 -156.98 8.51 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.039 -1.076 . . . . 0.0 113.454 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.82 117.44 24.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.739 0.78 . . . . 0.0 109.607 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.34 -4.24 23.5 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -165.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.479 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 6.6 m120 -122.25 164.49 17.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.651 -0.774 . . . . 0.0 108.987 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' O ' HG12 ' A' ' 40' ' ' VAL . 26.4 ttpp -149.98 118.25 6.41 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.7 t -89.51 130.48 35.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.039 0.447 . . . . 0.0 110.624 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -123.65 112.95 35.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.132 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.474 -179.725 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 11.9 tp60 . . . . . 0 N--CA 1.445 -0.702 0 CA-C-O 121.271 0.558 . . . . 0.0 111.871 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.76 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 54.6 m -89.62 89.85 7.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.112 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.8 p -88.79 153.2 3.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 p -89.78 119.73 30.43 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.175 0.512 . . . . 0.0 110.57 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.86 -130.99 1.51 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.63 110.76 7.32 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.118 0.485 . . . . 0.0 110.132 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.485 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -99.14 -145.06 17.81 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.225 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.37 136.14 11.32 Favored Pre-proline 0 C--N 1.317 -0.812 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.79 135.88 42.66 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.442 2.095 . . . . 0.0 111.038 171.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.698 ' HG3' HE21 ' A' ' 11' ' ' GLN . 24.5 tttm . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.784 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 3.4 m-20 -89.04 149.0 23.43 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.786 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 61.2 m -58.57 144.35 43.12 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.234 0.54 . . . . 0.0 112.082 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.606 ' OG1' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -114.26 -23.87 9.22 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.676 176.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.668 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 43.1 mt-10 -136.15 153.69 51.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.304 -170.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.8 m -88.46 120.86 30.23 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.7 -11.56 13.77 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -172.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.668 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -88.01 164.34 15.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.2 p30 -134.93 -58.0 0.81 Allowed 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.2 mt -58.16 61.81 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.383 1.073 . . . . 0.0 113.42 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.786 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.6 166.3 33.8 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.233 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.78 94.16 6.36 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.563 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . 49.3 t -73.79 -74.49 0.18 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.356 -172.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -91.92 150.16 21.18 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 27.15 -91.5 0.01 OUTLIER Glycine 0 N--CA 1.472 1.07 0 O-C-N 124.548 1.155 . . . . 0.0 114.535 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.01 32.73 4.0 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.413 0.625 . . . . 0.0 110.948 173.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.538 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -82.06 112.91 19.55 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.694 177.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.8 t -88.37 91.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -69.14 146.64 52.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.39 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.29 -152.51 6.32 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.07 137.02 32.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.489 0.644 . . . . 0.0 109.357 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.17 -9.93 46.78 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -167.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -126.93 158.63 36.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.861 -0.669 . . . . 0.0 109.892 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 18.3 ttpp -139.55 121.21 15.29 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 74.1 m -89.76 143.38 26.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.724 0.297 . . . . 0.0 111.13 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.8 pt -135.36 131.12 51.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.289 0.566 . . . . 0.0 110.768 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.41 HD11 ' N ' ' A' ' 30' ' ' LEU . 6.7 mp . . . . . 0 C--N 1.316 -0.85 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.372 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.787 ' HA ' HE21 ' A' ' 38' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 120.591 0.234 . . . . 0.0 111.218 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 91.8 m -101.21 114.89 29.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.046 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 27' ' ' LYS . 1.2 p -104.16 157.22 5.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.9 p -91.36 123.78 35.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.077 0.465 . . . . 0.0 111.162 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.8 -120.23 0.75 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.502 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 13.6 pt-20 -151.95 123.38 7.79 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.493 -0.416 . . . . 0.0 110.452 174.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.539 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -107.72 -151.96 17.07 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.937 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.07 144.01 51.36 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.72 135.43 67.17 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.216 1.944 . . . . 0.0 110.819 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.784 ' HE3' ' O ' ' A' ' 5' ' ' ASP . 14.6 tttm . . . . . 0 N--CA 1.435 -1.18 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.755 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.628 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 82.7 p . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.45 172.22 9.96 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.701 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 31.3 m -73.37 136.37 44.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.023 0.44 . . . . 0.0 111.248 -177.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 m -102.31 -21.93 14.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -139.5 156.22 47.06 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.115 0.484 . . . . 0.0 110.701 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.9 m -90.16 107.75 19.32 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.025 -0.988 . . . . 0.0 108.53 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 124.79 -0.53 8.49 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -169.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -88.15 -171.1 3.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.6 p30 -159.04 -55.2 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.604 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 74.1 mt -60.8 61.34 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.805 0.842 . . . . 0.0 112.905 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.701 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -154.03 166.91 31.53 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.14 178.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.5 OUTLIER -79.01 91.58 4.87 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.72 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 33.1 t -92.65 -65.04 1.03 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.188 0.518 . . . . 0.0 111.245 -174.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -83.69 103.79 13.28 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.793 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.36 -95.29 0.01 OUTLIER Glycine 0 C--N 1.294 -1.753 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.796 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.3 p -121.33 11.99 10.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.743 0.306 . . . . 0.0 111.236 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.463 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.9 OUTLIER -73.11 126.07 29.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.07 0.462 . . . . 0.0 110.635 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 t -89.83 102.55 13.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.089 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 1.3 m -85.3 162.83 18.94 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.915 0.388 . . . . 0.0 111.37 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -148.76 -140.04 3.24 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.726 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -84.8 134.73 34.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.292 0.567 . . . . 0.0 109.56 -173.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.89 -16.46 28.11 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -169.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -119.61 158.38 26.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.061 0.458 . . . . 0.0 110.786 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.601 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 4.4 tppp? -130.51 107.71 9.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.049 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.559 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 85.8 m -89.31 126.81 35.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.538 0.208 . . . . 0.0 110.77 -177.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -128.82 127.94 66.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.196 0.522 . . . . 0.0 111.163 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 30' ' ' LEU . 5.5 mp . . . . . 0 C--N 1.322 -0.59 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.495 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 . . . . . 0 C--O 1.231 0.1 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 69.8 m -94.26 100.55 12.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.401 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.489 HG11 ' O ' ' A' ' 27' ' ' LYS . 4.1 p -90.84 158.48 2.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.3 p -89.13 125.69 35.15 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.623 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.97 -123.37 0.87 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.955 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -152.3 109.01 3.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.174 0.511 . . . . 0.0 110.294 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.601 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -90.2 -147.61 18.1 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.287 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.528 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -133.8 142.03 42.13 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.7 134.19 61.35 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.129 1.886 . . . . 0.0 110.851 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HG3' HE21 ' A' ' 11' ' ' GLN . 1.6 ttpm? . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 -171.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 4.7 p . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.421 ' H ' ' HB ' ' A' ' 4' ' ' THR . 7.7 m-20 -87.51 155.95 19.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.719 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.1 m -63.81 137.14 57.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.986 0.422 . . . . 0.0 111.621 -176.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m -107.5 -31.4 8.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.047 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.82 157.01 46.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.609 -175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 m -88.39 122.1 31.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.476 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.94 -6.5 21.97 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.8 164.97 14.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.9 p30 -136.77 -57.12 0.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.8 mt -59.55 61.39 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.111 0.965 . . . . 0.0 112.984 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.719 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.77 167.29 30.7 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.394 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -81.62 105.24 12.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 34.2 t -94.57 -70.85 0.69 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.654 -172.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 20.4 tt0 -86.84 79.38 8.82 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.106 0.955 . . . . 0.0 109.68 -175.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 -91.88 0.28 Allowed Glycine 0 C--N 1.294 -1.781 0 CA-C-N 113.551 -1.659 . . . . 0.0 111.612 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 p -109.25 -3.45 17.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.658 0.266 . . . . 0.0 110.929 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 18.8 m-80 -64.84 114.79 4.73 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.184 0.516 . . . . 0.0 111.124 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.01 104.36 14.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.918 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.91 151.32 37.37 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.959 0.409 . . . . 0.0 110.233 179.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -140.14 -153.5 6.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.97 144.75 27.45 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.13 -3.42 80.28 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -165.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -135.0 156.3 49.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.467 ' O ' HG11 ' A' ' 40' ' ' VAL . 28.6 ttpp -142.12 123.15 14.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.969 0.414 . . . . 0.0 109.981 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 14.4 t -90.04 139.48 30.57 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.911 0.386 . . . . 0.0 110.688 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.9 pt -132.38 124.04 51.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.761 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.055 -176.677 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 93.9 m -96.67 109.14 21.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.773 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 27' ' ' LYS . 2.7 p -103.6 162.96 3.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 p -90.18 129.23 36.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.487 0.661 . . . . 0.0 111.198 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.51 -144.43 8.96 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.91 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -128.31 105.61 8.46 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.974 0.416 . . . . 0.0 110.267 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.81 -151.99 22.88 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.202 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.21 142.5 35.61 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.17 142.69 77.49 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.381 2.054 . . . . 0.0 111.428 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -175.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.555 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.24 150.51 24.32 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 13.3 m -62.15 128.84 38.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.024 0.44 . . . . 0.0 110.479 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -95.71 -17.17 21.47 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.868 -177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.669 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 36.1 mt-10 -138.37 151.69 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.786 -170.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.1 m -87.67 124.21 33.31 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 115.35 -6.58 21.06 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.876 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.669 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.84 162.48 15.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.1 p30 -132.74 -59.24 0.91 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 73.8 mt -60.29 61.47 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -174.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -155.41 172.75 17.7 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.985 177.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -85.87 80.55 8.87 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.756 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 17.5 t -60.66 -70.72 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.205 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -95.78 137.84 34.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 30.43 -96.7 0.01 OUTLIER Glycine 0 N--CA 1.467 0.708 0 O-C-N 124.733 1.271 . . . . 0.0 114.712 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 p -120.08 17.0 12.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.275 0.56 . . . . 0.0 111.46 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.583 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -85.38 103.82 14.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.554 -178.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -87.93 102.9 13.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -74.26 153.3 39.47 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.735 -176.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.31 -134.88 3.26 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.127 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.65 126.88 35.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.053 0.454 . . . . 0.0 110.259 -171.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.26 -13.2 31.08 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -119.85 161.33 21.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.242 -0.479 . . . . 0.0 109.924 176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.51 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.8 ttpp -146.25 123.08 11.27 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.84 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.756 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.2 t -89.04 141.92 28.08 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.718 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.5 pt -133.42 128.75 55.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.31 0.576 . . . . 0.0 109.998 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.45 -177.305 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.46 0.06 0 CA-C-O 120.953 0.406 . . . . 0.0 111.79 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 90.3 m -99.48 106.18 18.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.516 175.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.2 p -95.99 158.99 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.1 p -88.98 126.84 35.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.8 0.333 . . . . 0.0 111.112 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.68 -119.12 0.73 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.006 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 9.2 pt-20 -147.02 117.0 7.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.91 -149.12 21.14 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.537 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.7 144.9 19.87 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.369 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.6 144.55 74.25 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.362 2.041 . . . . 0.0 110.436 173.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 1.8 ttpm? . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -170.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.449 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 4.8 m-20 -86.93 148.05 25.51 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 21.9 m -60.8 133.58 56.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.502 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -109.91 -29.62 8.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.877 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 159.43 30.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.347 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -87.52 117.2 26.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.569 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.98 -6.82 9.42 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.214 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.557 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.42 160.44 16.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.639 0.257 . . . . 0.0 110.426 177.29 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.4 p30 -133.79 -57.28 0.88 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 78.9 mt -61.47 60.58 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.003 0.921 . . . . 0.0 112.886 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -155.05 162.33 41.08 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.448 179.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.68 85.36 5.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.1 0.476 . . . . 0.0 109.953 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.793 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 26.1 t -66.28 -73.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.429 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.08 144.12 26.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.116 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 22.76 -90.53 0.01 OUTLIER Glycine 0 N--CA 1.47 0.918 0 O-C-N 125.028 1.455 . . . . 0.0 114.699 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 p -121.6 -1.7 9.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.794 0.331 . . . . 0.0 111.197 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -70.29 104.06 2.56 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.629 0.728 . . . . 0.0 110.997 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 21.3 t -88.84 101.05 11.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.922 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -65.82 156.92 31.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.972 -175.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -134.71 -152.92 6.7 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -85.96 139.15 31.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.28 -15.63 50.28 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -120.48 166.22 13.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.4 ttpp -149.99 117.4 6.09 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.793 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.5 t -88.92 136.31 33.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.887 0.375 . . . . 0.0 110.266 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.2 pt -127.01 128.35 70.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.299 0.571 . . . . 0.0 110.243 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.318 -0.761 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.871 -176.926 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.032 0.444 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 91.8 m -89.41 96.03 10.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.916 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.6 p -90.23 160.13 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 p -88.88 132.0 34.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.285 0.564 . . . . 0.0 111.368 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.91 -128.6 1.68 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.876 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -143.14 112.85 6.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.344 0.593 . . . . 0.0 110.28 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -93.53 -148.09 23.03 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.419 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.93 142.71 22.81 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.83 139.4 78.19 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.198 1.932 . . . . 0.0 110.676 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.557 ' HG3' HE21 ' A' ' 11' ' ' GLN . 16.5 tttm . . . . . 0 N--CA 1.432 -1.352 0 CA-C-O 120.99 0.424 . . . . 0.0 110.493 -173.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.604 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.407 ' H ' ' HB ' ' A' ' 4' ' ' THR . 0.3 OUTLIER -85.77 147.76 26.17 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 10.2 m -59.35 129.87 44.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.117 0.484 . . . . 0.0 110.796 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 m -103.08 -27.08 12.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.601 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.36 159.36 36.42 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.403 -176.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 46.5 m -87.05 118.66 26.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.292 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.88 -4.72 11.54 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.12 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.06 161.82 16.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.706 0.288 . . . . 0.0 110.402 175.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' CYS . 6.1 p30 -135.66 -56.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.126 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.611 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 88.9 mt -62.15 63.13 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.375 1.047 . . . . 0.0 112.161 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -153.94 162.6 41.09 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.332 177.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.73 81.46 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.804 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 43.2 t -67.87 -79.87 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.385 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 11.1 tp10 -72.86 157.59 37.17 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -3.38 -78.3 0.01 OUTLIER Glycine 0 N--CA 1.472 1.094 0 O-C-N 125.284 1.615 . . . . 0.0 115.446 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.0 p -126.64 15.03 7.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.009 0.433 . . . . 0.0 111.125 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.555 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -83.85 111.2 18.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.755 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.9 t -87.92 103.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -74.94 163.82 27.22 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.081 -176.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.77 -138.34 2.83 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.849 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -85.91 125.8 33.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.195 0.521 . . . . 0.0 109.917 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -19.54 11.38 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -172.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -124.33 161.38 26.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 40' ' ' VAL . 25.6 ttpp -141.9 117.92 10.61 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.804 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 32.8 t -91.05 135.27 33.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.095 0.474 . . . . 0.0 110.572 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 23.3 pt -132.38 144.81 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.137 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 C--N 1.311 -1.093 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.327 176.786 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? . . . . . 0 C--O 1.233 0.23 0 CA-C-O 121.034 0.445 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 92.8 m -89.7 96.02 10.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.152 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 27' ' ' LYS . 3.1 p -89.8 166.12 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.9 p -88.52 127.4 35.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.263 0.554 . . . . 0.0 111.178 -176.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.5 -135.54 3.57 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.985 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -141.36 110.3 6.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.432 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -92.68 -149.74 25.23 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.261 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.31 144.87 29.93 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 51.3 Cg_exo -55.3 140.35 81.74 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.387 2.058 . . . . 0.0 111.408 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 11.3 tttm . . . . . 0 N--CA 1.438 -1.064 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.164 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.1 155.55 20.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.744 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 3.8 m -61.18 134.26 56.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.366 0.603 . . . . 0.0 111.592 -173.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 m -100.13 -18.17 17.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.711 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -145.46 157.85 43.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.591 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 m -89.37 120.22 30.52 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.489 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.07 -2.9 14.43 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.532 -170.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.16 172.39 9.11 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.9 p30 -143.52 -55.81 0.39 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 74.6 mt -61.61 66.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.925 0.869 . . . . 0.0 112.478 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.744 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -153.83 168.93 24.68 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.112 -1.403 . . . . 0.0 109.592 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.71 84.41 4.05 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 92.5 m -72.77 -80.21 0.07 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.473 -175.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -88.0 121.01 29.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.358 -173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.47 -90.31 0.01 OUTLIER Glycine 0 C--N 1.304 -1.235 0 O-C-N 123.985 0.803 . . . . 0.0 111.436 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.84 10.54 4.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.7 0.286 . . . . 0.0 111.561 173.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -71.17 126.11 28.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.164 0.506 . . . . 0.0 110.718 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 3.7 t -88.61 93.85 4.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.882 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.756 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -65.97 154.82 38.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 -176.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.01 -156.23 8.66 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -87.39 132.74 33.87 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.55 -22.26 8.86 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -168.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -117.6 159.95 22.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.09 171.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.549 ' O ' HG11 ' A' ' 40' ' ' VAL . 19.2 ttpp -133.62 113.97 12.99 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.303 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 51.7 t -90.22 130.51 36.34 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.6 pt -123.76 127.24 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.459 0.647 . . . . 0.0 111.023 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.023 176.137 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.469 0 CA-C-O 121.295 0.569 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.756 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 81.0 m -89.57 95.7 10.38 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.696 176.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.549 HG11 ' O ' ' A' ' 27' ' ' LYS . 5.0 p -89.03 160.33 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.0 p -89.24 126.06 35.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.227 0.537 . . . . 0.0 111.422 -175.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.9 -122.36 0.9 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 11.8 pt-20 -150.23 123.59 8.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.177 0.513 . . . . 0.0 110.417 173.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.404 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -107.52 -145.81 12.3 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.381 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.22 142.62 21.98 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.462 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 51.1 Cg_exo -57.41 144.09 92.49 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.581 2.187 . . . . 0.0 111.243 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HD3' ' HB3' ' A' ' 14' ' ' CYS . 2.1 ttpm? . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.534 0.207 . . . . 0.0 111.445 -172.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -87.89 152.29 22.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 11.5 m -60.0 133.24 55.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.558 -178.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -113.44 -15.28 12.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.517 0.675 . . . . 0.0 110.273 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.704 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 46.1 mt-10 -134.2 151.64 51.42 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.217 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -88.11 124.36 33.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.06 -4.21 27.09 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.328 -173.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.704 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.27 162.11 16.04 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.7 p30 -136.04 -56.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 73.6 mt -61.83 62.18 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.96 0.788 . . . . 0.0 112.918 -177.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -155.48 175.25 14.12 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.596 178.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.2 106.57 14.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.74 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 40.2 t -98.73 -65.9 0.93 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.434 0.635 . . . . 0.0 110.966 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.13 107.07 18.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.879 -175.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.73 -90.04 0.01 OUTLIER Glycine 0 C--N 1.299 -1.521 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.007 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 p -124.49 2.08 8.34 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.0 0.429 . . . . 0.0 111.424 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.486 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -70.25 125.14 25.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.782 -175.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.06 105.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.348 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -72.91 155.47 39.84 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.24 -143.22 4.38 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.636 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -86.21 139.12 31.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.486 0.66 . . . . 0.0 110.266 -176.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.71 -9.94 58.82 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.718 -172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -125.73 160.77 28.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.033 174.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' HG11 ' A' ' 40' ' ' VAL . 28.7 ttpp -143.74 119.55 10.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.536 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.74 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 17.5 t -89.16 133.18 34.5 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.847 0.356 . . . . 0.0 110.304 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 pt -128.29 123.01 59.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.379 0.609 . . . . 0.0 110.883 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--N 1.319 -0.758 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.474 176.526 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 72.8 m -89.12 110.51 21.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.859 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.494 HG11 ' O ' ' A' ' 27' ' ' LYS . 2.7 p -103.29 159.95 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 p -88.98 128.33 35.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.228 0.537 . . . . 0.0 111.122 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.6 -133.93 2.73 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.245 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -139.51 111.1 7.15 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.155 0.502 . . . . 0.0 109.938 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.75 -152.98 28.77 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.433 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.28 139.03 30.38 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.5 135.15 68.01 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.351 2.034 . . . . 0.0 110.907 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.611 ' HG3' HE21 ' A' ' 11' ' ' GLN . 18.7 tttt . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.448 ' HB ' ' H ' ' A' ' 5' ' ' ASP . 1.5 p . . . . . 0 N--CA 1.443 -0.788 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.448 ' H ' ' HB ' ' A' ' 4' ' ' THR . 8.0 m-20 -85.24 142.61 29.28 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -174.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 35.0 m -50.28 133.15 24.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.503 0.668 . . . . 0.0 111.128 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -115.07 -10.25 12.24 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.595 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.623 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 41.8 mt-10 -143.94 151.04 39.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.631 -173.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 m -89.01 126.95 35.64 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.455 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.3 -1.03 34.98 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.762 ' HG2' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.19 164.85 14.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 8.8 p30 -139.74 -57.05 0.57 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 75.4 mt -62.1 59.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.979 0.895 . . . . 0.0 112.415 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.791 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 1.6 p -155.39 150.6 26.9 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.126 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.65 89.85 2.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.629 0.728 . . . . 0.0 109.949 177.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 34.1 t -62.66 -73.51 0.11 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.358 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 1.2 tm-20 -87.53 163.31 16.73 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -23.04 -72.53 0.01 OUTLIER Glycine 0 N--CA 1.472 1.058 0 O-C-N 124.26 0.975 . . . . 0.0 115.366 -169.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.9 p -115.72 14.72 16.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.238 0.542 . . . . 0.0 110.46 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.536 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -80.81 92.19 6.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.889 177.179 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 41.9 t -87.91 97.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.704 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.47 158.81 32.09 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.8 -173.301 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -141.42 -146.26 4.69 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -87.0 134.72 33.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.196 0.522 . . . . 0.0 109.641 -174.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.01 -13.91 37.51 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -170.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -123.89 165.84 16.68 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.8 ttpp -148.89 118.46 6.97 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 13.7 t -89.41 132.46 34.98 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.8 pt -128.36 120.39 52.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.303 0.573 . . . . 0.0 110.707 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 N--CA 1.443 -0.811 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.581 178.449 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 . . . . . 0 C--O 1.233 0.236 0 CA-C-O 121.002 0.43 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.704 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 99.5 m -91.18 99.49 12.48 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.861 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 27' ' ' LYS . 5.3 p -89.69 160.77 2.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.2 p -87.62 129.99 34.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.25 0.547 . . . . 0.0 111.124 -176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.34 -135.12 3.51 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.669 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.86 108.98 7.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.034 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.57 -148.72 24.59 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.327 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -144.09 144.8 27.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 122.469 0.308 . . . . 0.0 110.299 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 33.2 Cg_exo -60.01 154.89 47.83 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.718 2.279 . . . . 0.0 111.65 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.791 ' HG3' ' HB3' ' A' ' 14' ' ' CYS . 2.0 mtmt . . . . . 0 N--CA 1.446 -0.644 0 CA-C-O 121.052 0.453 . . . . 0.0 110.725 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.477 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 13.6 p . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.0 141.85 28.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 9.1 m -59.12 137.65 57.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.473 0.178 . . . . 0.0 111.145 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -118.75 -25.48 6.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.917 0.389 . . . . 0.0 111.204 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.48 156.32 35.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.993 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 m -89.07 114.47 25.71 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.358 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.65 -0.67 9.36 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.333 -173.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.591 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.28 171.93 9.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.4 p30 -145.45 -56.73 0.32 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 65.8 mt -62.67 58.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.148 0.905 . . . . 0.0 112.492 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.05 159.33 41.51 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.957 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -73.05 102.78 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.037 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 29.6 t -89.44 -70.48 0.66 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.71 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 9.3 tp10 -79.56 158.99 27.02 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -6.93 -78.02 0.01 OUTLIER Glycine 0 N--CA 1.473 1.162 0 O-C-N 124.984 1.428 . . . . 0.0 115.241 -176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.9 p -122.5 14.43 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.843 0.354 . . . . 0.0 111.264 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.555 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -83.97 108.05 16.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.624 -178.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 9.2 t -92.06 104.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 1.2 m -82.32 168.85 17.15 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.187 -174.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -145.34 -149.27 4.98 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.56 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -86.79 134.28 33.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.441 0.639 . . . . 0.0 109.997 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.445 ' C ' HD21 ' A' ' 26' ' ' ASN . . . 112.5 -17.17 23.74 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -165.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.445 HD21 ' C ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -118.82 163.13 17.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.903 -0.649 . . . . 0.0 109.498 172.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 24.9 ttpp -144.61 117.96 9.04 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 173.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 33.7 t -89.17 132.31 34.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.733 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 pt -129.64 127.0 63.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.274 0.559 . . . . 0.0 110.879 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.401 HD13 ' N ' ' A' ' 30' ' ' LEU . 6.1 mp . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.518 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 1.6 tp60 . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 70.8 m -95.43 100.38 12.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.721 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.1 p -91.58 162.17 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -89.14 127.33 35.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.554 0.693 . . . . 0.0 111.779 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.47 -134.02 2.86 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.534 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -143.83 111.19 5.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.448 0.624 . . . . 0.0 110.495 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.489 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -89.22 -138.29 6.64 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.311 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.9 148.0 31.39 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 122.671 0.388 . . . . 0.0 110.341 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 134.87 60.76 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.602 2.201 . . . . 0.0 111.186 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.591 ' HG3' HE21 ' A' ' 11' ' ' GLN . 13.7 tttt . . . . . 0 N--CA 1.448 -0.574 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.2 p . . . . . 0 N--CA 1.444 -0.742 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.416 ' H ' ' HB ' ' A' ' 4' ' ' THR . 10.2 m-20 -87.66 153.83 21.07 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.111 -176.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 17.0 m -65.64 135.87 55.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.574 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 m -103.93 -23.03 13.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.071 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.98 162.77 34.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.241 0.544 . . . . 0.0 110.942 -173.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.0 m -87.12 122.0 30.35 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.151 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.86 -5.92 18.15 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.901 -173.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 1.004 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.86 161.04 15.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 175.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' CYS . 6.8 p30 -136.05 -55.93 0.76 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.07 55.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.247 0.967 . . . . 0.0 112.893 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 p -155.36 160.48 40.74 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.845 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -77.6 97.24 5.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.364 0.602 . . . . 0.0 109.393 177.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.768 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 13.0 t -72.65 -77.31 0.1 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.703 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -86.85 162.11 17.95 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 3.29 -87.99 0.0 OUTLIER Glycine 0 N--CA 1.474 1.174 0 O-C-N 124.964 1.415 . . . . 0.0 114.969 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.1 p -123.07 22.05 9.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.463 0.649 . . . . 0.0 110.237 172.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -78.57 99.04 6.35 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.209 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 31.0 t -88.32 99.94 9.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.014 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.732 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -73.07 155.98 39.21 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.651 -176.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.67 -154.05 6.23 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.643 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -85.78 135.13 33.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.434 0.617 . . . . 0.0 109.52 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.25 -9.35 53.92 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -127.34 164.15 22.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.557 -0.822 . . . . 0.0 109.278 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG11 ' A' ' 40' ' ' VAL . 27.3 ttpp -150.28 121.46 7.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.211 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.768 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.9 t -89.23 138.0 31.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.956 0.408 . . . . 0.0 110.232 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -128.08 124.47 62.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.436 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.374 176.475 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.426 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 56.4 tp60 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.0 111.694 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.732 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 59.7 m -90.83 92.89 8.99 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.868 171.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 27' ' ' LYS . 4.7 p -90.16 159.76 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.9 p -88.65 127.03 35.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.387 0.613 . . . . 0.0 110.685 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.67 -148.44 11.92 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.895 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -122.22 106.34 11.04 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.28 -144.14 12.47 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.091 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 1.004 HG22 ' HG3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -150.04 146.18 19.91 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.167 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.39 119.77 7.15 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.375 2.05 . . . . 0.0 111.841 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 8.4 tmtt? . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.442 -0.844 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.56 152.14 22.43 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.78 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 4.8 m -63.01 133.36 54.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.205 0.526 . . . . 0.0 111.225 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -105.45 -23.11 12.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.692 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.429 ' HB2' HE22 ' A' ' 11' ' ' GLN . 2.3 mm-40 -130.52 153.98 48.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.339 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.5 m -88.27 112.0 22.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.1 -0.13 7.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.004 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.557 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.64 171.84 9.72 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.6 p30 -142.41 -57.44 0.45 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 82.8 mt -62.87 61.62 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.815 0.846 . . . . 0.0 112.354 -178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.78 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -153.51 171.23 19.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.821 -179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mt -83.45 88.36 6.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 41.9 t -80.49 -61.53 1.95 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.875 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.99 113.7 25.34 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.976 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 46.33 -97.32 0.01 OUTLIER Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.754 -175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -115.1 0.99 13.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.489 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -70.3 123.05 20.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.978 0.418 . . . . 0.0 110.607 -175.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.26 97.39 6.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.486 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.825 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.6 OUTLIER -74.69 167.29 22.09 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.541 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.02 -124.76 0.72 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.802 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -86.26 124.46 32.67 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.174 0.511 . . . . 0.0 110.312 -169.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.44 -2.7 37.02 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.045 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -130.89 154.35 48.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.323 0.582 . . . . 0.0 110.867 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.592 ' O ' HG13 ' A' ' 40' ' ' VAL . 5.2 ttpp -129.57 111.63 12.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.174 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.493 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 61.7 m -91.56 124.33 35.64 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.162 0.506 . . . . 0.0 111.09 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.3 pt -128.0 139.3 52.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.819 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.776 178.566 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.854 0.359 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.825 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 70.8 m -90.68 95.76 10.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.944 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 27' ' ' LYS . 3.5 p -90.23 159.67 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -88.83 130.51 35.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.216 0.531 . . . . 0.0 111.464 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.69 -132.29 2.53 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.705 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -137.41 112.69 9.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.009 0.433 . . . . 0.0 110.335 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.454 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -100.99 -146.89 19.87 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.205 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.453 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -147.11 148.43 32.16 Favored Pre-proline 0 C--N 1.324 -0.533 0 C-N-CA 122.18 0.192 . . . . 0.0 110.664 -178.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 45' ' ' THR . 51.1 Cg_exo -55.8 148.76 54.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.196 1.931 . . . . 0.0 110.785 173.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.557 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 9.5 tttm . . . . . 0 N--CA 1.438 -1.064 0 CA-C-O 120.691 0.281 . . . . 0.0 111.481 -171.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.22 139.99 29.94 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.75 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 28.2 m -60.24 130.8 48.43 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 109.937 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -113.08 -28.58 7.62 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.208 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.49 153.02 38.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.844 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 58.9 m -88.44 114.56 25.19 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.392 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.14 -9.56 6.64 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.94 -173.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.631 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -86.61 168.31 13.75 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 6.1 p30 -140.15 -55.24 0.54 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.76 56.24 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.249 0.968 . . . . 0.0 112.854 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.75 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.33 160.78 41.9 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.444 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -71.77 108.14 4.93 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.645 0.736 . . . . 0.0 109.371 174.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.629 ' HA ' ' HG ' ' A' ' 6' ' ' CYS . 53.3 t -89.47 -71.34 0.61 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.168 -176.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 8.8 tp10 -82.42 161.18 22.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -8.55 -78.03 0.01 OUTLIER Glycine 0 N--CA 1.473 1.147 0 O-C-N 124.905 1.378 . . . . 0.0 115.483 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.3 p -121.16 15.23 11.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 0.0 111.232 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.58 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -87.06 103.81 15.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.6 -179.264 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 37.0 t -89.53 105.14 15.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.778 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -78.44 169.74 17.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.382 -177.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -153.39 -133.69 1.89 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.823 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -85.3 141.31 30.16 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.274 0.559 . . . . 0.0 110.536 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.12 -10.26 69.87 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.184 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -120.15 160.11 23.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.971 0.415 . . . . 0.0 110.497 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.565 ' O ' HG12 ' A' ' 40' ' ' VAL . 19.3 ttpp -142.45 108.54 5.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.295 176.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.502 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 67.7 m -89.46 135.09 33.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.137 -174.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 19.0 pt -131.72 138.08 53.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.375 0.607 . . . . 0.0 110.543 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 C--N 1.317 -0.827 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.549 -179.311 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.037 0.446 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.778 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 77.7 m -90.43 101.09 13.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.767 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -96.08 158.98 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.0 p -88.31 128.63 35.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.774 0.321 . . . . 0.0 111.124 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.7 -121.28 0.88 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.673 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.539 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 6.9 pt-20 -149.79 125.95 10.68 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 173.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.52 -147.49 11.34 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.611 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.35 144.53 50.01 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.453 -0.374 . . . . 0.0 110.569 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.65 141.68 86.69 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.009 1.806 . . . . 0.0 109.924 171.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.631 ' HG3' HE21 ' A' ' 11' ' ' GLN . 2.0 ttpm? . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.676 -172.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 3.0 p . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.28 146.25 26.03 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 33.7 m -59.34 129.65 43.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.183 0.516 . . . . 0.0 110.185 175.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -102.36 -13.93 17.12 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.37 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.424 ' HB2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -150.17 163.76 37.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.209 0.528 . . . . 0.0 110.913 -174.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m -86.11 122.33 29.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.329 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.873 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 120.88 -7.89 10.83 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.531 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.587 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.8 169.06 11.94 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 122.868 -0.196 . . . . 0.0 110.575 178.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.47 -57.29 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.35 56.62 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.345 1.028 . . . . 0.0 113.095 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.77 161.91 41.32 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.833 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.03 89.02 2.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.375 173.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 36.4 t -57.2 -78.04 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.635 175.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 29.2 tt0 -87.56 161.92 17.48 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -16.0 -71.52 0.01 OUTLIER Glycine 0 N--CA 1.471 0.984 0 O-C-N 124.661 1.225 . . . . 0.0 115.665 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 p -116.66 5.96 13.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.063 0.458 . . . . 0.0 111.339 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.538 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -80.42 93.87 6.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.471 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 46.2 t -88.54 97.74 7.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -70.7 160.72 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.224 -175.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.92 -141.78 3.76 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.852 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -87.13 135.3 33.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.165 0.507 . . . . 0.0 109.953 -172.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.51 -7.59 59.76 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -122.66 156.71 33.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.036 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.873 ' HD2' ' HA2' ' A' ' 10' ' ' GLY . 4.7 ttpp -138.59 121.41 16.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.831 176.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 30.0 t -89.94 130.74 36.11 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.38 137.2 54.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.423 0.63 . . . . 0.0 110.462 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.315 -0.912 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.793 -172.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 8.3 tp-100 . . . . . 0 C--O 1.23 0.066 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 86.5 m -90.46 104.46 17.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.586 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.8 p -97.26 164.92 2.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 p -95.25 116.27 28.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.074 0.464 . . . . 0.0 111.156 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.52 -126.95 0.97 Allowed Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.001 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 111.2 6.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.481 0.657 . . . . 0.0 110.769 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.64 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -97.4 -151.87 28.04 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.725 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.11 147.46 22.21 Favored Pre-proline 0 C--N 1.321 -0.64 0 C-N-CA 122.511 0.325 . . . . 0.0 110.679 -176.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.49 148.71 41.93 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.425 2.083 . . . . 0.0 110.497 170.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.587 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 2.2 ttpm? . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -165.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.32 157.66 18.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 2.7 m -67.25 133.92 50.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.321 0.581 . . . . 0.0 111.688 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -106.52 -22.57 12.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.859 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -139.98 157.83 45.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.031 0.443 . . . . 0.0 110.729 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 m -88.28 118.88 28.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.016 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.86 -5.53 10.53 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.805 -173.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.567 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -87.8 176.49 7.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.0 p30 -148.81 -54.14 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 98.0 mt -60.55 65.95 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.898 0.856 . . . . 0.0 112.256 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 p -154.1 165.91 34.71 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.317 -1.311 . . . . 0.0 109.451 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.3 85.54 3.09 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 99.6 m -74.85 -78.48 0.1 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.037 -174.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -85.61 115.09 23.09 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.317 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 48.75 -94.7 0.01 OUTLIER Glycine 0 C--N 1.298 -1.552 0 O-C-N 124.136 0.897 . . . . 0.0 112.006 -173.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -117.88 0.13 11.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.0 111.737 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.496 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -72.15 123.04 22.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.96 0.41 . . . . 0.0 110.64 -176.342 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 t -88.68 106.01 16.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.796 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.3 161.94 28.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.581 -177.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.9 -143.78 3.88 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.833 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -86.75 138.36 31.68 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.282 0.563 . . . . 0.0 110.151 -172.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.17 -10.23 58.19 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -169.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -127.06 153.42 45.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 120.96 0.41 . . . . 0.0 110.202 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.548 ' O ' HG12 ' A' ' 40' ' ' VAL . 14.2 ttpp -134.21 113.2 11.76 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.279 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 15.0 t -89.51 130.7 35.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.906 0.384 . . . . 0.0 110.439 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -129.46 130.22 67.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.574 0.702 . . . . 0.0 111.276 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.609 176.718 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.822 0.344 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.796 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 81.0 m -89.48 97.19 11.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.702 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.3 p -89.73 160.97 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.4 p -88.84 128.68 35.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.469 0.652 . . . . 0.0 111.37 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.43 -142.64 7.44 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.542 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -128.19 113.96 16.37 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.747 0.308 . . . . 0.0 110.779 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.496 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -100.87 -146.16 18.55 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.004 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.95 144.86 22.97 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 122.641 0.376 . . . . 0.0 110.701 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.35 145.22 94.55 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.289 1.993 . . . . 0.0 110.067 171.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.567 ' HG3' HE21 ' A' ' 11' ' ' GLN . 2.0 ttpm? . . . . . 0 C--N 1.32 -0.675 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.549 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.921 0.391 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 51.5 t -122.59 106.58 17.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.873 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -93.24 157.95 16.0 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.3 p -136.37 -178.08 5.0 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.87 -176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.36 155.65 19.59 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.721 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 9.6 m -65.11 133.68 52.13 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.2 m -106.02 -28.65 10.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.003 0.43 . . . . 0.0 111.089 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.423 ' HB2' HE22 ' A' ' 11' ' ' GLN . 3.4 mm-40 -125.31 158.21 34.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.0 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -87.85 125.96 34.76 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 116.4 -5.74 19.2 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.064 -173.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.953 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -91.16 157.87 16.95 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.507 0.194 . . . . 0.0 110.917 176.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 14' ' ' CYS . 3.0 p30 -127.61 -59.26 1.22 Allowed 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 87.1 mt -60.64 59.5 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.482 1.114 . . . . 0.0 113.635 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.721 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -155.15 169.27 24.54 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.264 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.5 103.13 10.15 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.758 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 12.8 t -86.56 -72.87 0.48 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.617 0.723 . . . . 0.0 110.624 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -91.38 107.46 19.22 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.334 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.85 -82.41 0.01 OUTLIER Glycine 0 C--N 1.307 -1.038 0 O-C-N 124.694 1.246 . . . . 0.0 113.296 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.4 p -127.21 -3.16 6.3 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.534 0.334 . . . . 0.0 111.418 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -66.75 116.18 7.37 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.219 0.533 . . . . 0.0 111.27 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 t -88.68 93.83 4.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.871 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -63.37 145.79 54.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.803 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.87 -132.22 3.21 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.783 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -88.43 139.97 29.95 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.17 0.51 . . . . 0.0 110.525 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.29 -11.73 71.14 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.791 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -121.54 164.61 16.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.033 0.444 . . . . 0.0 110.286 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' O ' HG13 ' A' ' 40' ' ' VAL . 24.9 ttpp -150.67 124.91 9.42 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.734 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.758 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.6 t -89.62 135.82 33.39 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.947 0.403 . . . . 0.0 110.503 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -125.05 120.86 59.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.561 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 5.9 mp -95.35 101.16 12.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.573 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.9 -118.29 2.87 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.81 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -152.94 164.19 38.39 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.23 -126.27 25.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.985 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.63 -13.83 36.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.149 0.5 . . . . 0.0 109.701 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 t -99.58 53.55 0.94 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -95.88 -13.56 23.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.555 -173.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.9 118.67 4.97 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 35.3 tp60 -151.29 140.15 20.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.64 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 79.3 m -91.65 92.76 8.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.852 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 27' ' ' LYS . 6.2 p -89.57 155.72 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -88.23 132.26 34.44 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.459 0.647 . . . . 0.0 111.179 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.16 -128.09 1.65 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.09 117.62 13.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.223 0.535 . . . . 0.0 110.033 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -93.8 -146.64 20.5 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.596 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.712 HG21 ' HG3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -150.42 145.67 18.84 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.89 118.83 5.74 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.364 2.042 . . . . 0.0 110.969 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.953 ' HG3' HE21 ' A' ' 11' ' ' GLN . 15.9 tttt -84.63 116.6 65.93 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.097 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.2 136.54 56.44 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 C-N-CA 122.384 2.056 . . . . 0.0 111.845 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -151.47 -28.18 0.19 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.195 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 p -119.55 134.25 55.31 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.497 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.5 m170 . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.023 0.439 . . . . 0.0 110.616 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.287 0.565 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.7 t -88.39 90.25 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.363 0.601 . . . . 0.0 110.477 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -114.15 -176.14 2.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.102 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.525 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 2.5 p -121.91 -159.33 0.81 Allowed 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.98 161.78 18.02 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.171 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 17.7 m -64.5 137.94 58.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.721 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 ' HG2' ' A' ' 8' ' ' GLU . 6.2 t -106.76 -16.73 14.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.2 0.524 . . . . 0.0 110.444 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.617 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 4.9 mm-40 -138.26 154.99 49.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.741 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -88.07 127.2 35.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.608 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.43 -6.68 31.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.617 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.16 157.28 18.34 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.9 p30 -129.23 -60.02 1.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.66 60.65 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.306 1.042 . . . . 0.0 113.511 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.78 169.76 23.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.005 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -81.26 112.49 18.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.769 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 36.4 t -98.12 -79.42 0.47 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.651 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.92 111.09 18.93 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.414 -172.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.17 -92.33 0.01 OUTLIER Glycine 0 C--N 1.297 -1.596 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.327 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 p -121.16 2.06 10.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.709 0.29 . . . . 0.0 111.343 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -68.09 125.72 27.25 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.534 0.683 . . . . 0.0 111.381 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.26 108.64 19.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.496 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.778 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -74.6 149.77 39.94 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.123 176.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.33 -149.35 5.09 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.571 -0.611 . . . . 0.0 111.571 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -87.33 133.01 33.76 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.04 -8.24 38.63 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -133.57 166.84 21.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.611 -0.795 . . . . 0.0 109.253 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 24.3 ttpp -149.41 117.9 6.52 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.769 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.0 t -89.39 125.53 35.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.206 0.527 . . . . 0.0 110.865 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.5 pt -121.07 124.18 71.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.851 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 6.8 mp -75.78 89.03 2.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.292 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 35' ' ' SER . . . 124.62 115.84 2.14 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.21 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 16.6 tpt180 -154.09 79.82 1.12 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.26 -91.03 1.23 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.03 12.88 12.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.467 0.651 . . . . 0.0 109.553 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.495 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 22.7 t -88.58 148.63 23.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.504 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -97.04 -40.48 8.83 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.779 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 2.0 p-10 -152.35 120.02 6.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -121.87 137.3 54.83 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.343 -174.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.778 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 97.5 m -90.14 86.96 6.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.949 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.528 HG11 ' O ' ' A' ' 27' ' ' LYS . 3.2 p -88.02 165.89 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 p -88.97 132.22 34.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.67 0.748 . . . . 0.0 111.271 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.8 -140.39 6.4 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -138.82 111.31 7.55 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.536 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -86.5 -155.28 26.57 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.941 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.22 141.8 43.19 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.494 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 50.0 Cg_exo -54.2 140.82 71.38 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.996 1.797 . . . . 0.0 109.931 173.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.531 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 42.0 tttt -86.79 112.35 46.42 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-O 120.706 0.289 . . . . 0.0 111.334 -169.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 21.0 Cg_exo -65.76 142.39 69.74 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.827 2.351 . . . . 0.0 110.87 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.511 ' HG3' ' H ' ' A' ' 50' ' ' SER . 10.5 pt20 -164.07 -55.66 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.851 -169.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.511 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 32.9 t -150.24 148.42 28.87 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.884 0.849 . . . . 0.0 111.501 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.33 97.76 5.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.107 0.48 . . . . 0.0 110.309 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -102.54 -174.71 2.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.187 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.42 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.4 p -129.73 -175.37 3.58 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.74 -174.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.11 144.41 26.51 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.751 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.3 m -60.2 132.3 53.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 m -111.37 -12.99 13.97 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.195 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.671 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 37.4 mt-10 -136.05 156.01 49.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.892 -172.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.8 m -89.24 118.8 29.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.117 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.62 1.41 24.47 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.779 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.68 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -92.93 158.9 15.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.6 p30 -134.31 -57.38 0.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 76.6 mt -63.26 59.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.103 0.877 . . . . 0.0 112.587 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.751 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -154.43 164.9 37.93 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.778 177.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.95 98.69 7.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.762 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 14.6 t -74.16 -77.83 0.11 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.435 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 28.2 tt0 -84.13 154.52 23.09 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 11.44 -89.75 0.0 OUTLIER Glycine 0 N--CA 1.471 1.023 0 O-C-N 125.003 1.439 . . . . 0.0 115.062 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.0 p -120.07 16.96 12.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.268 0.556 . . . . 0.0 111.074 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 24.2 m-80 -79.03 98.21 6.39 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.531 0.681 . . . . 0.0 110.578 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 40.7 t -88.43 98.04 7.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.933 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -78.71 160.22 27.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.149 -174.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -143.3 -136.95 3.22 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.042 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -87.8 133.77 33.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.201 0.524 . . . . 0.0 109.86 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.7 -8.76 51.5 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.287 -173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -125.99 164.06 21.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.444 -0.378 . . . . 0.0 110.12 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 43' ' ' GLU . 27.4 ttpp -148.23 120.43 8.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.745 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.762 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 10.4 t -88.84 136.96 32.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.856 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 pt -127.78 134.5 65.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.239 0.543 . . . . 0.0 110.28 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.675 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 44.0 mt -103.86 84.02 2.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.412 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.449 ' C ' ' HA ' ' A' ' 36' ' ' LYS . . . -108.77 -109.72 3.32 Favored Glycine 0 C--N 1.317 -0.501 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.647 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.418 ' HD3' ' N ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -152.87 168.2 26.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -176.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 36' ' ' LYS . . . 68.33 -118.49 9.37 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.092 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -94.83 -15.27 23.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.472 0.653 . . . . 0.0 109.35 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 t -100.46 26.69 6.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.947 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 3.2 ptpt -78.43 -31.28 48.04 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.296 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -153.87 80.08 1.14 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.724 ' HA ' HE21 ' A' ' 38' ' ' GLN . 0.0 OUTLIER -134.68 140.44 46.0 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.666 -171.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 89.4 m -92.02 97.95 11.26 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.135 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.472 HG11 ' O ' ' A' ' 27' ' ' LYS . 4.8 p -89.67 161.8 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.2 p -89.11 129.39 35.73 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.368 0.604 . . . . 0.0 111.58 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.87 -132.33 2.62 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.183 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.507 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 5.8 pt-20 -136.95 119.24 15.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.266 0.555 . . . . 0.0 110.756 175.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.86 -143.87 15.64 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.208 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.22 142.71 17.21 Favored Pre-proline 0 C--N 1.324 -0.514 0 C-N-CA 122.507 0.323 . . . . 0.0 110.399 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.495 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 32.0 Cg_exo -59.0 132.79 49.37 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.655 2.237 . . . . 0.0 111.159 174.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.68 ' HG3' HE21 ' A' ' 11' ' ' GLN . 1.8 ttpm? -89.6 108.23 23.82 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.77 -175.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 21.3 Cg_exo -65.07 147.54 88.8 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.589 2.193 . . . . 0.0 111.804 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -139.02 -38.59 0.5 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.565 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.3 m -90.24 -30.61 17.43 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 51.5 m80 . . . . . 0 CA--C 1.512 -0.517 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.133 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 120.941 0.4 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 t -100.04 76.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.582 0.706 . . . . 0.0 110.056 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -97.77 153.34 18.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.868 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.511 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 5.5 p -135.32 -164.37 1.52 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.353 -175.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.32 145.52 26.31 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 26.1 m -59.54 134.14 56.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.959 0.409 . . . . 0.0 110.941 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 m -110.61 -31.67 7.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.61 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.591 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 25.6 mp0 -115.1 152.52 32.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.717 -176.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 m -88.88 119.91 29.8 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 117.46 -5.85 16.89 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.999 -173.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.689 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.08 166.33 13.93 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' CYS . 8.6 p30 -135.62 -58.19 0.78 Allowed 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.75 60.56 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.119 0.887 . . . . 0.0 112.944 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -153.76 161.28 42.22 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.359 178.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -81.77 100.03 9.3 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 30.8 t -82.34 -74.93 0.32 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.843 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 2.0 tm-20 -78.38 148.16 33.8 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 10.02 -85.87 0.0 OUTLIER Glycine 0 N--CA 1.471 1.016 0 O-C-N 124.972 1.42 . . . . 0.0 115.372 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.9 p -119.81 5.36 10.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.967 0.413 . . . . 0.0 111.248 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.9 OUTLIER -71.38 107.64 4.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.227 0.537 . . . . 0.0 110.502 -177.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.9 t -89.09 98.55 8.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.497 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.738 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -66.88 153.72 42.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.211 -178.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.71 -128.17 1.69 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.095 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.67 134.45 33.65 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.207 0.527 . . . . 0.0 109.956 -174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.66 0.63 66.62 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.644 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.412 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 51.9 m-80 -133.96 164.48 27.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.126 0.488 . . . . 0.0 110.794 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 25.0 ttpp -150.61 123.34 8.6 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.494 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 27.8 t -89.94 133.08 34.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.986 0.422 . . . . 0.0 110.6 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.69 112.42 33.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.431 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 5.3 mp -86.78 80.67 8.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.569 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.17 -112.23 2.35 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.709 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 35' ' ' SER . 38.7 ttp180 -155.26 157.07 36.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -173.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.72 -137.24 13.3 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.829 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.15 -7.38 56.99 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 167.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 53.8 m -92.64 23.64 3.96 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 112.462 -2.154 . . . . 0.0 110.35 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 12.1 ptmm? -59.26 -36.88 76.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.298 -176.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 3.5 p-10 -152.87 128.93 10.37 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 33.1 tp60 -145.12 138.53 26.68 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.452 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.738 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 60.3 m -89.36 87.93 7.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.946 172.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG11 ' O ' ' A' ' 27' ' ' LYS . 3.9 p -89.23 159.31 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -88.9 130.62 35.39 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.258 0.551 . . . . 0.0 111.186 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.91 -134.83 3.3 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.5 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.517 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 8.8 pt-20 -133.8 113.86 12.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.099 0.476 . . . . 0.0 109.888 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -96.18 -149.75 26.02 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.523 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.39 142.47 26.68 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 122.568 0.347 . . . . 0.0 110.324 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.426 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 32.5 Cg_exo -58.42 129.55 33.2 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.301 2.0 . . . . 0.0 110.851 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.689 ' HG3' HE21 ' A' ' 11' ' ' GLN . 15.2 tttt -89.11 113.29 55.64 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.349 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 9.4 Cg_exo -71.93 148.74 52.07 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.867 2.378 . . . . 0.0 111.691 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -99.21 -4.13 32.74 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.962 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.4 p -88.97 55.75 3.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.591 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.505 ' HE1' ' HE2' ' A' ' 47' ' ' LYS . 23.0 m80 . . . . . 0 CA--C 1.509 -0.607 0 CA-C-O 121.455 0.645 . . . . 0.0 110.924 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.671 0.272 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.99 104.23 16.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.823 0.344 . . . . 0.0 110.739 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -89.75 160.44 16.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.092 0.472 . . . . 0.0 110.371 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.471 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.7 p -139.38 -165.06 1.79 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.339 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.524 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 7.4 m-20 -87.72 149.53 24.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.774 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 25.9 m -61.45 134.75 57.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.858 0.361 . . . . 0.0 110.755 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -112.1 -20.85 11.78 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.265 0.555 . . . . 0.0 110.406 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -134.92 154.99 51.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.333 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -86.63 124.44 32.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.8 -10.05 16.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.663 -172.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.698 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.95 154.05 20.14 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.1 p30 -126.79 -61.85 1.16 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.4 mt -58.99 63.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.011 0.925 . . . . 0.0 113.05 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.774 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.15 162.32 41.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.871 177.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -78.37 87.84 4.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 13.9 t -61.3 -77.55 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.253 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.637 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 6.8 tp10 -82.56 164.91 20.53 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -8.41 -71.86 0.01 OUTLIER Glycine 0 N--CA 1.472 1.089 0 O-C-N 124.88 1.363 . . . . 0.0 115.269 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.4 p -127.67 4.38 6.11 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.697 -0.296 . . . . 0.0 111.392 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.513 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -78.8 110.64 14.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 110.737 -179.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 40.6 t -89.88 106.78 17.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.74 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.76 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -68.42 146.98 52.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.92 177.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.98 -156.98 8.51 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.039 -1.076 . . . . 0.0 113.454 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.82 117.44 24.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.739 0.78 . . . . 0.0 109.607 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.34 -4.24 23.5 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -165.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.479 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 6.6 m120 -122.25 164.49 17.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.651 -0.774 . . . . 0.0 108.987 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.537 ' O ' HG12 ' A' ' 40' ' ' VAL . 26.4 ttpp -149.98 118.25 6.41 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.7 t -89.51 130.48 35.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.039 0.447 . . . . 0.0 110.624 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -123.65 112.95 35.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.132 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 5.8 mp -80.33 79.5 6.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.474 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.14 -109.72 1.55 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.724 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.26 168.5 27.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.88 -142.26 18.3 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.378 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.96 -2.0 58.34 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 167.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 m -98.17 25.47 6.13 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.731 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.608 ' HG3' ' OD1' ' A' ' 37' ' ' ASN . 9.6 pttm -58.58 -26.88 64.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.008 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.637 ' ND2' ' HA ' ' A' ' 17' ' ' GLU . 18.3 p-10 -153.41 82.28 1.18 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 11.9 tp60 -94.57 135.67 35.76 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.871 -169.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.76 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 54.6 m -89.62 89.85 7.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.112 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.8 p -88.79 153.2 3.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 p -89.78 119.73 30.43 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.175 0.512 . . . . 0.0 110.57 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.86 -130.99 1.51 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.63 110.76 7.32 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.118 0.485 . . . . 0.0 110.132 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.485 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -99.14 -145.06 17.81 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.225 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.37 136.14 11.32 Favored Pre-proline 0 C--N 1.317 -0.812 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.79 135.88 42.66 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.442 2.095 . . . . 0.0 111.038 171.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.698 ' HG3' HE21 ' A' ' 11' ' ' GLN . 24.5 tttm -86.61 120.9 72.2 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.67 135.47 27.63 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.018 2.479 . . . . 0.0 112.505 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -133.38 -33.87 1.09 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.25 -171.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -88.9 -64.17 1.18 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.928 176.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 55.2 m80 . . . . . 0 CA--C 1.508 -0.638 0 CA-C-O 121.396 0.617 . . . . 0.0 110.219 -177.56 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.969 0.414 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.6 t -113.2 110.33 31.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.399 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -115.15 168.51 9.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.293 0.568 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 p -127.36 -172.8 2.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.815 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.784 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 3.4 m-20 -89.04 149.0 23.43 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.786 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 61.2 m -58.57 144.35 43.12 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.234 0.54 . . . . 0.0 112.082 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.606 ' OG1' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -114.26 -23.87 9.22 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.676 176.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.668 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 43.1 mt-10 -136.15 153.69 51.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.304 -170.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.8 m -88.46 120.86 30.23 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.7 -11.56 13.77 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -172.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.668 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -88.01 164.34 15.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.2 p30 -134.93 -58.0 0.81 Allowed 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.2 mt -58.16 61.81 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.383 1.073 . . . . 0.0 113.42 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.786 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.6 166.3 33.8 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.233 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.78 94.16 6.36 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.563 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . 49.3 t -73.79 -74.49 0.18 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.356 -172.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -91.92 150.16 21.18 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 27.15 -91.5 0.01 OUTLIER Glycine 0 N--CA 1.472 1.07 0 O-C-N 124.548 1.155 . . . . 0.0 114.535 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.01 32.73 4.0 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.413 0.625 . . . . 0.0 110.948 173.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.538 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -82.06 112.91 19.55 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.694 177.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.8 t -88.37 91.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -69.14 146.64 52.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.39 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.29 -152.51 6.32 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.07 137.02 32.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.489 0.644 . . . . 0.0 109.357 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.17 -9.93 46.78 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -167.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -126.93 158.63 36.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.861 -0.669 . . . . 0.0 109.892 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 18.3 ttpp -139.55 121.21 15.29 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 74.1 m -89.76 143.38 26.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.724 0.297 . . . . 0.0 111.13 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.8 pt -135.36 131.12 51.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.289 0.566 . . . . 0.0 110.768 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.7 mp -91.3 117.81 29.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.372 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.64 -115.99 2.31 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.768 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -141.67 160.56 39.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.639 0.257 . . . . 0.0 111.334 -174.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.11 -124.56 11.4 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.023 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -93.06 -10.13 37.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 t -90.73 30.65 1.14 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.638 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -64.86 -21.2 66.75 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.899 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.438 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -153.56 96.55 2.03 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.787 ' HA ' HE21 ' A' ' 38' ' ' GLN . 0.0 OUTLIER -119.63 148.3 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.218 -173.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 91.8 m -101.21 114.89 29.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.046 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 27' ' ' LYS . 1.2 p -104.16 157.22 5.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.9 p -91.36 123.78 35.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.077 0.465 . . . . 0.0 111.162 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.8 -120.23 0.75 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.502 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 13.6 pt-20 -151.95 123.38 7.79 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.493 -0.416 . . . . 0.0 110.452 174.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.539 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -107.72 -151.96 17.07 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.937 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.07 144.01 51.36 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.72 135.43 67.17 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.216 1.944 . . . . 0.0 110.819 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.784 ' HE3' ' O ' ' A' ' 5' ' ' ASP . 14.6 tttm -88.41 138.56 30.19 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.755 -174.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.94 139.32 25.7 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.551 2.168 . . . . 0.0 111.222 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -132.9 -17.29 2.46 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.951 -165.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -87.04 148.41 25.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.4 m170 . . . . . 0 CA--C 1.511 -0.544 0 CA-C-O 121.376 0.608 . . . . 0.0 111.98 -168.664 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 65.6 t . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.837 0.351 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.95 110.42 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.418 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -91.02 -177.15 4.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.173 0.511 . . . . 0.0 110.816 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.628 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 82.7 p -125.4 -167.89 1.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.45 172.22 9.96 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.701 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 31.3 m -73.37 136.37 44.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.023 0.44 . . . . 0.0 111.248 -177.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 m -102.31 -21.93 14.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -139.5 156.22 47.06 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.115 0.484 . . . . 0.0 110.701 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.9 m -90.16 107.75 19.32 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.025 -0.988 . . . . 0.0 108.53 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 124.79 -0.53 8.49 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -169.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -88.15 -171.1 3.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.6 p30 -159.04 -55.2 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.604 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 74.1 mt -60.8 61.34 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.805 0.842 . . . . 0.0 112.905 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.701 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -154.03 166.91 31.53 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.14 178.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.5 OUTLIER -79.01 91.58 4.87 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.72 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 33.1 t -92.65 -65.04 1.03 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.188 0.518 . . . . 0.0 111.245 -174.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -83.69 103.79 13.28 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.793 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.36 -95.29 0.01 OUTLIER Glycine 0 C--N 1.294 -1.753 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.796 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.3 p -121.33 11.99 10.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.743 0.306 . . . . 0.0 111.236 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.463 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.9 OUTLIER -73.11 126.07 29.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.07 0.462 . . . . 0.0 110.635 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 t -89.83 102.55 13.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.089 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 1.3 m -85.3 162.83 18.94 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.915 0.388 . . . . 0.0 111.37 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -148.76 -140.04 3.24 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.726 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -84.8 134.73 34.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.292 0.567 . . . . 0.0 109.56 -173.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.89 -16.46 28.11 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -169.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -119.61 158.38 26.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.061 0.458 . . . . 0.0 110.786 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.601 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 4.4 tppp? -130.51 107.71 9.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.049 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.559 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 85.8 m -89.31 126.81 35.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.538 0.208 . . . . 0.0 110.77 -177.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -128.82 127.94 66.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.196 0.522 . . . . 0.0 111.163 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.56 ' HG ' ' OD1' ' A' ' 37' ' ' ASN . 5.5 mp -87.02 81.11 8.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.495 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.02 -113.0 1.71 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.158 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -164.55 176.58 8.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.84 -116.32 7.23 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.345 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -96.5 -22.78 16.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.571 0.701 . . . . 0.0 109.132 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -91.64 37.29 0.96 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.979 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.612 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -64.92 -32.25 73.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.902 -175.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.612 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 10.7 t30 -155.1 75.28 0.95 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -115.63 146.67 41.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -165.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 69.8 m -94.26 100.55 12.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.401 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.489 HG11 ' O ' ' A' ' 27' ' ' LYS . 4.1 p -90.84 158.48 2.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.3 p -89.13 125.69 35.15 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.623 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.97 -123.37 0.87 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.955 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -152.3 109.01 3.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.174 0.511 . . . . 0.0 110.294 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.601 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -90.2 -147.61 18.1 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.287 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.528 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -133.8 142.03 42.13 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.7 134.19 61.35 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.129 1.886 . . . . 0.0 110.851 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HG3' HE21 ' A' ' 11' ' ' GLN . 1.6 ttpm? -88.34 113.84 57.0 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 -171.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.24 151.08 18.05 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.115 2.544 . . . . 0.0 111.521 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -124.25 -42.98 2.09 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -168.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.9 m -102.98 -92.57 0.33 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.095 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.6 m80 . . . . . 0 CA--C 1.513 -0.446 0 CA-C-O 121.03 0.443 . . . . 0.0 110.804 -171.28 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.847 0.356 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 t -112.62 79.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.103 0.478 . . . . 0.0 110.739 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -95.0 154.93 16.94 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 4.7 p -134.91 -159.88 1.0 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.23 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.421 ' H ' ' HB ' ' A' ' 4' ' ' THR . 7.7 m-20 -87.51 155.95 19.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.719 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.1 m -63.81 137.14 57.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.986 0.422 . . . . 0.0 111.621 -176.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m -107.5 -31.4 8.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.047 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.82 157.01 46.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.609 -175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 m -88.39 122.1 31.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.476 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.94 -6.5 21.97 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.8 164.97 14.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.9 p30 -136.77 -57.12 0.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.8 mt -59.55 61.39 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.111 0.965 . . . . 0.0 112.984 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.719 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.77 167.29 30.7 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.394 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -81.62 105.24 12.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 34.2 t -94.57 -70.85 0.69 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.654 -172.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 20.4 tt0 -86.84 79.38 8.82 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.106 0.955 . . . . 0.0 109.68 -175.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 -91.88 0.28 Allowed Glycine 0 C--N 1.294 -1.781 0 CA-C-N 113.551 -1.659 . . . . 0.0 111.612 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 p -109.25 -3.45 17.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.658 0.266 . . . . 0.0 110.929 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 18.8 m-80 -64.84 114.79 4.73 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.184 0.516 . . . . 0.0 111.124 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.01 104.36 14.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.918 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.91 151.32 37.37 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.959 0.409 . . . . 0.0 110.233 179.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -140.14 -153.5 6.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.97 144.75 27.45 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.13 -3.42 80.28 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -165.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -135.0 156.3 49.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' O ' HG11 ' A' ' 40' ' ' VAL . 28.6 ttpp -142.12 123.15 14.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.969 0.414 . . . . 0.0 109.981 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 14.4 t -90.04 139.48 30.57 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.911 0.386 . . . . 0.0 110.688 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.9 pt -132.38 124.04 51.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.761 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.0 mp -81.3 98.29 8.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.055 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 36' ' ' LYS . . . 99.54 114.85 3.62 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.584 -0.735 . . . . 0.0 113.463 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.526 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -169.26 114.46 0.56 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.62 -115.73 8.19 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.829 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -98.43 48.75 0.99 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.05 0.452 . . . . 0.0 109.902 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.535 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 8.0 t -148.4 156.04 41.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.354 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -129.58 -8.78 4.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.826 174.301 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.482 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -154.7 81.71 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' HG2' ' HD2' ' A' ' 32' ' ' ARG . 27.7 tp60 -113.48 141.51 47.03 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -167.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 93.9 m -96.67 109.14 21.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.773 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 27' ' ' LYS . 2.7 p -103.6 162.96 3.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 p -90.18 129.23 36.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.487 0.661 . . . . 0.0 111.198 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.51 -144.43 8.96 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.91 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -128.31 105.61 8.46 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.974 0.416 . . . . 0.0 110.267 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.81 -151.99 22.88 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.202 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.21 142.5 35.61 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.17 142.69 77.49 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.381 2.054 . . . . 0.0 111.428 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -87.29 119.22 70.78 Favored Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.0 148.06 1.15 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.476 3.451 . . . . 0.0 114.019 -174.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.12 -24.69 3.39 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.429 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 92.1 p -88.32 -35.09 17.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.112 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 . . . . . 0 CA--C 1.501 -0.909 0 CA-C-O 121.899 0.856 . . . . 0.0 110.194 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.5 t -88.47 83.72 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -165.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -90.05 150.21 22.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 164.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.555 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -150.8 -173.18 4.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.76 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.24 150.51 24.32 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 13.3 m -62.15 128.84 38.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.024 0.44 . . . . 0.0 110.479 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -95.71 -17.17 21.47 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.868 -177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.669 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 36.1 mt-10 -138.37 151.69 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.786 -170.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.1 m -87.67 124.21 33.31 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 115.35 -6.58 21.06 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.876 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.669 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.84 162.48 15.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.1 p30 -132.74 -59.24 0.91 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 73.8 mt -60.29 61.47 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -174.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -155.41 172.75 17.7 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.985 177.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -85.87 80.55 8.87 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.756 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 17.5 t -60.66 -70.72 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.205 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -95.78 137.84 34.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 30.43 -96.7 0.01 OUTLIER Glycine 0 N--CA 1.467 0.708 0 O-C-N 124.733 1.271 . . . . 0.0 114.712 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 p -120.08 17.0 12.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.275 0.56 . . . . 0.0 111.46 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.583 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -85.38 103.82 14.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.554 -178.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -87.93 102.9 13.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -74.26 153.3 39.47 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.735 -176.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.31 -134.88 3.26 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.127 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.65 126.88 35.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.053 0.454 . . . . 0.0 110.259 -171.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.26 -13.2 31.08 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -119.85 161.33 21.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.242 -0.479 . . . . 0.0 109.924 176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.51 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.8 ttpp -146.25 123.08 11.27 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.84 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.756 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.2 t -89.04 141.92 28.08 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.718 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.5 pt -133.42 128.75 55.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.31 0.576 . . . . 0.0 109.998 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.21 120.6 40.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.45 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 35' ' ' SER . . . 74.46 96.26 0.11 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.323 -0.853 . . . . 0.0 114.099 172.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' A' ' 32' ' ' ARG . 2.5 tpt180 -159.98 94.66 1.13 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.04 -110.26 3.0 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -94.67 1.96 55.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.068 0.461 . . . . 0.0 109.984 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.444 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 9.3 t -90.03 146.15 24.56 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.992 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.642 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -135.37 -32.5 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.019 175.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.642 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -155.64 77.7 0.98 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -115.71 146.78 41.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.953 0.406 . . . . 0.0 111.79 -171.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 90.3 m -99.48 106.18 18.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.516 175.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.2 p -95.99 158.99 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.1 p -88.98 126.84 35.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.8 0.333 . . . . 0.0 111.112 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.68 -119.12 0.73 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.006 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 9.2 pt-20 -147.02 117.0 7.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.91 -149.12 21.14 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.537 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.7 144.9 19.87 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.369 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.577 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 53.0 Cg_exo -55.6 144.55 74.25 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.362 2.041 . . . . 0.0 110.436 173.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 1.8 ttpm? -87.99 107.7 17.35 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 7.6 Cg_exo -73.09 152.0 50.47 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.692 2.261 . . . . 0.0 111.607 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.25 -66.23 0.2 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 t -145.15 -172.77 3.93 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.4 m170 . . . . . 0 CA--C 1.505 -0.756 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 175.231 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.8 t -114.75 124.16 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.23 162.75 26.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.148 0.499 . . . . 0.0 110.464 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -147.96 -177.51 5.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.632 176.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.449 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 4.8 m-20 -86.93 148.05 25.51 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 21.9 m -60.8 133.58 56.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.502 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -109.91 -29.62 8.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.877 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 159.43 30.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.347 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -87.52 117.2 26.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.569 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.98 -6.82 9.42 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.214 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.557 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.42 160.44 16.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.639 0.257 . . . . 0.0 110.426 177.29 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.4 p30 -133.79 -57.28 0.88 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 78.9 mt -61.47 60.58 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.003 0.921 . . . . 0.0 112.886 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -155.05 162.33 41.08 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.448 179.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.68 85.36 5.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.1 0.476 . . . . 0.0 109.953 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.793 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 26.1 t -66.28 -73.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.429 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.08 144.12 26.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.116 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 22.76 -90.53 0.01 OUTLIER Glycine 0 N--CA 1.47 0.918 0 O-C-N 125.028 1.455 . . . . 0.0 114.699 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 p -121.6 -1.7 9.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.794 0.331 . . . . 0.0 111.197 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -70.29 104.06 2.56 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.629 0.728 . . . . 0.0 110.997 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 21.3 t -88.84 101.05 11.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.922 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -65.82 156.92 31.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.972 -175.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -134.71 -152.92 6.7 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -85.96 139.15 31.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.28 -15.63 50.28 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -120.48 166.22 13.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.4 ttpp -149.99 117.4 6.09 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.793 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.5 t -88.92 136.31 33.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.887 0.375 . . . . 0.0 110.266 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.2 pt -127.01 128.35 70.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.299 0.571 . . . . 0.0 110.243 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 5.8 mp -107.71 104.36 13.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.871 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 35' ' ' SER . . . 85.74 77.5 1.2 Allowed Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.76 176.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -136.69 66.97 1.46 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.11 -100.38 2.32 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.763 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.57 12.47 22.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.338 0.59 . . . . 0.0 109.707 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.448 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 3.1 t -113.25 144.62 42.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.777 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -132.71 -38.21 1.02 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.784 0.326 . . . . 0.0 110.253 174.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -155.12 97.35 1.91 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.01 138.89 28.69 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.135 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 91.8 m -89.41 96.03 10.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.916 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.6 p -90.23 160.13 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 p -88.88 132.0 34.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.285 0.564 . . . . 0.0 111.368 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.91 -128.6 1.68 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.876 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -143.14 112.85 6.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.344 0.593 . . . . 0.0 110.28 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -93.53 -148.09 23.03 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.419 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.93 142.71 22.81 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.83 139.4 78.19 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.198 1.932 . . . . 0.0 110.676 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.557 ' HG3' HE21 ' A' ' 11' ' ' GLN . 16.5 tttm -86.46 123.97 70.42 Favored Pre-proline 0 N--CA 1.432 -1.352 0 CA-C-O 120.99 0.424 . . . . 0.0 110.493 -173.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.49 142.53 98.1 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.791 2.327 . . . . 0.0 112.27 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.767 ' HG3' ' H ' ' A' ' 50' ' ' SER . 4.7 pt20 -160.94 -69.86 0.06 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.07 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.767 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 4.9 t -112.6 63.19 0.63 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.804 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 . . . . . 0 CA--C 1.503 -0.845 0 CA-C-O 121.33 0.586 . . . . 0.0 110.366 178.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 81.9 t . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.2 t -125.1 84.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 110.391 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -88.76 156.5 18.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.47 0.652 . . . . 0.0 109.886 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.604 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -151.32 -157.54 0.82 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.953 -177.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.407 ' H ' ' HB ' ' A' ' 4' ' ' THR . 0.3 OUTLIER -85.77 147.76 26.17 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 10.2 m -59.35 129.87 44.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.117 0.484 . . . . 0.0 110.796 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 m -103.08 -27.08 12.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.601 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.36 159.36 36.42 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.403 -176.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 46.5 m -87.05 118.66 26.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.292 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.88 -4.72 11.54 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.12 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.06 161.82 16.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.706 0.288 . . . . 0.0 110.402 175.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' CYS . 6.1 p30 -135.66 -56.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.126 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.611 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 88.9 mt -62.15 63.13 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.375 1.047 . . . . 0.0 112.161 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -153.94 162.6 41.09 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.332 177.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.73 81.46 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.804 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 43.2 t -67.87 -79.87 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.385 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 11.1 tp10 -72.86 157.59 37.17 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -3.38 -78.3 0.01 OUTLIER Glycine 0 N--CA 1.472 1.094 0 O-C-N 125.284 1.615 . . . . 0.0 115.446 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.0 p -126.64 15.03 7.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.009 0.433 . . . . 0.0 111.125 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.555 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -83.85 111.2 18.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.755 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.9 t -87.92 103.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -74.94 163.82 27.22 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.081 -176.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.77 -138.34 2.83 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.849 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -85.91 125.8 33.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.195 0.521 . . . . 0.0 109.917 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -19.54 11.38 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -172.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -124.33 161.38 26.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' HG13 ' A' ' 40' ' ' VAL . 25.6 ttpp -141.9 117.92 10.61 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.804 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 32.8 t -91.05 135.27 33.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.095 0.474 . . . . 0.0 110.572 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 23.3 pt -132.38 144.81 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.137 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.652 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.1 mp -97.15 98.06 9.72 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.327 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.8 -120.19 4.42 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.456 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -149.13 174.07 12.74 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.14 -132.45 42.66 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.299 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -89.34 -2.25 58.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.182 0.515 . . . . 0.0 109.696 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -104.88 47.44 0.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.799 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.77 -16.94 49.4 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.504 -177.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.553 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 26.2 t-20 -155.14 94.56 1.64 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -134.14 137.81 44.77 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.359 -172.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 92.8 m -89.7 96.02 10.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.152 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 27' ' ' LYS . 3.1 p -89.8 166.12 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.9 p -88.52 127.4 35.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.263 0.554 . . . . 0.0 111.178 -176.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.5 -135.54 3.57 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.985 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -141.36 110.3 6.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -92.68 -149.74 25.23 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.261 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.31 144.87 29.93 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 51.3 Cg_exo -55.3 140.35 81.74 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.387 2.058 . . . . 0.0 111.408 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 11.3 tttm -87.65 138.57 31.56 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.164 -176.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.437 ' HD2' ' HG2' ' A' ' 47' ' ' LYS . 83.7 Cg_exo -49.15 142.2 21.59 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.304 2.669 . . . . 0.0 113.419 177.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -148.59 -10.77 0.35 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.557 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.3 m -151.51 35.17 0.56 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.486 -172.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.2 m170 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.271 0.557 . . . . 0.0 110.734 177.543 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.917 0.389 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.67 97.21 6.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.084 0.468 . . . . 0.0 110.014 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -89.68 160.5 16.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.033 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.6 -178.02 5.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.252 -174.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.1 155.55 20.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.744 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 3.8 m -61.18 134.26 56.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.366 0.603 . . . . 0.0 111.592 -173.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 m -100.13 -18.17 17.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.711 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -145.46 157.85 43.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.591 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 m -89.37 120.22 30.52 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.489 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.07 -2.9 14.43 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.532 -170.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.16 172.39 9.11 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.9 p30 -143.52 -55.81 0.39 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 74.6 mt -61.61 66.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.925 0.869 . . . . 0.0 112.478 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.744 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -153.83 168.93 24.68 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.112 -1.403 . . . . 0.0 109.592 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.71 84.41 4.05 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 92.5 m -72.77 -80.21 0.07 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.473 -175.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -88.0 121.01 29.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.358 -173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.47 -90.31 0.01 OUTLIER Glycine 0 C--N 1.304 -1.235 0 O-C-N 123.985 0.803 . . . . 0.0 111.436 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.84 10.54 4.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.7 0.286 . . . . 0.0 111.561 173.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -71.17 126.11 28.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.164 0.506 . . . . 0.0 110.718 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 3.7 t -88.61 93.85 4.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.882 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.756 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -65.97 154.82 38.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 -176.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.01 -156.23 8.66 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -87.39 132.74 33.87 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.55 -22.26 8.86 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -168.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -117.6 159.95 22.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.09 171.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.549 ' O ' HG11 ' A' ' 40' ' ' VAL . 19.2 ttpp -133.62 113.97 12.99 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.303 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 51.7 t -90.22 130.51 36.34 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.6 pt -123.76 127.24 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.459 0.647 . . . . 0.0 111.023 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 20.4 mt -84.08 109.91 18.06 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.023 176.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.41 -112.51 3.56 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.129 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -167.26 163.85 15.38 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.25 -119.24 8.52 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.14 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.91 -5.26 53.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.167 0.508 . . . . 0.0 109.719 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 t -114.2 34.99 4.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.643 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.62 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -63.91 -21.08 66.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.896 -178.459 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.62 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 21.5 t-20 -153.46 131.02 11.43 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.35 124.73 9.54 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.468 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.756 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 81.0 m -89.57 95.7 10.38 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.696 176.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.549 HG11 ' O ' ' A' ' 27' ' ' LYS . 5.0 p -89.03 160.33 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.0 p -89.24 126.06 35.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.227 0.537 . . . . 0.0 111.422 -175.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.9 -122.36 0.9 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 11.8 pt-20 -150.23 123.59 8.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.177 0.513 . . . . 0.0 110.417 173.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -107.52 -145.81 12.3 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.381 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.22 142.62 21.98 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.462 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 51.1 Cg_exo -57.41 144.09 92.49 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.581 2.187 . . . . 0.0 111.243 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HD3' ' HB3' ' A' ' 14' ' ' CYS . 2.1 ttpm? -89.08 108.56 24.79 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.534 0.207 . . . . 0.0 111.445 -172.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 6.2 Cg_exo -72.22 169.68 20.96 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.04 2.493 . . . . 0.0 111.932 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -156.97 -33.02 0.08 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.987 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 t -104.42 138.63 40.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.813 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.408 . . . . 0.0 110.071 -179.17 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 121.017 0.437 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -107.56 90.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.125 0.488 . . . . 0.0 110.831 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -98.65 162.52 13.09 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p -133.57 176.2 8.75 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -87.89 152.29 22.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 11.5 m -60.0 133.24 55.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.558 -178.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -113.44 -15.28 12.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.517 0.675 . . . . 0.0 110.273 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.704 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 46.1 mt-10 -134.2 151.64 51.42 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.217 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -88.11 124.36 33.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.06 -4.21 27.09 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.328 -173.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.704 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.27 162.11 16.04 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.7 p30 -136.04 -56.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 73.6 mt -61.83 62.18 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.96 0.788 . . . . 0.0 112.918 -177.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -155.48 175.25 14.12 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.596 178.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.2 106.57 14.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.74 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 40.2 t -98.73 -65.9 0.93 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.434 0.635 . . . . 0.0 110.966 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.13 107.07 18.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.879 -175.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.73 -90.04 0.01 OUTLIER Glycine 0 C--N 1.299 -1.521 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.007 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 p -124.49 2.08 8.34 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.0 0.429 . . . . 0.0 111.424 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.486 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -70.25 125.14 25.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.782 -175.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.06 105.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.348 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -72.91 155.47 39.84 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.24 -143.22 4.38 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.636 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -86.21 139.12 31.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.486 0.66 . . . . 0.0 110.266 -176.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.71 -9.94 58.82 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.718 -172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -125.73 160.77 28.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.033 174.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' HG11 ' A' ' 40' ' ' VAL . 28.7 ttpp -143.74 119.55 10.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.536 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.74 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 17.5 t -89.16 133.18 34.5 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.847 0.356 . . . . 0.0 110.304 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 pt -128.29 123.01 59.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.379 0.609 . . . . 0.0 110.883 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.7 mp -79.4 97.84 6.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.474 176.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.44 -120.21 3.26 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.028 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 16.0 mmt180 -147.77 160.11 43.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.59 -115.64 7.53 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.059 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -89.6 -21.98 22.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.546 0.689 . . . . 0.0 109.639 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 t -93.62 31.86 1.5 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.253 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.63 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -65.05 -28.04 69.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.559 -175.209 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.63 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 2.7 t30 -154.93 89.8 1.25 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -128.09 145.05 51.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -170.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 72.8 m -89.12 110.51 21.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.859 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.494 HG11 ' O ' ' A' ' 27' ' ' LYS . 2.7 p -103.29 159.95 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 p -88.98 128.33 35.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.228 0.537 . . . . 0.0 111.122 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.6 -133.93 2.73 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.245 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -139.51 111.1 7.15 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.155 0.502 . . . . 0.0 109.938 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.75 -152.98 28.77 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.433 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.28 139.03 30.38 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.5 135.15 68.01 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.351 2.034 . . . . 0.0 110.907 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.611 ' HG3' HE21 ' A' ' 11' ' ' GLN . 18.7 tttt -87.79 113.68 55.64 Favored Pre-proline 0 N--CA 1.443 -0.801 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.13 145.77 74.18 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.721 2.28 . . . . 0.0 112.571 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -142.95 -42.23 0.31 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.159 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -88.12 174.71 8.09 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.796 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.5 m80 . . . . . 0 CA--C 1.507 -0.699 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.31 -178.837 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.137 0.494 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.91 120.37 63.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -115.01 178.88 4.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.448 ' HB ' ' H ' ' A' ' 5' ' ' ASP . 1.5 p -137.59 -161.44 1.17 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.693 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' H ' ' HB ' ' A' ' 4' ' ' THR . 8.0 m-20 -85.24 142.61 29.28 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -174.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 35.0 m -50.28 133.15 24.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.503 0.668 . . . . 0.0 111.128 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -115.07 -10.25 12.24 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.595 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.623 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 41.8 mt-10 -143.94 151.04 39.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.631 -173.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 m -89.01 126.95 35.64 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.455 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.3 -1.03 34.98 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.762 ' HG2' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.19 164.85 14.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 8.8 p30 -139.74 -57.05 0.57 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 75.4 mt -62.1 59.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.979 0.895 . . . . 0.0 112.415 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.791 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 1.6 p -155.39 150.6 26.9 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.126 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.65 89.85 2.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.629 0.728 . . . . 0.0 109.949 177.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 34.1 t -62.66 -73.51 0.11 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.358 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 1.2 tm-20 -87.53 163.31 16.73 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -23.04 -72.53 0.01 OUTLIER Glycine 0 N--CA 1.472 1.058 0 O-C-N 124.26 0.975 . . . . 0.0 115.366 -169.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.9 p -115.72 14.72 16.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.238 0.542 . . . . 0.0 110.46 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.536 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -80.81 92.19 6.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.889 177.179 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 41.9 t -87.91 97.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.704 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.47 158.81 32.09 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.8 -173.301 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -141.42 -146.26 4.69 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -87.0 134.72 33.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.196 0.522 . . . . 0.0 109.641 -174.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.01 -13.91 37.51 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -170.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -123.89 165.84 16.68 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.8 ttpp -148.89 118.46 6.97 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 13.7 t -89.41 132.46 34.98 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.8 pt -128.36 120.39 52.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.303 0.573 . . . . 0.0 110.707 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.2 mp -87.87 101.18 13.48 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.581 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -104.27 -118.22 4.45 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.862 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -151.38 159.68 44.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.686 0.279 . . . . 0.0 110.673 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.62 -122.21 8.36 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.301 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.04 -3.47 58.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.121 0.486 . . . . 0.0 109.856 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 t -120.38 55.95 1.0 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.988 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -100.53 -18.48 16.62 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.489 -178.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.453 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 27.5 t-20 -154.46 94.31 1.68 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -145.97 143.37 29.45 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.438 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.704 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 99.5 m -91.18 99.49 12.48 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.861 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 27' ' ' LYS . 5.3 p -89.69 160.77 2.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.2 p -87.62 129.99 34.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.25 0.547 . . . . 0.0 111.124 -176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.34 -135.12 3.51 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.669 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.86 108.98 7.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.034 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.57 -148.72 24.59 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.327 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -144.09 144.8 27.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 122.469 0.308 . . . . 0.0 110.299 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 33.2 Cg_exo -60.01 154.89 47.83 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.718 2.279 . . . . 0.0 111.65 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.791 ' HG3' ' HB3' ' A' ' 14' ' ' CYS . 2.0 mtmt -87.55 132.58 40.33 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-O 121.052 0.453 . . . . 0.0 110.725 -178.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 6.2 Cg_exo -71.25 146.12 50.36 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.791 2.327 . . . . 0.0 112.196 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -133.35 -36.41 0.99 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.999 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.5 m -89.17 111.29 22.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.455 173.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.2 m80 . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.489 -178.554 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.651 0.263 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.1 t -123.48 116.91 49.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.434 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -140.08 154.72 47.14 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.477 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 13.6 p -144.36 -176.11 4.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.358 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.0 141.85 28.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 9.1 m -59.12 137.65 57.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.473 0.178 . . . . 0.0 111.145 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -118.75 -25.48 6.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.917 0.389 . . . . 0.0 111.204 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.48 156.32 35.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.993 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 m -89.07 114.47 25.71 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.358 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.65 -0.67 9.36 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.333 -173.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.591 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.28 171.93 9.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.4 p30 -145.45 -56.73 0.32 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 65.8 mt -62.67 58.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.148 0.905 . . . . 0.0 112.492 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.05 159.33 41.51 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.957 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -73.05 102.78 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.037 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 29.6 t -89.44 -70.48 0.66 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.71 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 9.3 tp10 -79.56 158.99 27.02 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -6.93 -78.02 0.01 OUTLIER Glycine 0 N--CA 1.473 1.162 0 O-C-N 124.984 1.428 . . . . 0.0 115.241 -176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.9 p -122.5 14.43 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.843 0.354 . . . . 0.0 111.264 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.555 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -83.97 108.05 16.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.624 -178.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 9.2 t -92.06 104.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 1.2 m -82.32 168.85 17.15 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.187 -174.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -145.34 -149.27 4.98 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.56 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -86.79 134.28 33.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.441 0.639 . . . . 0.0 109.997 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.445 ' C ' HD21 ' A' ' 26' ' ' ASN . . . 112.5 -17.17 23.74 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -165.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.445 HD21 ' C ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -118.82 163.13 17.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.903 -0.649 . . . . 0.0 109.498 172.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 24.9 ttpp -144.61 117.96 9.04 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 173.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 33.7 t -89.17 132.31 34.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.733 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 pt -129.64 127.0 63.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.274 0.559 . . . . 0.0 110.879 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.464 ' HG ' ' OD1' ' A' ' 37' ' ' ASN . 6.1 mp -89.91 122.22 32.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.32 -119.41 1.54 Allowed Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -147.55 171.78 15.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.61 -116.2 8.94 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.782 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -89.17 -15.45 33.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.527 0.679 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t -104.44 29.42 6.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.952 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 2.9 pttp -52.54 -59.52 4.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.657 -176.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.464 ' OD1' ' HG ' ' A' ' 30' ' ' LEU . 3.3 t30 -153.82 77.15 1.09 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -178.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.518 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 1.6 tp60 -117.87 150.18 39.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -163.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 70.8 m -95.43 100.38 12.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.721 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.1 p -91.58 162.17 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -89.14 127.33 35.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.554 0.693 . . . . 0.0 111.779 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.47 -134.02 2.86 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.534 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -143.83 111.19 5.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.448 0.624 . . . . 0.0 110.495 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.489 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -89.22 -138.29 6.64 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.311 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.9 148.0 31.39 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 122.671 0.388 . . . . 0.0 110.341 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 134.87 60.76 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.602 2.201 . . . . 0.0 111.186 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.591 ' HG3' HE21 ' A' ' 11' ' ' GLN . 13.7 tttt -89.97 132.66 35.61 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 -175.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.99 142.02 86.25 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.78 2.32 . . . . 0.0 112.035 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 7.7 pt20 -176.33 -18.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.332 0.587 . . . . 0.0 111.397 -169.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.9 m -88.59 66.91 8.34 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.722 0.773 . . . . 0.0 110.066 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 . . . . . 0 CA--C 1.509 -0.609 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.049 -178.42 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.96 0.41 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 51.2 t -107.71 119.66 57.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.576 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -112.26 174.83 5.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.202 0.525 . . . . 0.0 110.545 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.2 p -133.82 -163.32 1.35 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.416 ' H ' ' HB ' ' A' ' 4' ' ' THR . 10.2 m-20 -87.66 153.83 21.07 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.111 -176.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 17.0 m -65.64 135.87 55.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.574 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 m -103.93 -23.03 13.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.071 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.98 162.77 34.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.241 0.544 . . . . 0.0 110.942 -173.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.0 m -87.12 122.0 30.35 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.151 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.86 -5.92 18.15 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.901 -173.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 1.004 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.86 161.04 15.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 175.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' CYS . 6.8 p30 -136.05 -55.93 0.76 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.07 55.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.247 0.967 . . . . 0.0 112.893 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 p -155.36 160.48 40.74 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.845 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -77.6 97.24 5.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.364 0.602 . . . . 0.0 109.393 177.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.768 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 13.0 t -72.65 -77.31 0.1 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.703 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -86.85 162.11 17.95 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 3.29 -87.99 0.0 OUTLIER Glycine 0 N--CA 1.474 1.174 0 O-C-N 124.964 1.415 . . . . 0.0 114.969 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.1 p -123.07 22.05 9.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.463 0.649 . . . . 0.0 110.237 172.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -78.57 99.04 6.35 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.209 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 31.0 t -88.32 99.94 9.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.014 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.732 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -73.07 155.98 39.21 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.651 -176.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.67 -154.05 6.23 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.643 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -85.78 135.13 33.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.434 0.617 . . . . 0.0 109.52 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.25 -9.35 53.92 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -127.34 164.15 22.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.557 -0.822 . . . . 0.0 109.278 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' O ' HG11 ' A' ' 40' ' ' VAL . 27.3 ttpp -150.28 121.46 7.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.211 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.768 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.9 t -89.23 138.0 31.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.956 0.408 . . . . 0.0 110.232 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -128.08 124.47 62.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.436 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.712 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.6 mp -92.88 80.67 4.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.374 176.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.87 -109.05 2.41 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.752 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -155.93 160.81 40.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.394 -0.225 . . . . 0.0 110.394 -175.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.86 -121.58 7.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.869 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.11 -10.74 29.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.398 0.618 . . . . 0.0 109.434 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.4 t -99.57 22.85 10.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.145 0.974 . . . . 0.0 109.413 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 14.3 pttp -66.81 -27.01 67.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.662 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -153.3 91.09 1.47 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.426 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 56.4 tp60 -127.65 139.63 52.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.108 0.48 . . . . 0.0 111.694 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.732 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 59.7 m -90.83 92.89 8.99 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.868 171.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 27' ' ' LYS . 4.7 p -90.16 159.76 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.9 p -88.65 127.03 35.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.387 0.613 . . . . 0.0 110.685 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.67 -148.44 11.92 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.895 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -122.22 106.34 11.04 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.28 -144.14 12.47 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.091 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 1.004 HG22 ' HG3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -150.04 146.18 19.91 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.167 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.39 119.77 7.15 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.375 2.05 . . . . 0.0 111.841 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 8.4 tmtt? -84.5 117.04 67.78 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.52 154.02 67.42 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.278 2.652 . . . . 0.0 115.405 -168.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -113.25 -20.02 11.56 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.901 -1.954 . . . . 0.0 108.734 173.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 m -89.47 -65.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.675 175.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.074 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 121.203 0.525 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 67.5 t -89.39 115.64 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -89.67 174.58 7.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.545 0.688 . . . . 0.0 111.628 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -121.55 -176.52 3.33 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.138 -175.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.56 152.14 22.43 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.78 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 4.8 m -63.01 133.36 54.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.205 0.526 . . . . 0.0 111.225 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -105.45 -23.11 12.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.692 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.429 ' HB2' HE22 ' A' ' 11' ' ' GLN . 2.3 mm-40 -130.52 153.98 48.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.339 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.5 m -88.27 112.0 22.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.1 -0.13 7.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.004 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.557 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.64 171.84 9.72 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.6 p30 -142.41 -57.44 0.45 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 82.8 mt -62.87 61.62 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.815 0.846 . . . . 0.0 112.354 -178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.78 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -153.51 171.23 19.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.821 -179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mt -83.45 88.36 6.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 41.9 t -80.49 -61.53 1.95 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.875 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.99 113.7 25.34 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.976 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 46.33 -97.32 0.01 OUTLIER Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.754 -175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -115.1 0.99 13.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.489 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -70.3 123.05 20.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.978 0.418 . . . . 0.0 110.607 -175.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.26 97.39 6.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.486 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.825 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.6 OUTLIER -74.69 167.29 22.09 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.541 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.02 -124.76 0.72 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.802 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -86.26 124.46 32.67 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.174 0.511 . . . . 0.0 110.312 -169.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.44 -2.7 37.02 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.045 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -130.89 154.35 48.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.323 0.582 . . . . 0.0 110.867 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.592 ' O ' HG13 ' A' ' 40' ' ' VAL . 5.2 ttpp -129.57 111.63 12.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.174 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.493 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 61.7 m -91.56 124.33 35.64 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.162 0.506 . . . . 0.0 111.09 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.3 pt -128.0 139.3 52.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.819 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 8.6 mp -59.27 121.16 10.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.776 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -65.26 -45.48 90.94 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.527 -1.215 . . . . 0.0 113.313 -175.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 73.33 153.79 0.14 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.302 0.641 . . . . 0.0 111.058 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.36 -104.32 1.18 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.844 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -93.32 15.24 16.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.63 0.729 . . . . 0.0 109.573 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 t -143.7 171.9 13.56 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.674 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.595 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -139.66 -33.47 0.6 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.112 176.015 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.595 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 0.5 OUTLIER -154.83 140.99 18.49 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 176.239 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -141.4 140.67 33.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.854 0.359 . . . . 0.0 110.755 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.825 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 70.8 m -90.68 95.76 10.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.944 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 27' ' ' LYS . 3.5 p -90.23 159.67 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -88.83 130.51 35.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.216 0.531 . . . . 0.0 111.464 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.69 -132.29 2.53 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.705 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -137.41 112.69 9.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.009 0.433 . . . . 0.0 110.335 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -100.99 -146.89 19.87 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.205 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.453 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -147.11 148.43 32.16 Favored Pre-proline 0 C--N 1.324 -0.533 0 C-N-CA 122.18 0.192 . . . . 0.0 110.664 -178.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 45' ' ' THR . 51.1 Cg_exo -55.8 148.76 54.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.196 1.931 . . . . 0.0 110.785 173.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.557 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 9.5 tttm -89.31 113.06 54.94 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-O 120.691 0.281 . . . . 0.0 111.481 -171.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.34 163.47 20.4 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.599 2.2 . . . . 0.0 112.294 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -155.03 -44.01 0.08 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.991 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -86.93 -51.08 6.25 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.445 0.641 . . . . 0.0 109.699 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.4 m170 . . . . . 0 CA--C 1.508 -0.637 0 CA-C-O 121.35 0.595 . . . . 0.0 109.905 -179.312 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 121.001 0.429 . . . . 0.0 111.42 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.3 t -116.78 109.82 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.062 0.458 . . . . 0.0 110.822 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.441 ' CD1' HG13 ' A' ' 21' ' ' VAL . 97.2 m-85 -103.27 177.4 4.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.733 176.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 p -136.26 166.46 23.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.268 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.22 139.99 29.94 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.75 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 28.2 m -60.24 130.8 48.43 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 109.937 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -113.08 -28.58 7.62 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.208 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.49 153.02 38.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.844 -177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 58.9 m -88.44 114.56 25.19 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.392 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.14 -9.56 6.64 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.94 -173.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.631 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -86.61 168.31 13.75 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 6.1 p30 -140.15 -55.24 0.54 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.76 56.24 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.249 0.968 . . . . 0.0 112.854 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.75 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.33 160.78 41.9 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.444 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -71.77 108.14 4.93 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.645 0.736 . . . . 0.0 109.371 174.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.629 ' HA ' ' HG ' ' A' ' 6' ' ' CYS . 53.3 t -89.47 -71.34 0.61 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.168 -176.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 8.8 tp10 -82.42 161.18 22.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -8.55 -78.03 0.01 OUTLIER Glycine 0 N--CA 1.473 1.147 0 O-C-N 124.905 1.378 . . . . 0.0 115.483 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.3 p -121.16 15.23 11.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 0.0 111.232 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.58 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -87.06 103.81 15.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.6 -179.264 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 37.0 t -89.53 105.14 15.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.778 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -78.44 169.74 17.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.382 -177.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -153.39 -133.69 1.89 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.823 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -85.3 141.31 30.16 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.274 0.559 . . . . 0.0 110.536 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.12 -10.26 69.87 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.184 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -120.15 160.11 23.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.971 0.415 . . . . 0.0 110.497 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.565 ' O ' HG12 ' A' ' 40' ' ' VAL . 19.3 ttpp -142.45 108.54 5.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.295 176.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.502 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 67.7 m -89.46 135.09 33.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.137 -174.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 19.0 pt -131.72 138.08 53.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.375 0.607 . . . . 0.0 110.543 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.1 mp -95.38 101.85 13.61 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.549 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.97 -113.41 3.5 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.95 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' N ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -155.6 162.75 40.58 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.65 -139.5 17.27 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.098 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.55 -4.48 59.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 170.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.3 m -94.38 30.58 1.93 Allowed 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 113.139 -1.846 . . . . 0.0 110.158 175.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.633 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 1.3 pptp? -64.76 -31.32 72.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.863 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.633 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -154.98 95.73 1.77 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.145 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.79 139.83 45.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.037 0.446 . . . . 0.0 111.293 -172.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.778 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 77.7 m -90.43 101.09 13.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.767 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -96.08 158.98 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.0 p -88.31 128.63 35.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.774 0.321 . . . . 0.0 111.124 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.7 -121.28 0.88 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.673 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.539 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 6.9 pt-20 -149.79 125.95 10.68 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 173.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.52 -147.49 11.34 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.611 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.35 144.53 50.01 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.453 -0.374 . . . . 0.0 110.569 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.456 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 26.1 Cg_exo -62.65 141.68 86.69 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.009 1.806 . . . . 0.0 109.924 171.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.631 ' HG3' HE21 ' A' ' 11' ' ' GLN . 2.0 ttpm? -88.14 111.93 46.2 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.676 -172.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 18.2 Cg_exo -68.2 176.73 5.17 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.175 2.584 . . . . 0.0 111.641 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.3 -37.09 6.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.814 -174.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -103.82 -57.9 1.96 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.511 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.6 m80 . . . . . 0 CA--C 1.509 -0.603 0 CA-C-O 121.049 0.452 . . . . 0.0 110.451 177.272 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 121.288 0.565 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.6 t -89.34 147.1 5.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -87.84 155.51 19.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.27 0.557 . . . . 0.0 110.313 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 3.0 p -138.42 -176.56 4.5 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.542 -177.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.28 146.25 26.03 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 33.7 m -59.34 129.65 43.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.183 0.516 . . . . 0.0 110.185 175.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -102.36 -13.93 17.12 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.37 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.424 ' HB2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -150.17 163.76 37.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.209 0.528 . . . . 0.0 110.913 -174.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m -86.11 122.33 29.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.329 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.873 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 120.88 -7.89 10.83 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.531 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.587 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.8 169.06 11.94 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 122.868 -0.196 . . . . 0.0 110.575 178.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.47 -57.29 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.35 56.62 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.345 1.028 . . . . 0.0 113.095 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.765 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.77 161.91 41.32 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.833 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.03 89.02 2.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.375 173.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 36.4 t -57.2 -78.04 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.635 175.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 29.2 tt0 -87.56 161.92 17.48 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -16.0 -71.52 0.01 OUTLIER Glycine 0 N--CA 1.471 0.984 0 O-C-N 124.661 1.225 . . . . 0.0 115.665 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 p -116.66 5.96 13.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.063 0.458 . . . . 0.0 111.339 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.538 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -80.42 93.87 6.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.471 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 46.2 t -88.54 97.74 7.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -70.7 160.72 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.224 -175.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.92 -141.78 3.76 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.852 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -87.13 135.3 33.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.165 0.507 . . . . 0.0 109.953 -172.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.51 -7.59 59.76 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -122.66 156.71 33.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.036 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.873 ' HD2' ' HA2' ' A' ' 10' ' ' GLY . 4.7 ttpp -138.59 121.41 16.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.831 176.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 30.0 t -89.94 130.74 36.11 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.38 137.2 54.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.423 0.63 . . . . 0.0 110.462 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.637 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -113.83 103.3 11.06 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.793 -172.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.92 -122.53 2.51 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.385 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -153.13 -170.45 3.62 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.356 0.263 . . . . 0.0 110.45 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.58 -112.07 4.62 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.087 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -113.21 4.03 16.3 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.7 t -109.52 32.5 4.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.384 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 68.8 mttt -60.45 -50.31 74.09 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 121.704 0.764 . . . . 0.0 110.123 -177.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -154.25 100.82 2.33 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.595 -172.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 8.3 tp-100 -135.73 143.65 45.45 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.203 -174.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 86.5 m -90.46 104.46 17.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.586 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.8 p -97.26 164.92 2.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 p -95.25 116.27 28.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.074 0.464 . . . . 0.0 111.156 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.52 -126.95 0.97 Allowed Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.001 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 111.2 6.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.481 0.657 . . . . 0.0 110.769 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.64 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -97.4 -151.87 28.04 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.725 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.11 147.46 22.21 Favored Pre-proline 0 C--N 1.321 -0.64 0 C-N-CA 122.511 0.325 . . . . 0.0 110.679 -176.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.507 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 52.5 Cg_exo -54.49 148.71 41.93 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.425 2.083 . . . . 0.0 110.497 170.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.587 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 2.2 ttpm? -88.62 115.49 63.55 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -165.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 10.5 Cg_exo -72.55 -170.54 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.135 2.557 . . . . 0.0 110.117 167.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -168.89 -54.96 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.612 0.244 . . . . 0.0 111.402 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.1 m -146.25 -57.83 0.3 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.123 0.487 . . . . 0.0 110.473 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.0 m80 . . . . . 0 CA--C 1.508 -0.64 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.163 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.3 t . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.45 109.36 21.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 120.752 0.31 . . . . 0.0 110.666 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -104.22 174.06 6.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.131 0.491 . . . . 0.0 110.355 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p -130.07 -164.09 1.38 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.656 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.32 157.66 18.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 2.7 m -67.25 133.92 50.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.321 0.581 . . . . 0.0 111.688 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -106.52 -22.57 12.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.859 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -139.98 157.83 45.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.031 0.443 . . . . 0.0 110.729 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 m -88.28 118.88 28.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.016 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.86 -5.53 10.53 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.805 -173.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.567 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -87.8 176.49 7.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.0 p30 -148.81 -54.14 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 98.0 mt -60.55 65.95 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.898 0.856 . . . . 0.0 112.256 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 p -154.1 165.91 34.71 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.317 -1.311 . . . . 0.0 109.451 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.3 85.54 3.09 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 99.6 m -74.85 -78.48 0.1 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.037 -174.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -85.61 115.09 23.09 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.317 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 48.75 -94.7 0.01 OUTLIER Glycine 0 C--N 1.298 -1.552 0 O-C-N 124.136 0.897 . . . . 0.0 112.006 -173.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -117.88 0.13 11.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.0 111.737 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.496 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -72.15 123.04 22.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.96 0.41 . . . . 0.0 110.64 -176.342 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 t -88.68 106.01 16.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.796 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.3 161.94 28.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.581 -177.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.9 -143.78 3.88 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.833 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -86.75 138.36 31.68 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.282 0.563 . . . . 0.0 110.151 -172.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.17 -10.23 58.19 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -169.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -127.06 153.42 45.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 120.96 0.41 . . . . 0.0 110.202 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.548 ' O ' HG12 ' A' ' 40' ' ' VAL . 14.2 ttpp -134.21 113.2 11.76 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.279 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 15.0 t -89.51 130.7 35.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.906 0.384 . . . . 0.0 110.439 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -129.46 130.22 67.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.574 0.702 . . . . 0.0 111.276 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 24.5 mt -82.26 94.25 7.28 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.609 176.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.54 -111.77 1.33 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.731 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -163.94 153.02 13.91 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.67 -139.5 14.66 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.177 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -87.94 -4.25 58.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 166.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 m -94.58 30.11 2.1 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.166 -1.834 . . . . 0.0 110.448 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 1.9 pptp? -77.5 -10.74 59.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.764 -176.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -154.26 108.42 3.0 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -135.2 141.66 45.9 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.176 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.796 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 81.0 m -89.48 97.19 11.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.702 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.3 p -89.73 160.97 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.4 p -88.84 128.68 35.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.469 0.652 . . . . 0.0 111.37 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.43 -142.64 7.44 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.542 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -128.19 113.96 16.37 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.747 0.308 . . . . 0.0 110.779 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.496 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -100.87 -146.16 18.55 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.004 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.95 144.86 22.97 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 122.641 0.376 . . . . 0.0 110.701 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.448 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 41.9 Cg_exo -58.35 145.22 94.55 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.289 1.993 . . . . 0.0 110.067 171.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.567 ' HG3' HE21 ' A' ' 11' ' ' GLN . 2.0 ttpm? -89.04 110.37 37.58 Favored Pre-proline 0 C--N 1.32 -0.675 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.549 -174.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 31.3 Cg_exo -58.71 155.66 36.29 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 122.978 2.452 . . . . 0.0 112.099 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -132.46 -37.29 1.08 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.309 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.8 p -125.75 138.02 53.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.464 0.65 . . . . 0.0 112.504 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.9 m170 . . . . . 0 CA--C 1.513 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.639 177.04 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.36 155.65 19.59 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.809 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 9.6 m -65.11 133.68 52.13 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.2 m -106.02 -28.65 10.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.003 0.43 . . . . 0.0 111.089 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.437 ' CB ' HE22 ' A' ' 11' ' ' GLN . 3.4 mm-40 -125.31 158.21 34.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.0 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -87.85 125.96 34.76 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 116.4 -5.74 19.2 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.064 -173.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.741 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.8 OUTLIER -91.16 157.87 16.95 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.507 0.194 . . . . 0.0 110.917 176.482 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 14' ' ' CYS . 3.0 p30 -127.61 -59.26 1.22 Allowed 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 87.1 mt -60.64 59.5 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.482 1.114 . . . . 0.0 113.635 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.809 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -155.15 169.27 24.54 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.264 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.5 103.13 10.15 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 12.8 t -86.56 -72.87 0.48 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.617 0.723 . . . . 0.0 110.624 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -91.38 107.46 19.22 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.334 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.85 -82.41 0.01 OUTLIER Glycine 0 C--N 1.307 -1.038 0 O-C-N 124.694 1.246 . . . . 0.0 113.296 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.4 p -127.21 -3.16 6.3 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.534 0.334 . . . . 0.0 111.418 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -66.75 116.18 7.37 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.219 0.533 . . . . 0.0 111.27 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 t -88.68 93.83 4.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.871 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.711 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -63.37 145.79 54.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.803 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.87 -132.22 3.21 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.783 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -88.43 139.97 29.95 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.17 0.51 . . . . 0.0 110.525 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.29 -11.73 71.14 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.791 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -121.54 164.61 16.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.033 0.444 . . . . 0.0 110.286 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 40' ' ' VAL . 24.9 ttpp -150.67 124.91 9.42 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.734 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.6 t -89.62 135.82 33.39 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.947 0.403 . . . . 0.0 110.503 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -125.05 120.86 59.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.561 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 6' ' ' CYS . 5.9 mp . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.573 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 7.7 tp-100 . . . . . 0 CA--C 1.519 -0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 111.64 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.711 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 79.3 m -91.65 92.76 8.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.852 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 27' ' ' LYS . 6.2 p -89.57 155.72 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -88.23 132.26 34.44 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.459 0.647 . . . . 0.0 111.179 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.16 -128.09 1.65 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.09 117.62 13.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.223 0.535 . . . . 0.0 110.033 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -93.8 -146.64 20.5 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.596 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.741 HG22 ' HG3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -150.42 145.67 18.84 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.89 118.83 5.74 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.364 2.042 . . . . 0.0 110.969 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.619 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 15.9 tttt . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.097 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.538 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 2.5 p . . . . . 0 N--CA 1.441 -0.892 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.425 ' H ' ' HB ' ' A' ' 4' ' ' THR . 1.8 m-20 -86.98 161.78 18.02 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.171 -175.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 17.7 m -64.5 137.94 58.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.721 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.484 HG23 ' HG2' ' A' ' 8' ' ' GLU . 6.2 t -106.76 -16.73 14.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.2 0.524 . . . . 0.0 110.444 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.484 ' HG2' HG23 ' A' ' 7' ' ' THR . 4.9 mm-40 -138.26 154.99 49.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.741 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -88.07 127.2 35.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.608 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.43 -6.68 31.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.564 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -89.16 157.28 18.34 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.9 p30 -129.23 -60.02 1.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.66 60.65 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.306 1.042 . . . . 0.0 113.511 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.78 169.76 23.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.005 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -81.26 112.49 18.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.764 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 36.4 t -98.12 -79.42 0.47 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.651 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.92 111.09 18.93 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.414 -172.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.17 -92.33 0.01 OUTLIER Glycine 0 C--N 1.297 -1.596 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.327 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 p -121.16 2.06 10.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.709 0.29 . . . . 0.0 111.343 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -68.09 125.72 27.25 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.534 0.683 . . . . 0.0 111.381 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.26 108.64 19.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.496 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.743 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -74.6 149.77 39.94 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.123 176.095 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.33 -149.35 5.09 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.571 -0.611 . . . . 0.0 111.571 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -87.33 133.01 33.76 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.04 -8.24 38.63 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -133.57 166.84 21.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.611 -0.795 . . . . 0.0 109.253 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.55 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 24.3 ttpp -149.41 117.9 6.52 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.764 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 16.0 t -89.39 125.53 35.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.206 0.527 . . . . 0.0 110.865 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.5 pt -121.07 124.18 71.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.851 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.292 179.085 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 7.4 tp60 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.733 0.301 . . . . 0.0 111.343 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.743 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 97.5 m -90.14 86.96 6.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.949 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.2 p -88.02 165.89 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 p -88.97 132.22 34.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.67 0.748 . . . . 0.0 111.271 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.8 -140.39 6.4 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -138.82 111.31 7.55 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.55 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -86.5 -155.28 26.57 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.941 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.22 141.8 43.19 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.2 140.82 71.38 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.996 1.797 . . . . 0.0 109.931 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 42.0 tttt . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 120.706 0.289 . . . . 0.0 111.334 -169.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.11 144.41 26.51 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.776 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 20.3 m -60.2 132.3 53.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 m -111.37 -12.99 13.97 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.195 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.526 ' HB2' ' OE1' ' A' ' 11' ' ' GLN . 37.4 mt-10 -136.05 156.01 49.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.892 -172.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.8 m -89.24 118.8 29.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.117 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.62 1.41 24.47 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.779 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.526 ' OE1' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -92.93 158.9 15.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.119 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.6 p30 -134.31 -57.38 0.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 76.6 mt -63.26 59.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.103 0.877 . . . . 0.0 112.587 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.776 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -154.43 164.9 37.93 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.778 177.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.95 98.69 7.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.787 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 14.6 t -74.16 -77.83 0.11 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.435 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 28.2 tt0 -84.13 154.52 23.09 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 11.44 -89.75 0.0 OUTLIER Glycine 0 N--CA 1.471 1.023 0 O-C-N 125.003 1.439 . . . . 0.0 115.062 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.0 p -120.07 16.96 12.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.268 0.556 . . . . 0.0 111.074 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 24.2 m-80 -79.03 98.21 6.39 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.531 0.681 . . . . 0.0 110.578 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 40.7 t -88.43 98.04 7.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.933 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -78.71 160.22 27.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.149 -174.046 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -143.3 -136.95 3.22 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.042 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -87.8 133.77 33.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.201 0.524 . . . . 0.0 109.86 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.7 -8.76 51.5 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.287 -173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -125.99 164.06 21.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.444 -0.378 . . . . 0.0 110.12 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HD3' ' O ' ' A' ' 43' ' ' GLU . 27.4 ttpp -148.23 120.43 8.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.745 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.787 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 10.4 t -88.84 136.96 32.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.856 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 pt -127.78 134.5 65.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.239 0.543 . . . . 0.0 110.28 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 mt . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.412 -179.53 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 6.7 tp60 . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.166 0.508 . . . . 0.0 111.666 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 89.4 m -92.02 97.95 11.26 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.135 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.8 p -89.67 161.8 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.2 p -89.11 129.39 35.73 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.368 0.604 . . . . 0.0 111.58 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.87 -132.33 2.62 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.183 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 5.8 pt-20 -136.95 119.24 15.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.266 0.555 . . . . 0.0 110.756 175.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.86 -143.87 15.64 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.208 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.22 142.71 17.21 Favored Pre-proline 0 C--N 1.324 -0.514 0 C-N-CA 122.507 0.323 . . . . 0.0 110.399 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 32.0 Cg_exo -59.0 132.79 49.37 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.655 2.237 . . . . 0.0 111.159 174.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 6' ' ' CYS . 1.8 ttpm? . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.77 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.521 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 5.5 p . . . . . 0 N--CA 1.444 -0.757 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.32 145.52 26.31 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.7 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 26.1 m -59.54 134.14 56.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.959 0.409 . . . . 0.0 110.941 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 m -110.61 -31.67 7.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.61 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.45 ' HB2' ' OE1' ' A' ' 11' ' ' GLN . 25.6 mp0 -115.1 152.52 32.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.717 -176.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 m -88.88 119.91 29.8 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 117.46 -5.85 16.89 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.999 -173.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.45 ' OE1' ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -89.08 166.33 13.93 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' CYS . 8.6 p30 -135.62 -58.19 0.78 Allowed 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.75 60.56 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.119 0.887 . . . . 0.0 112.944 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.7 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -153.76 161.28 42.22 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.359 178.282 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -81.77 100.03 9.3 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.85 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 30.8 t -82.34 -74.93 0.32 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.843 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 2.0 tm-20 -78.38 148.16 33.8 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 10.02 -85.87 0.0 OUTLIER Glycine 0 N--CA 1.471 1.016 0 O-C-N 124.972 1.42 . . . . 0.0 115.372 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.9 p -119.81 5.36 10.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.967 0.413 . . . . 0.0 111.248 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 5.0 m-20 -71.38 107.64 4.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.227 0.537 . . . . 0.0 110.502 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.9 t -89.09 98.55 8.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.497 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -66.88 153.72 42.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.211 -178.699 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -148.71 -128.17 1.69 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.095 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.67 134.45 33.65 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.207 0.527 . . . . 0.0 109.956 -174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.66 0.63 66.62 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.644 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.43 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 51.9 m-80 -133.96 164.48 27.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.126 0.488 . . . . 0.0 110.794 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 25.0 ttpp -150.61 123.34 8.6 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.494 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.85 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 27.8 t -89.94 133.08 34.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.986 0.422 . . . . 0.0 110.6 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.69 112.42 33.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.431 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.569 178.104 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 7.3 tp-100 . . . . . 0 CA--C 1.517 -0.302 0 CA-C-O 120.979 0.418 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 60.3 m -89.36 87.93 7.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.946 172.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.9 p -89.23 159.31 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -88.9 130.62 35.39 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.258 0.551 . . . . 0.0 111.186 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.91 -134.83 3.3 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.5 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.526 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 8.8 pt-20 -133.8 113.86 12.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.099 0.476 . . . . 0.0 109.888 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.555 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -96.18 -149.75 26.02 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.523 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.39 142.47 26.68 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 122.568 0.347 . . . . 0.0 110.324 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.42 129.55 33.2 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.301 2.0 . . . . 0.0 110.851 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.2 tttt . . . . . 0 N--CA 1.446 -0.67 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.349 -174.388 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.482 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.7 p . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.531 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 7.4 m-20 -87.72 149.53 24.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.674 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 25.9 m -61.45 134.75 57.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.858 0.361 . . . . 0.0 110.755 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -112.1 -20.85 11.78 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.265 0.555 . . . . 0.0 110.406 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -134.92 154.99 51.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.333 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -86.63 124.44 32.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.8 -10.05 16.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.663 -172.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -89.95 154.05 20.14 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.1 p30 -126.79 -61.85 1.16 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.427 HD23 ' HA2' ' A' ' 23' ' ' GLY . 94.4 mt -58.99 63.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.011 0.925 . . . . 0.0 113.05 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.674 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.15 162.32 41.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.871 177.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -78.37 87.84 4.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.602 ' HA ' ' SG ' ' A' ' 6' ' ' CYS . 13.9 t -61.3 -77.55 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.253 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 6.8 tp10 -82.56 164.91 20.53 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -8.41 -71.86 0.01 OUTLIER Glycine 0 N--CA 1.472 1.089 0 O-C-N 124.88 1.363 . . . . 0.0 115.269 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.4 p -127.67 4.38 6.11 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.697 -0.296 . . . . 0.0 111.392 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 3.8 m-20 -78.8 110.64 14.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 110.737 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 40.6 t -89.88 106.78 17.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.74 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.76 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -68.42 146.98 52.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.92 177.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -131.98 -156.98 8.51 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.039 -1.076 . . . . 0.0 113.454 -177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.82 117.44 24.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.739 0.78 . . . . 0.0 109.607 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.34 -4.24 23.5 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -165.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.494 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 6.6 m120 -122.25 164.49 17.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.651 -0.774 . . . . 0.0 108.987 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 40' ' ' VAL . 26.4 ttpp -149.98 118.25 6.41 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.479 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.7 t -89.51 130.48 35.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.039 0.447 . . . . 0.0 110.624 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -123.65 112.95 35.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.132 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.474 -179.725 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 11.9 tp60 . . . . . 0 N--CA 1.445 -0.702 0 CA-C-O 121.271 0.558 . . . . 0.0 111.871 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.76 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 54.6 m -89.62 89.85 7.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.112 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.8 p -88.79 153.2 3.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 p -89.78 119.73 30.43 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.175 0.512 . . . . 0.0 110.57 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.86 -130.99 1.51 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.63 110.76 7.32 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.118 0.485 . . . . 0.0 110.132 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.501 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -99.14 -145.06 17.81 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.225 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.37 136.14 11.32 Favored Pre-proline 0 C--N 1.317 -0.812 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.79 135.88 42.66 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.442 2.095 . . . . 0.0 111.038 171.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 5' ' ' ASP . 24.5 tttm . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.791 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 3.4 m-20 -89.04 149.0 23.43 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.734 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 61.2 m -58.57 144.35 43.12 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.234 0.54 . . . . 0.0 112.082 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.624 ' OG1' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -114.26 -23.87 9.22 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.676 176.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.508 ' HB2' ' OE1' ' A' ' 11' ' ' GLN . 43.1 mt-10 -136.15 153.69 51.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.304 -170.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.8 m -88.46 120.86 30.23 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.7 -11.56 13.77 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -172.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.508 ' OE1' ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -88.01 164.34 15.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.412 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.2 p30 -134.93 -58.0 0.81 Allowed 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.415 HD23 ' HA2' ' A' ' 23' ' ' GLY . 87.2 mt -58.16 61.81 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.383 1.073 . . . . 0.0 113.42 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.734 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.6 166.3 33.8 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.233 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.78 94.16 6.36 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.552 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . 49.3 t -73.79 -74.49 0.18 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.356 -172.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -91.92 150.16 21.18 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 27.15 -91.5 0.01 OUTLIER Glycine 0 N--CA 1.472 1.07 0 O-C-N 124.548 1.155 . . . . 0.0 114.535 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.01 32.73 4.0 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.413 0.625 . . . . 0.0 110.948 173.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.06 112.91 19.55 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.694 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.8 t -88.37 91.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -69.14 146.64 52.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.39 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -136.29 -152.51 6.32 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.07 137.02 32.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.489 0.644 . . . . 0.0 109.357 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.17 -9.93 46.78 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -167.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -126.93 158.63 36.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.861 -0.669 . . . . 0.0 109.892 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 18.3 ttpp -139.55 121.21 15.29 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 74.1 m -89.76 143.38 26.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.724 0.297 . . . . 0.0 111.13 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.8 pt -135.36 131.12 51.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.289 0.566 . . . . 0.0 110.768 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--N 1.316 -0.85 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.372 176.17 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 120.591 0.234 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 91.8 m -101.21 114.89 29.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.046 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 27' ' ' LYS . 1.2 p -104.16 157.22 5.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.9 p -91.36 123.78 35.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.077 0.465 . . . . 0.0 111.162 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.8 -120.23 0.75 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.502 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 13.6 pt-20 -151.95 123.38 7.79 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.493 -0.416 . . . . 0.0 110.452 174.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.562 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -107.72 -151.96 17.07 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.937 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.07 144.01 51.36 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.72 135.43 67.17 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.216 1.944 . . . . 0.0 110.819 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.791 ' HE3' ' O ' ' A' ' 5' ' ' ASP . 14.6 tttm . . . . . 0 N--CA 1.435 -1.18 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.755 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.638 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 82.7 p . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.45 172.22 9.96 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.807 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 31.3 m -73.37 136.37 44.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.023 0.44 . . . . 0.0 111.248 -177.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 m -102.31 -21.93 14.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -139.5 156.22 47.06 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.115 0.484 . . . . 0.0 110.701 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.9 m -90.16 107.75 19.32 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.025 -0.988 . . . . 0.0 108.53 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.566 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 124.79 -0.53 8.49 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -169.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -88.15 -171.1 3.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.6 p30 -159.04 -55.2 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 74.1 mt -60.8 61.34 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.805 0.842 . . . . 0.0 112.905 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.807 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -154.03 166.91 31.53 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.14 178.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.5 OUTLIER -79.01 91.58 4.87 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.004 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.721 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 33.1 t -92.65 -65.04 1.03 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.188 0.518 . . . . 0.0 111.245 -174.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -83.69 103.79 13.28 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.793 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.36 -95.29 0.01 OUTLIER Glycine 0 C--N 1.294 -1.753 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.796 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.3 p -121.33 11.99 10.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.743 0.306 . . . . 0.0 111.236 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -73.11 126.07 29.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.07 0.462 . . . . 0.0 110.635 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 t -89.83 102.55 13.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.089 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 13' ' ' LEU . 1.3 m -85.3 162.83 18.94 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.915 0.388 . . . . 0.0 111.37 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -148.76 -140.04 3.24 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.726 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -84.8 134.73 34.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.292 0.567 . . . . 0.0 109.56 -173.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.89 -16.46 28.11 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -169.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -119.61 158.38 26.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.061 0.458 . . . . 0.0 110.786 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.629 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 4.4 tppp? -130.51 107.71 9.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.049 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 85.8 m -89.31 126.81 35.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.538 0.208 . . . . 0.0 110.77 -177.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -128.82 127.94 66.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.196 0.522 . . . . 0.0 111.163 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 30' ' ' LEU . 5.5 mp . . . . . 0 C--N 1.322 -0.59 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.495 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 . . . . . 0 C--O 1.231 0.1 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 16' ' ' CYS . 69.8 m -94.26 100.55 12.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.401 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.1 p -90.84 158.48 2.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.3 p -89.13 125.69 35.15 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.623 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.97 -123.37 0.87 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.955 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -152.3 109.01 3.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.174 0.511 . . . . 0.0 110.294 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.629 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -90.2 -147.61 18.1 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.287 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.547 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -133.8 142.03 42.13 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.7 134.19 61.35 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.129 1.886 . . . . 0.0 110.851 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HD3' ' HB3' ' A' ' 14' ' ' CYS . 1.6 ttpm? . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 -171.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 4.7 p . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.51 155.95 19.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.719 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.1 m -63.81 137.14 57.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.986 0.422 . . . . 0.0 111.621 -176.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m -107.5 -31.4 8.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.047 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.82 157.01 46.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.609 -175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 m -88.39 122.1 31.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.476 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.94 -6.5 21.97 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.8 164.97 14.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.9 p30 -136.77 -57.12 0.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.414 HD23 ' HA2' ' A' ' 23' ' ' GLY . 91.8 mt -59.55 61.39 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.111 0.965 . . . . 0.0 112.984 -176.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.719 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.77 167.29 30.7 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.394 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -81.62 105.24 12.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.704 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 34.2 t -94.57 -70.85 0.69 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.654 -172.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 20.4 tt0 -86.84 79.38 8.82 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.106 0.955 . . . . 0.0 109.68 -175.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 -91.88 0.28 Allowed Glycine 0 C--N 1.294 -1.781 0 CA-C-N 113.551 -1.659 . . . . 0.0 111.612 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 p -109.25 -3.45 17.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.658 0.266 . . . . 0.0 110.929 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 18.8 m-80 -64.84 114.79 4.73 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.184 0.516 . . . . 0.0 111.124 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.01 104.36 14.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.918 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.91 151.32 37.37 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.959 0.409 . . . . 0.0 110.233 179.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -140.14 -153.5 6.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.97 144.75 27.45 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.13 -3.42 80.28 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -165.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -135.0 156.3 49.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.6 ttpp -142.12 123.15 14.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.969 0.414 . . . . 0.0 109.981 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.704 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 14.4 t -90.04 139.48 30.57 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.911 0.386 . . . . 0.0 110.688 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.9 pt -132.38 124.04 51.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.761 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.055 -176.677 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.427 HE21 ' H ' ' A' ' 39' ' ' CYS . 27.7 tp60 . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 93.9 m -96.67 109.14 21.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.773 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.7 p -103.6 162.96 3.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 p -90.18 129.23 36.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.487 0.661 . . . . 0.0 111.198 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.51 -144.43 8.96 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.91 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -128.31 105.61 8.46 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.974 0.416 . . . . 0.0 110.267 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.81 -151.99 22.88 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.202 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.21 142.5 35.61 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.17 142.69 77.49 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.381 2.054 . . . . 0.0 111.428 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HD3' ' HB3' ' A' ' 14' ' ' CYS . 2.3 ttpm? . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.566 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.24 150.51 24.32 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.777 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 13.3 m -62.15 128.84 38.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.024 0.44 . . . . 0.0 110.479 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -95.71 -17.17 21.47 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.868 -177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HB2' ' OE1' ' A' ' 11' ' ' GLN . 36.1 mt-10 -138.37 151.69 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.786 -170.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.1 m -87.67 124.21 33.31 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.472 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 115.35 -6.58 21.06 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.876 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.526 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -89.84 162.48 15.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.1 p30 -132.74 -59.24 0.91 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 73.8 mt -60.29 61.47 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -174.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.777 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -155.41 172.75 17.7 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.985 177.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -85.87 80.55 8.87 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.601 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 17.5 t -60.66 -70.72 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.205 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -95.78 137.84 34.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 30.43 -96.7 0.01 OUTLIER Glycine 0 N--CA 1.467 0.708 0 O-C-N 124.733 1.271 . . . . 0.0 114.712 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 p -120.08 17.0 12.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.275 0.56 . . . . 0.0 111.46 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -85.38 103.82 14.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.554 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -87.93 102.9 13.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -74.26 153.3 39.47 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.735 -176.368 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.31 -134.88 3.26 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.127 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.65 126.88 35.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.053 0.454 . . . . 0.0 110.259 -171.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.26 -13.2 31.08 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -119.85 161.33 21.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.242 -0.479 . . . . 0.0 109.924 176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.8 ttpp -146.25 123.08 11.27 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.84 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.601 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.2 t -89.04 141.92 28.08 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.718 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.5 pt -133.42 128.75 55.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.31 0.576 . . . . 0.0 109.998 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 6' ' ' CYS . 6.6 mp . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.45 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.46 0.06 0 CA-C-O 120.953 0.406 . . . . 0.0 111.79 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 90.3 m -99.48 106.18 18.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.516 175.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.2 p -95.99 158.99 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.1 p -88.98 126.84 35.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.8 0.333 . . . . 0.0 111.112 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.68 -119.12 0.73 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.006 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 9.2 pt-20 -147.02 117.0 7.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -102.91 -149.12 21.14 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.537 -177.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.7 144.9 19.87 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.369 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.6 144.55 74.25 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.362 2.041 . . . . 0.0 110.436 173.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 1.8 ttpm? . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -170.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.458 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 4.8 m-20 -86.93 148.05 25.51 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.704 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 21.9 m -60.8 133.58 56.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.502 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -109.91 -29.62 8.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.877 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 159.43 30.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.347 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -87.52 117.2 26.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.569 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.98 -6.82 9.42 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.214 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -89.42 160.44 16.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.639 0.257 . . . . 0.0 110.426 177.29 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.4 p30 -133.79 -57.28 0.88 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 78.9 mt -61.47 60.58 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.003 0.921 . . . . 0.0 112.886 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.704 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -155.05 162.33 41.08 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.448 179.154 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.68 85.36 5.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.1 0.476 . . . . 0.0 109.953 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.712 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 26.1 t -66.28 -73.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.429 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.08 144.12 26.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.116 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 22.76 -90.53 0.01 OUTLIER Glycine 0 N--CA 1.47 0.918 0 O-C-N 125.028 1.455 . . . . 0.0 114.699 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 p -121.6 -1.7 9.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.794 0.331 . . . . 0.0 111.197 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -70.29 104.06 2.56 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.629 0.728 . . . . 0.0 110.997 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 21.3 t -88.84 101.05 11.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.922 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -65.82 156.92 31.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.972 -175.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -134.71 -152.92 6.7 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -85.96 139.15 31.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.28 -15.63 50.28 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -120.48 166.22 13.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.4 ttpp -149.99 117.4 6.09 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.712 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 16.5 t -88.92 136.31 33.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.887 0.375 . . . . 0.0 110.266 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.2 pt -127.01 128.35 70.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.299 0.571 . . . . 0.0 110.243 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.318 -0.761 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.871 -176.926 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.032 0.444 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 91.8 m -89.41 96.03 10.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.916 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.6 p -90.23 160.13 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 p -88.88 132.0 34.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.285 0.564 . . . . 0.0 111.368 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.91 -128.6 1.68 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.876 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -143.14 112.85 6.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.344 0.593 . . . . 0.0 110.28 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.444 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -93.53 -148.09 23.03 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.419 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.93 142.71 22.81 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.83 139.4 78.19 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.198 1.932 . . . . 0.0 110.676 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.556 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 16.5 tttm . . . . . 0 N--CA 1.432 -1.352 0 CA-C-O 120.99 0.424 . . . . 0.0 110.493 -173.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.612 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.77 147.76 26.17 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 10.2 m -59.35 129.87 44.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.117 0.484 . . . . 0.0 110.796 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 m -103.08 -27.08 12.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.601 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.36 159.36 36.42 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.403 -176.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 46.5 m -87.05 118.66 26.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.292 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.88 -4.72 11.54 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.12 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.506 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -89.06 161.82 16.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.706 0.288 . . . . 0.0 110.402 175.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 14' ' ' CYS . 6.1 p30 -135.66 -56.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.126 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 88.9 mt -62.15 63.13 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.375 1.047 . . . . 0.0 112.161 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -153.94 162.6 41.09 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.332 177.575 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.73 81.46 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.388 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.738 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 43.2 t -67.87 -79.87 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.385 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 11.1 tp10 -72.86 157.59 37.17 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -3.38 -78.3 0.01 OUTLIER Glycine 0 N--CA 1.472 1.094 0 O-C-N 125.284 1.615 . . . . 0.0 115.446 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.0 p -126.64 15.03 7.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.009 0.433 . . . . 0.0 111.125 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 4.9 m-20 -83.85 111.2 18.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.755 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.9 t -87.92 103.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -74.94 163.82 27.22 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.081 -176.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.77 -138.34 2.83 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.849 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -85.91 125.8 33.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.195 0.521 . . . . 0.0 109.917 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -19.54 11.38 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -172.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -124.33 161.38 26.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' O ' HG12 ' A' ' 40' ' ' VAL . 25.6 ttpp -141.9 117.92 10.61 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.738 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 32.8 t -91.05 135.27 33.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.095 0.474 . . . . 0.0 110.572 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 23.3 pt -132.38 144.81 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.137 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 C--N 1.311 -1.093 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.327 176.786 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? . . . . . 0 C--O 1.233 0.23 0 CA-C-O 121.034 0.445 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 92.8 m -89.7 96.02 10.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.152 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.1 p -89.8 166.12 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.9 p -88.52 127.4 35.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.263 0.554 . . . . 0.0 111.178 -176.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.5 -135.54 3.57 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.985 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -141.36 110.3 6.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.448 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -92.68 -149.74 25.23 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.261 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.31 144.87 29.93 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 51.3 Cg_exo -55.3 140.35 81.74 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.387 2.058 . . . . 0.0 111.408 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.506 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 11.3 tttm . . . . . 0 N--CA 1.438 -1.064 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.164 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.1 155.55 20.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.782 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 3.8 m -61.18 134.26 56.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.366 0.603 . . . . 0.0 111.592 -173.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 m -100.13 -18.17 17.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.711 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -145.46 157.85 43.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.591 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 m -89.37 120.22 30.52 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.489 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.07 -2.9 14.43 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.532 -170.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.16 172.39 9.11 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.9 p30 -143.52 -55.81 0.39 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 74.6 mt -61.61 66.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.925 0.869 . . . . 0.0 112.478 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.782 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -153.83 168.93 24.68 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.112 -1.403 . . . . 0.0 109.592 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.71 84.41 4.05 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 92.5 m -72.77 -80.21 0.07 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.473 -175.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -88.0 121.01 29.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.358 -173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.47 -90.31 0.01 OUTLIER Glycine 0 C--N 1.304 -1.235 0 O-C-N 123.985 0.803 . . . . 0.0 111.436 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.84 10.54 4.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.7 0.286 . . . . 0.0 111.561 173.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -71.17 126.11 28.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.164 0.506 . . . . 0.0 110.718 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 3.7 t -88.61 93.85 4.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.882 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.664 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -65.97 154.82 38.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 -176.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.01 -156.23 8.66 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -87.39 132.74 33.87 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.55 -22.26 8.86 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -168.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -117.6 159.95 22.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.09 171.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.551 ' O ' HG12 ' A' ' 40' ' ' VAL . 19.2 ttpp -133.62 113.97 12.99 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.303 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 51.7 t -90.22 130.51 36.34 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.6 pt -123.76 127.24 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.459 0.647 . . . . 0.0 111.023 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.023 176.137 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.469 0 CA-C-O 121.295 0.569 . . . . 0.0 110.468 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.664 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 81.0 m -89.57 95.7 10.38 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.696 176.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 27' ' ' LYS . 5.0 p -89.03 160.33 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.0 p -89.24 126.06 35.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.227 0.537 . . . . 0.0 111.422 -175.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.9 -122.36 0.9 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 11.8 pt-20 -150.23 123.59 8.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.177 0.513 . . . . 0.0 110.417 173.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -107.52 -145.81 12.3 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.381 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.22 142.62 21.98 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 51.1 Cg_exo -57.41 144.09 92.49 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.581 2.187 . . . . 0.0 111.243 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' A' ' 14' ' ' CYS . 2.1 ttpm? . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.534 0.207 . . . . 0.0 111.445 -172.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -87.89 152.29 22.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 11.5 m -60.0 133.24 55.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.558 -178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -113.44 -15.28 12.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.517 0.675 . . . . 0.0 110.273 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.556 ' HB2' ' OE1' ' A' ' 11' ' ' GLN . 46.1 mt-10 -134.2 151.64 51.42 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.217 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -88.11 124.36 33.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.06 -4.21 27.09 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.328 -173.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.556 ' OE1' ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -89.27 162.11 16.04 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.438 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.7 p30 -136.04 -56.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 73.6 mt -61.83 62.18 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.96 0.788 . . . . 0.0 112.918 -177.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -155.48 175.25 14.12 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.596 178.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.2 106.57 14.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 40.2 t -98.73 -65.9 0.93 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.434 0.635 . . . . 0.0 110.966 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.13 107.07 18.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.879 -175.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.73 -90.04 0.01 OUTLIER Glycine 0 C--N 1.299 -1.521 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.007 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 p -124.49 2.08 8.34 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.0 0.429 . . . . 0.0 111.424 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -70.25 125.14 25.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.782 -175.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.06 105.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.348 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -72.91 155.47 39.84 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.24 -143.22 4.38 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.636 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -86.21 139.12 31.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.486 0.66 . . . . 0.0 110.266 -176.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.71 -9.94 58.82 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.718 -172.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -125.73 160.77 28.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.033 174.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.7 ttpp -143.74 119.55 10.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.536 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 17.5 t -89.16 133.18 34.5 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.847 0.356 . . . . 0.0 110.304 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 pt -128.29 123.01 59.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.379 0.609 . . . . 0.0 110.883 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 30' ' ' LEU . 6.7 mp . . . . . 0 C--N 1.319 -0.758 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.474 176.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 72.8 m -89.12 110.51 21.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.859 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.7 p -103.29 159.95 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 p -88.98 128.33 35.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.228 0.537 . . . . 0.0 111.122 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.6 -133.93 2.73 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.245 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -139.51 111.1 7.15 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.155 0.502 . . . . 0.0 109.938 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.75 -152.98 28.77 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.433 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.28 139.03 30.38 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.5 135.15 68.01 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.351 2.034 . . . . 0.0 110.907 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.7 tttt . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -176.293 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.5 p . . . . . 0 N--CA 1.443 -0.788 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -85.24 142.61 29.28 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -174.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.727 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 35.0 m -50.28 133.15 24.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.503 0.668 . . . . 0.0 111.128 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -115.07 -10.25 12.24 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.595 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.476 ' HB2' ' OE1' ' A' ' 11' ' ' GLN . 41.8 mt-10 -143.94 151.04 39.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.631 -173.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 m -89.01 126.95 35.64 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.455 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.3 -1.03 34.98 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.789 ' HG2' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.19 164.85 14.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.634 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 8.8 p30 -139.74 -57.05 0.57 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 75.4 mt -62.1 59.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.979 0.895 . . . . 0.0 112.415 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.768 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 1.6 p -155.39 150.6 26.9 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.126 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.65 89.85 2.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.629 0.728 . . . . 0.0 109.949 177.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.791 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 34.1 t -62.66 -73.51 0.11 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.358 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 1.2 tm-20 -87.53 163.31 16.73 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -23.04 -72.53 0.01 OUTLIER Glycine 0 N--CA 1.472 1.058 0 O-C-N 124.26 0.975 . . . . 0.0 115.366 -169.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.9 p -115.72 14.72 16.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.238 0.542 . . . . 0.0 110.46 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 3.8 m-20 -80.81 92.19 6.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.889 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 41.9 t -87.91 97.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.702 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.47 158.81 32.09 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.8 -173.301 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -141.42 -146.26 4.69 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -87.0 134.72 33.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.196 0.522 . . . . 0.0 109.641 -174.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.01 -13.91 37.51 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -170.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -123.89 165.84 16.68 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.8 ttpp -148.89 118.46 6.97 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.791 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 13.7 t -89.41 132.46 34.98 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.8 pt -128.36 120.39 52.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.303 0.573 . . . . 0.0 110.707 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 N--CA 1.443 -0.811 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.581 178.449 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 . . . . . 0 C--O 1.233 0.236 0 CA-C-O 121.002 0.43 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.702 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 99.5 m -91.18 99.49 12.48 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.861 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 27' ' ' LYS . 5.3 p -89.69 160.77 2.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.2 p -87.62 129.99 34.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.25 0.547 . . . . 0.0 111.124 -176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.34 -135.12 3.51 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.669 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.86 108.98 7.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.034 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.57 -148.72 24.59 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.327 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.471 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -144.09 144.8 27.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 122.469 0.308 . . . . 0.0 110.299 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.511 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 33.2 Cg_exo -60.01 154.89 47.83 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.718 2.279 . . . . 0.0 111.65 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.789 ' HG2' ' HG2' ' A' ' 11' ' ' GLN . 2.0 mtmt . . . . . 0 N--CA 1.446 -0.644 0 CA-C-O 121.052 0.453 . . . . 0.0 110.725 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.485 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 13.6 p . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.0 141.85 28.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.752 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 9.1 m -59.12 137.65 57.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.473 0.178 . . . . 0.0 111.145 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -118.75 -25.48 6.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.917 0.389 . . . . 0.0 111.204 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.48 156.32 35.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.993 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 m -89.07 114.47 25.71 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.358 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.65 -0.67 9.36 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.333 -173.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.28 171.93 9.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.4 p30 -145.45 -56.73 0.32 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 65.8 mt -62.67 58.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.148 0.905 . . . . 0.0 112.492 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.752 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.05 159.33 41.51 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.957 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -73.05 102.78 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.037 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.755 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 29.6 t -89.44 -70.48 0.66 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.71 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 9.3 tp10 -79.56 158.99 27.02 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -6.93 -78.02 0.01 OUTLIER Glycine 0 N--CA 1.473 1.162 0 O-C-N 124.984 1.428 . . . . 0.0 115.241 -176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.9 p -122.5 14.43 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.843 0.354 . . . . 0.0 111.264 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 3.6 m-20 -83.97 108.05 16.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.624 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 9.2 t -92.06 104.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.811 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 1.2 m -82.32 168.85 17.15 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.187 -174.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -145.34 -149.27 4.98 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.56 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -86.79 134.28 33.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.441 0.639 . . . . 0.0 109.997 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.5 -17.17 23.74 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -165.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -118.82 163.13 17.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.903 -0.649 . . . . 0.0 109.498 172.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 24.9 ttpp -144.61 117.96 9.04 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 173.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.755 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 33.7 t -89.17 132.31 34.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.733 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 pt -129.64 127.0 63.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.274 0.559 . . . . 0.0 110.879 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 30' ' ' LEU . 6.1 mp . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 1.6 tp60 . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.811 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 70.8 m -95.43 100.38 12.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.721 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.1 p -91.58 162.17 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -89.14 127.33 35.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.554 0.693 . . . . 0.0 111.779 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.47 -134.02 2.86 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.534 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -143.83 111.19 5.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.448 0.624 . . . . 0.0 110.495 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -89.22 -138.29 6.64 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.311 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.4 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -146.9 148.0 31.39 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 122.671 0.388 . . . . 0.0 110.341 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.4 ' HD2' HG22 ' A' ' 45' ' ' THR . 31.4 Cg_exo -59.56 134.87 60.76 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.602 2.201 . . . . 0.0 111.186 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 tttt . . . . . 0 N--CA 1.448 -0.574 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 -175.974 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.486 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.2 p . . . . . 0 N--CA 1.444 -0.742 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -87.66 153.83 21.07 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.111 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.755 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 17.0 m -65.64 135.87 55.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.574 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 m -103.93 -23.03 13.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.071 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.98 162.77 34.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.241 0.544 . . . . 0.0 110.942 -173.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.0 m -87.12 122.0 30.35 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.151 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.86 -5.92 18.15 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.901 -173.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 1.025 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.86 161.04 15.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 175.793 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' CYS . 6.8 p30 -136.05 -55.93 0.76 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.402 HD23 ' HA2' ' A' ' 23' ' ' GLY . 89.0 mt -61.07 55.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.247 0.967 . . . . 0.0 112.893 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.755 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 1.2 p -155.36 160.48 40.74 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.845 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -77.6 97.24 5.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.364 0.602 . . . . 0.0 109.393 177.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.617 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 13.0 t -72.65 -77.31 0.1 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.703 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -86.85 162.11 17.95 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 3.29 -87.99 0.0 OUTLIER Glycine 0 N--CA 1.474 1.174 0 O-C-N 124.964 1.415 . . . . 0.0 114.969 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.1 p -123.07 22.05 9.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.463 0.649 . . . . 0.0 110.237 172.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -78.57 99.04 6.35 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.209 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 31.0 t -88.32 99.94 9.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.014 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.668 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -73.07 155.98 39.21 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.651 -176.694 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -139.67 -154.05 6.23 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.643 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -85.78 135.13 33.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.434 0.617 . . . . 0.0 109.52 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.25 -9.35 53.92 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -127.34 164.15 22.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.557 -0.822 . . . . 0.0 109.278 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.3 ttpp -150.28 121.46 7.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.211 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.617 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.9 t -89.23 138.0 31.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.956 0.408 . . . . 0.0 110.232 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -128.08 124.47 62.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.436 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.374 176.475 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 56.4 tp60 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.0 111.694 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.668 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 59.7 m -90.83 92.89 8.99 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.868 171.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.7 p -90.16 159.76 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.9 p -88.65 127.03 35.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.387 0.613 . . . . 0.0 110.685 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.67 -148.44 11.92 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.895 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -122.22 106.34 11.04 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.28 -144.14 12.47 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.091 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 1.025 HG22 ' HG3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -150.04 146.18 19.91 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.167 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.39 119.77 7.15 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.375 2.05 . . . . 0.0 111.841 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 8.4 tmtt? . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.3 p . . . . . 0 N--CA 1.442 -0.844 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.56 152.14 22.43 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 4.8 m -63.01 133.36 54.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.205 0.526 . . . . 0.0 111.225 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -105.45 -23.11 12.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.692 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.451 ' HB2' HE22 ' A' ' 11' ' ' GLN . 2.3 mm-40 -130.52 153.98 48.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.339 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 51.5 m -88.27 112.0 22.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.1 -0.13 7.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.004 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.568 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.64 171.84 9.72 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.746 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.6 p30 -142.41 -57.44 0.45 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 82.8 mt -62.87 61.62 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.815 0.846 . . . . 0.0 112.354 -178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -153.51 171.23 19.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.821 -179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 4' ' ' THR . 2.5 mt -83.45 88.36 6.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.546 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 41.9 t -80.49 -61.53 1.95 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.875 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.99 113.7 25.34 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.976 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 46.33 -97.32 0.01 OUTLIER Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.754 -175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -115.1 0.99 13.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -70.3 123.05 20.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.978 0.418 . . . . 0.0 110.607 -175.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.26 97.39 6.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.486 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.6 OUTLIER -74.69 167.29 22.09 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.541 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.02 -124.76 0.72 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.802 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -86.26 124.46 32.67 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.174 0.511 . . . . 0.0 110.312 -169.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.44 -2.7 37.02 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.045 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -130.89 154.35 48.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.323 0.582 . . . . 0.0 110.867 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.589 ' O ' HG12 ' A' ' 40' ' ' VAL . 5.2 ttpp -129.57 111.63 12.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.174 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 61.7 m -91.56 124.33 35.64 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.162 0.506 . . . . 0.0 111.09 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 16.3 pt -128.0 139.3 52.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.819 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.776 178.566 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.854 0.359 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 70.8 m -90.68 95.76 10.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.944 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.5 p -90.23 159.67 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -88.83 130.51 35.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.216 0.531 . . . . 0.0 111.464 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.69 -132.29 2.53 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.705 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -137.41 112.69 9.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.009 0.433 . . . . 0.0 110.335 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.476 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -100.99 -146.89 19.87 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.205 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.475 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -147.11 148.43 32.16 Favored Pre-proline 0 C--N 1.324 -0.533 0 C-N-CA 122.18 0.192 . . . . 0.0 110.664 -178.474 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.475 ' HD2' HG22 ' A' ' 45' ' ' THR . 51.1 Cg_exo -55.8 148.76 54.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.196 1.931 . . . . 0.0 110.785 173.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 9.5 tttm . . . . . 0 N--CA 1.438 -1.064 0 CA-C-O 120.691 0.281 . . . . 0.0 111.481 -171.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.22 139.99 29.94 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.827 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 28.2 m -60.24 130.8 48.43 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 109.937 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -113.08 -28.58 7.62 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.208 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.461 ' HB3' HE22 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -121.49 153.02 38.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.844 -177.006 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 58.9 m -88.44 114.56 25.19 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.392 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.14 -9.56 6.64 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.94 -173.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.461 HE22 ' HB3' ' A' ' 8' ' ' GLU . 0.6 OUTLIER -86.61 168.31 13.75 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.32 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 6.1 p30 -140.15 -55.24 0.54 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 67.8 mt -62.76 56.24 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.249 0.968 . . . . 0.0 112.854 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.827 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.33 160.78 41.9 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.444 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -71.77 108.14 4.93 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.645 0.736 . . . . 0.0 109.371 174.873 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 53.3 t -89.47 -71.34 0.61 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.168 -176.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 8.8 tp10 -82.42 161.18 22.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -8.55 -78.03 0.01 OUTLIER Glycine 0 N--CA 1.473 1.147 0 O-C-N 124.905 1.378 . . . . 0.0 115.483 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.3 p -121.16 15.23 11.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 0.0 111.232 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 4.1 m-20 -87.06 103.81 15.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.6 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.68 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 37.0 t -89.53 105.14 15.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.778 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -78.44 169.74 17.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.382 -177.181 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -153.39 -133.69 1.89 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.823 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -85.3 141.31 30.16 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.274 0.559 . . . . 0.0 110.536 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.12 -10.26 69.87 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.184 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -120.15 160.11 23.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.971 0.415 . . . . 0.0 110.497 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.575 ' O ' HG12 ' A' ' 40' ' ' VAL . 19.3 ttpp -142.45 108.54 5.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.295 176.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.49 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 67.7 m -89.46 135.09 33.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.137 -174.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 19.0 pt -131.72 138.08 53.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.375 0.607 . . . . 0.0 110.543 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 C--N 1.317 -0.827 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.549 -179.311 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.037 0.446 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.778 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 77.7 m -90.43 101.09 13.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.767 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -96.08 158.98 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.425 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.0 p -88.31 128.63 35.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.774 0.321 . . . . 0.0 111.124 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.7 -121.28 0.88 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.673 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.542 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 6.9 pt-20 -149.79 125.95 10.68 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 173.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.52 -147.49 11.34 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.611 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.35 144.53 50.01 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.453 -0.374 . . . . 0.0 110.569 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.65 141.68 86.69 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.009 1.806 . . . . 0.0 109.924 171.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.676 -172.076 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 3.0 p . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.28 146.25 26.03 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.768 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 33.7 m -59.34 129.65 43.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.183 0.516 . . . . 0.0 110.185 175.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -102.36 -13.93 17.12 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.37 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.449 ' HB2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -150.17 163.76 37.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.209 0.528 . . . . 0.0 110.913 -174.277 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m -86.11 122.33 29.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.329 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.914 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 120.88 -7.89 10.83 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.531 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.597 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.8 169.06 11.94 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 122.868 -0.196 . . . . 0.0 110.575 178.125 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.47 -57.29 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.35 56.62 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.345 1.028 . . . . 0.0 113.095 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.768 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.77 161.91 41.32 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.833 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.03 89.02 2.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.375 173.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 36.4 t -57.2 -78.04 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.635 175.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 29.2 tt0 -87.56 161.92 17.48 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -16.0 -71.52 0.01 OUTLIER Glycine 0 N--CA 1.471 0.984 0 O-C-N 124.661 1.225 . . . . 0.0 115.665 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 p -116.66 5.96 13.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.063 0.458 . . . . 0.0 111.339 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 3.3 m-20 -80.42 93.87 6.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.471 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 46.2 t -88.54 97.74 7.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -70.7 160.72 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.224 -175.12 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.92 -141.78 3.76 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.852 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -87.13 135.3 33.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.165 0.507 . . . . 0.0 109.953 -172.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.51 -7.59 59.76 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -122.66 156.71 33.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.036 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.914 ' HD2' ' HA2' ' A' ' 10' ' ' GLY . 4.7 ttpp -138.59 121.41 16.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.831 176.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 30.0 t -89.94 130.74 36.11 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.38 137.2 54.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.423 0.63 . . . . 0.0 110.462 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.315 -0.912 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.793 -172.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 51.3 tp60 . . . . . 0 C--O 1.23 0.066 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 86.5 m -90.46 104.46 17.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.586 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.8 p -97.26 164.92 2.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 p -95.25 116.27 28.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.074 0.464 . . . . 0.0 111.156 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.52 -126.95 0.97 Allowed Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.001 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 111.2 6.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.481 0.657 . . . . 0.0 110.769 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.669 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -97.4 -151.87 28.04 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.725 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.412 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -150.11 147.46 22.21 Favored Pre-proline 0 C--N 1.321 -0.64 0 C-N-CA 122.511 0.325 . . . . 0.0 110.679 -176.264 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.412 ' HD2' HG22 ' A' ' 45' ' ' THR . 52.5 Cg_exo -54.49 148.71 41.93 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.425 2.083 . . . . 0.0 110.497 170.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 2.2 ttpm? . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -165.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.32 157.66 18.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.772 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 2.7 m -67.25 133.92 50.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.321 0.581 . . . . 0.0 111.688 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -106.52 -22.57 12.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.859 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -139.98 157.83 45.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.031 0.443 . . . . 0.0 110.729 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 m -88.28 118.88 28.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.016 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.86 -5.53 10.53 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.805 -173.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.8 176.49 7.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.0 p30 -148.81 -54.14 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 98.0 mt -60.55 65.95 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.898 0.856 . . . . 0.0 112.256 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.772 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 1.2 p -154.1 165.91 34.71 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.317 -1.311 . . . . 0.0 109.451 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.3 85.54 3.09 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 99.6 m -74.85 -78.48 0.1 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.037 -174.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -85.61 115.09 23.09 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.317 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 48.75 -94.7 0.01 OUTLIER Glycine 0 C--N 1.298 -1.552 0 O-C-N 124.136 0.897 . . . . 0.0 112.006 -173.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -117.88 0.13 11.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.0 111.737 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -72.15 123.04 22.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.96 0.41 . . . . 0.0 110.64 -176.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 t -88.68 106.01 16.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.656 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -75.3 161.94 28.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.581 -177.397 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.9 -143.78 3.88 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.833 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -86.75 138.36 31.68 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.282 0.563 . . . . 0.0 110.151 -172.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.17 -10.23 58.19 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -169.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -127.06 153.42 45.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 120.96 0.41 . . . . 0.0 110.202 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 40' ' ' VAL . 14.2 ttpp -134.21 113.2 11.76 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.279 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 15.0 t -89.51 130.7 35.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.906 0.384 . . . . 0.0 110.439 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -129.46 130.22 67.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.574 0.702 . . . . 0.0 111.276 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.609 176.718 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.822 0.344 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.635 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 81.0 m -89.48 97.19 11.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.702 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.3 p -89.73 160.97 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.4 p -88.84 128.68 35.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.469 0.652 . . . . 0.0 111.37 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.43 -142.64 7.44 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.542 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -128.19 113.96 16.37 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.747 0.308 . . . . 0.0 110.779 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -100.87 -146.16 18.55 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.004 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.95 144.86 22.97 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 122.641 0.376 . . . . 0.0 110.701 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.35 145.22 94.55 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.289 1.993 . . . . 0.0 110.067 171.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? . . . . . 0 C--N 1.32 -0.675 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.549 -174.638 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.921 0.391 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 51.5 t -122.59 106.58 17.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.873 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -93.24 157.95 16.0 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.3 p -136.37 -178.08 5.0 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.87 -176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.36 155.65 19.59 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.809 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 9.6 m -65.11 133.68 52.13 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.2 m -106.02 -28.65 10.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.003 0.43 . . . . 0.0 111.089 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.437 ' CB ' HE22 ' A' ' 11' ' ' GLN . 3.4 mm-40 -125.31 158.21 34.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.0 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -87.85 125.96 34.76 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 116.4 -5.74 19.2 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.064 -173.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.741 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.8 OUTLIER -91.16 157.87 16.95 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.507 0.194 . . . . 0.0 110.917 176.482 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 14' ' ' CYS . 3.0 p30 -127.61 -59.26 1.22 Allowed 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 87.1 mt -60.64 59.5 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.482 1.114 . . . . 0.0 113.635 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.809 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -155.15 169.27 24.54 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.264 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.5 103.13 10.15 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 12.8 t -86.56 -72.87 0.48 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.617 0.723 . . . . 0.0 110.624 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -91.38 107.46 19.22 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.334 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.85 -82.41 0.01 OUTLIER Glycine 0 C--N 1.307 -1.038 0 O-C-N 124.694 1.246 . . . . 0.0 113.296 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.4 p -127.21 -3.16 6.3 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.534 0.334 . . . . 0.0 111.418 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -66.75 116.18 7.37 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.219 0.533 . . . . 0.0 111.27 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 t -88.68 93.83 4.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.871 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.711 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -63.37 145.79 54.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.803 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.87 -132.22 3.21 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.783 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -88.43 139.97 29.95 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.17 0.51 . . . . 0.0 110.525 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.29 -11.73 71.14 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.791 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -121.54 164.61 16.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.033 0.444 . . . . 0.0 110.286 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 40' ' ' VAL . 24.9 ttpp -150.67 124.91 9.42 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.734 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.6 t -89.62 135.82 33.39 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.947 0.403 . . . . 0.0 110.503 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -125.05 120.86 59.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.561 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 5.9 mp -95.35 101.16 12.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.573 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.9 -118.29 2.87 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.81 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -152.94 164.19 38.39 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.23 -126.27 25.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.985 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.63 -13.83 36.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.149 0.5 . . . . 0.0 109.701 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 t -99.58 53.55 0.94 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -95.88 -13.56 23.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.555 -173.129 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.9 118.67 4.97 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 7.7 tp-100 -151.29 140.15 20.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.64 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.711 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 79.3 m -91.65 92.76 8.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.852 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 27' ' ' LYS . 6.2 p -89.57 155.72 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -88.23 132.26 34.44 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.459 0.647 . . . . 0.0 111.179 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.16 -128.09 1.65 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.09 117.62 13.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.223 0.535 . . . . 0.0 110.033 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -93.8 -146.64 20.5 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.596 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.741 HG22 ' HG3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -150.42 145.67 18.84 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.89 118.83 5.74 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.364 2.042 . . . . 0.0 110.969 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.619 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 15.9 tttt -84.63 116.6 65.93 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.097 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.2 136.54 56.44 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 C-N-CA 122.384 2.056 . . . . 0.0 111.845 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -151.47 -28.18 0.19 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.195 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 p -119.55 134.25 55.31 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.497 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.5 m170 . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.023 0.439 . . . . 0.0 110.616 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.287 0.565 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.7 t -88.39 90.25 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.363 0.601 . . . . 0.0 110.477 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -114.15 -176.14 2.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.102 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.538 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 2.5 p -121.91 -159.33 0.81 Allowed 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.425 ' H ' ' HB ' ' A' ' 4' ' ' THR . 1.8 m-20 -86.98 161.78 18.02 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.171 -175.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 17.7 m -64.5 137.94 58.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.721 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.484 HG23 ' HG2' ' A' ' 8' ' ' GLU . 6.2 t -106.76 -16.73 14.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.2 0.524 . . . . 0.0 110.444 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.484 ' HG2' HG23 ' A' ' 7' ' ' THR . 4.9 mm-40 -138.26 154.99 49.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.741 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -88.07 127.2 35.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.608 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.43 -6.68 31.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.564 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -89.16 157.28 18.34 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.9 p30 -129.23 -60.02 1.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.66 60.65 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.306 1.042 . . . . 0.0 113.511 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.78 169.76 23.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.005 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -81.26 112.49 18.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.764 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 36.4 t -98.12 -79.42 0.47 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.651 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.92 111.09 18.93 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.414 -172.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.17 -92.33 0.01 OUTLIER Glycine 0 C--N 1.297 -1.596 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.327 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 p -121.16 2.06 10.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.709 0.29 . . . . 0.0 111.343 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -68.09 125.72 27.25 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.534 0.683 . . . . 0.0 111.381 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.26 108.64 19.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.496 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.743 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -74.6 149.77 39.94 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.123 176.095 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.33 -149.35 5.09 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.571 -0.611 . . . . 0.0 111.571 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -87.33 133.01 33.76 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.04 -8.24 38.63 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -133.57 166.84 21.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.611 -0.795 . . . . 0.0 109.253 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.55 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 24.3 ttpp -149.41 117.9 6.52 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.764 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 16.0 t -89.39 125.53 35.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.206 0.527 . . . . 0.0 110.865 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.5 pt -121.07 124.18 71.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.851 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 6.8 mp -75.78 89.03 2.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.292 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 35' ' ' SER . . . 124.62 115.84 2.14 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.21 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 16.6 tpt180 -154.09 79.82 1.12 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.26 -91.03 1.23 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.03 12.88 12.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.467 0.651 . . . . 0.0 109.553 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.497 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 22.7 t -88.58 148.63 23.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.504 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -97.04 -40.48 8.83 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.779 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 2.0 p-10 -152.35 120.02 6.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 7.4 tp60 -121.87 137.3 54.83 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.343 -174.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.743 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 97.5 m -90.14 86.96 6.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.949 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.2 p -88.02 165.89 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 p -88.97 132.22 34.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.67 0.748 . . . . 0.0 111.271 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.8 -140.39 6.4 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -138.82 111.31 7.55 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.55 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -86.5 -155.28 26.57 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.941 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.22 141.8 43.19 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.488 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 50.0 Cg_exo -54.2 140.82 71.38 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.996 1.797 . . . . 0.0 109.931 173.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 42.0 tttt -86.79 112.35 46.42 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-O 120.706 0.289 . . . . 0.0 111.334 -169.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 21.0 Cg_exo -65.76 142.39 69.74 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.827 2.351 . . . . 0.0 110.87 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.517 ' HG3' ' H ' ' A' ' 50' ' ' SER . 10.5 pt20 -164.07 -55.66 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.851 -169.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.517 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 32.9 t -150.24 148.42 28.87 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.884 0.849 . . . . 0.0 111.501 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.33 97.76 5.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.107 0.48 . . . . 0.0 110.309 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -102.54 -174.71 2.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.187 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.4 p -129.73 -175.37 3.58 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.74 -174.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.11 144.41 26.51 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.776 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 20.3 m -60.2 132.3 53.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 m -111.37 -12.99 13.97 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.195 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.526 ' HB2' ' OE1' ' A' ' 11' ' ' GLN . 37.4 mt-10 -136.05 156.01 49.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.892 -172.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.8 m -89.24 118.8 29.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.117 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.62 1.41 24.47 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.779 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.526 ' OE1' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -92.93 158.9 15.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.119 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.6 p30 -134.31 -57.38 0.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 76.6 mt -63.26 59.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.103 0.877 . . . . 0.0 112.587 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.776 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -154.43 164.9 37.93 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.778 177.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.95 98.69 7.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.635 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 14.6 t -74.16 -77.83 0.11 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.435 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 28.2 tt0 -84.13 154.52 23.09 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 11.44 -89.75 0.0 OUTLIER Glycine 0 N--CA 1.471 1.023 0 O-C-N 125.003 1.439 . . . . 0.0 115.062 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.0 p -120.07 16.96 12.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.268 0.556 . . . . 0.0 111.074 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 24.2 m-80 -79.03 98.21 6.39 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.531 0.681 . . . . 0.0 110.578 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 40.7 t -88.43 98.04 7.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.933 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -78.71 160.22 27.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.149 -174.046 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -143.3 -136.95 3.22 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.042 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -87.8 133.77 33.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.201 0.524 . . . . 0.0 109.86 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.7 -8.76 51.5 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.287 -173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -125.99 164.06 21.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.444 -0.378 . . . . 0.0 110.12 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HD3' ' O ' ' A' ' 43' ' ' GLU . 27.4 ttpp -148.23 120.43 8.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.745 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.635 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 10.4 t -88.84 136.96 32.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.856 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 pt -127.78 134.5 65.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.239 0.543 . . . . 0.0 110.28 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.69 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 44.0 mt -103.86 84.02 2.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.412 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.457 ' C ' ' HA ' ' A' ' 36' ' ' LYS . . . -108.77 -109.72 3.32 Favored Glycine 0 C--N 1.317 -0.501 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.647 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.426 ' HD3' ' N ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -152.87 168.2 26.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -176.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 36' ' ' LYS . . . 68.33 -118.49 9.37 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.092 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -94.83 -15.27 23.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.472 0.653 . . . . 0.0 109.35 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 t -100.46 26.69 6.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.947 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 3.2 ptpt -78.43 -31.28 48.04 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.296 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -153.87 80.08 1.14 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 6.7 tp60 -134.68 140.44 46.0 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.666 -171.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 89.4 m -92.02 97.95 11.26 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.135 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.8 p -89.67 161.8 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.2 p -89.11 129.39 35.73 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.368 0.604 . . . . 0.0 111.58 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.87 -132.33 2.62 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.183 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 5.8 pt-20 -136.95 119.24 15.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.266 0.555 . . . . 0.0 110.756 175.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.86 -143.87 15.64 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.208 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.22 142.71 17.21 Favored Pre-proline 0 C--N 1.324 -0.514 0 C-N-CA 122.507 0.323 . . . . 0.0 110.399 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 32.0 Cg_exo -59.0 132.79 49.37 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.655 2.237 . . . . 0.0 111.159 174.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 6' ' ' CYS . 1.8 ttpm? -89.6 108.23 23.82 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.77 -175.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 21.3 Cg_exo -65.07 147.54 88.8 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.589 2.193 . . . . 0.0 111.804 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -139.02 -38.59 0.5 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.565 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.3 m -90.24 -30.61 17.43 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 51.5 m80 . . . . . 0 CA--C 1.512 -0.517 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.133 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 120.941 0.4 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 t -100.04 76.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.582 0.706 . . . . 0.0 110.056 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -97.77 153.34 18.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.868 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.521 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 5.5 p -135.32 -164.37 1.52 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.353 -175.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.32 145.52 26.31 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.7 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 26.1 m -59.54 134.14 56.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.959 0.409 . . . . 0.0 110.941 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 m -110.61 -31.67 7.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.61 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.45 ' HB2' ' OE1' ' A' ' 11' ' ' GLN . 25.6 mp0 -115.1 152.52 32.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.717 -176.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 m -88.88 119.91 29.8 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 117.46 -5.85 16.89 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.999 -173.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.45 ' OE1' ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -89.08 166.33 13.93 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' CYS . 8.6 p30 -135.62 -58.19 0.78 Allowed 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.75 60.56 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.119 0.887 . . . . 0.0 112.944 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.7 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -153.76 161.28 42.22 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.359 178.282 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -81.77 100.03 9.3 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.578 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 30.8 t -82.34 -74.93 0.32 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.843 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 2.0 tm-20 -78.38 148.16 33.8 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 10.02 -85.87 0.0 OUTLIER Glycine 0 N--CA 1.471 1.016 0 O-C-N 124.972 1.42 . . . . 0.0 115.372 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.9 p -119.81 5.36 10.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.967 0.413 . . . . 0.0 111.248 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 5.0 m-20 -71.38 107.64 4.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.227 0.537 . . . . 0.0 110.502 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.9 t -89.09 98.55 8.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.497 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -66.88 153.72 42.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.211 -178.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -148.71 -128.17 1.69 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.095 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.67 134.45 33.65 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.207 0.527 . . . . 0.0 109.956 -174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.66 0.63 66.62 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.644 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.43 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 51.9 m-80 -133.96 164.48 27.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.126 0.488 . . . . 0.0 110.794 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 25.0 ttpp -150.61 123.34 8.6 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.494 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 38' ' ' GLN . 27.8 t -89.94 133.08 34.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.986 0.422 . . . . 0.0 110.6 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.69 112.42 33.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.431 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 5.3 mp -86.78 80.67 8.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.569 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.17 -112.23 2.35 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.709 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 35' ' ' SER . 38.7 ttp180 -155.26 157.07 36.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -173.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.72 -137.24 13.3 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.829 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.15 -7.38 56.99 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 167.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 53.8 m -92.64 23.64 3.96 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 112.462 -2.154 . . . . 0.0 110.35 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 12.1 ptmm? -59.26 -36.88 76.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.298 -176.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 3.5 p-10 -152.87 128.93 10.37 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 7.3 tp-100 -145.12 138.53 26.68 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.452 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 60.3 m -89.36 87.93 7.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.946 172.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.9 p -89.23 159.31 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -88.9 130.62 35.39 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.258 0.551 . . . . 0.0 111.186 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.91 -134.83 3.3 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.5 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.526 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 8.8 pt-20 -133.8 113.86 12.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.099 0.476 . . . . 0.0 109.888 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.555 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -96.18 -149.75 26.02 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.523 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.39 142.47 26.68 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 122.568 0.347 . . . . 0.0 110.324 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.42 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 32.5 Cg_exo -58.42 129.55 33.2 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.301 2.0 . . . . 0.0 110.851 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.528 ' HE2' ' HE1' ' A' ' 51' ' ' HIS . 15.2 tttt -89.11 113.29 55.64 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.349 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 9.4 Cg_exo -71.93 148.74 52.07 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.867 2.378 . . . . 0.0 111.691 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -99.21 -4.13 32.74 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.962 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.4 p -88.97 55.75 3.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.591 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.528 ' HE1' ' HE2' ' A' ' 47' ' ' LYS . 23.0 m80 . . . . . 0 CA--C 1.509 -0.607 0 CA-C-O 121.455 0.645 . . . . 0.0 110.924 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.671 0.272 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.99 104.23 16.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.823 0.344 . . . . 0.0 110.739 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -89.75 160.44 16.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.092 0.472 . . . . 0.0 110.371 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.482 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.7 p -139.38 -165.06 1.79 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.339 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.531 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 7.4 m-20 -87.72 149.53 24.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.726 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 25.9 m -61.45 134.75 57.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.858 0.361 . . . . 0.0 110.755 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -112.1 -20.85 11.78 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.265 0.555 . . . . 0.0 110.406 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -134.92 154.99 51.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.333 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -86.63 124.44 32.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.8 -10.05 16.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.663 -172.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -89.95 154.05 20.14 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.1 p30 -126.79 -61.85 1.16 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.427 HD23 ' HA2' ' A' ' 23' ' ' GLY . 94.4 mt -58.99 63.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.011 0.925 . . . . 0.0 113.05 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.726 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.15 162.32 41.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.871 177.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -78.37 87.84 4.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.602 ' HA ' ' SG ' ' A' ' 6' ' ' CYS . 13.9 t -61.3 -77.55 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.253 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.634 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 6.8 tp10 -82.56 164.91 20.53 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -8.41 -71.86 0.01 OUTLIER Glycine 0 N--CA 1.472 1.089 0 O-C-N 124.88 1.363 . . . . 0.0 115.269 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.4 p -127.67 4.38 6.11 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.697 -0.296 . . . . 0.0 111.392 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 3.8 m-20 -78.8 110.64 14.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 110.737 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 40.6 t -89.88 106.78 17.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.74 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.76 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -68.42 146.98 52.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.92 177.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -131.98 -156.98 8.51 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.039 -1.076 . . . . 0.0 113.454 -177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.82 117.44 24.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.739 0.78 . . . . 0.0 109.607 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.34 -4.24 23.5 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -165.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.494 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 6.6 m120 -122.25 164.49 17.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.651 -0.774 . . . . 0.0 108.987 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 40' ' ' VAL . 26.4 ttpp -149.98 118.25 6.41 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.479 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.7 t -89.51 130.48 35.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.039 0.447 . . . . 0.0 110.624 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -123.65 112.95 35.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.132 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 5.8 mp -80.33 79.5 6.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.474 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.14 -109.72 1.55 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.724 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.26 168.5 27.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.88 -142.26 18.3 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.378 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.96 -2.0 58.34 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 167.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 m -98.17 25.47 6.13 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.731 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.625 ' HG3' ' OD1' ' A' ' 37' ' ' ASN . 9.6 pttm -58.58 -26.88 64.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.008 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.634 ' ND2' ' HA ' ' A' ' 17' ' ' GLU . 18.3 p-10 -153.41 82.28 1.18 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 11.9 tp60 -94.57 135.67 35.76 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.871 -169.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.76 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 54.6 m -89.62 89.85 7.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.112 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.8 p -88.79 153.2 3.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 p -89.78 119.73 30.43 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.175 0.512 . . . . 0.0 110.57 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.86 -130.99 1.51 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.63 110.76 7.32 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.118 0.485 . . . . 0.0 110.132 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.501 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -99.14 -145.06 17.81 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.225 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.37 136.14 11.32 Favored Pre-proline 0 C--N 1.317 -0.812 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.79 135.88 42.66 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.442 2.095 . . . . 0.0 111.038 171.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 5' ' ' ASP . 24.5 tttm -86.61 120.9 72.2 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.67 135.47 27.63 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.018 2.479 . . . . 0.0 112.505 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -133.38 -33.87 1.09 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.25 -171.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -88.9 -64.17 1.18 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.928 176.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 55.2 m80 . . . . . 0 CA--C 1.508 -0.638 0 CA-C-O 121.396 0.617 . . . . 0.0 110.219 -177.56 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.969 0.414 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.6 t -113.2 110.33 31.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.399 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -115.15 168.51 9.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.293 0.568 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 p -127.36 -172.8 2.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.815 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.791 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 3.4 m-20 -89.04 149.0 23.43 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.813 ' HB2' HD22 ' A' ' 37' ' ' ASN . 61.2 m -58.57 144.35 43.12 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.234 0.54 . . . . 0.0 112.082 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.624 ' OG1' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -114.26 -23.87 9.22 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.676 176.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.508 ' HB2' ' OE1' ' A' ' 11' ' ' GLN . 43.1 mt-10 -136.15 153.69 51.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.304 -170.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.8 m -88.46 120.86 30.23 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.7 -11.56 13.77 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -172.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.508 ' OE1' ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -88.01 164.34 15.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.412 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.2 p30 -134.93 -58.0 0.81 Allowed 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.415 HD23 ' HA2' ' A' ' 23' ' ' GLY . 87.2 mt -58.16 61.81 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.383 1.073 . . . . 0.0 113.42 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.734 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.6 166.3 33.8 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.233 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.78 94.16 6.36 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.552 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . 49.3 t -73.79 -74.49 0.18 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.356 -172.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -91.92 150.16 21.18 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 27.15 -91.5 0.01 OUTLIER Glycine 0 N--CA 1.472 1.07 0 O-C-N 124.548 1.155 . . . . 0.0 114.535 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.01 32.73 4.0 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.413 0.625 . . . . 0.0 110.948 173.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.06 112.91 19.55 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.694 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.8 t -88.37 91.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -69.14 146.64 52.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.39 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -136.29 -152.51 6.32 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.07 137.02 32.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.489 0.644 . . . . 0.0 109.357 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.17 -9.93 46.78 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -167.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -126.93 158.63 36.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.861 -0.669 . . . . 0.0 109.892 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 18.3 ttpp -139.55 121.21 15.29 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 74.1 m -89.76 143.38 26.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.724 0.297 . . . . 0.0 111.13 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.8 pt -135.36 131.12 51.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.289 0.566 . . . . 0.0 110.768 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.7 mp -91.3 117.81 29.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.372 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.64 -115.99 2.31 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.768 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -141.67 160.56 39.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.639 0.257 . . . . 0.0 111.334 -174.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.11 -124.56 11.4 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.023 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -93.06 -10.13 37.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 t -90.73 30.65 1.14 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.638 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -64.86 -21.2 66.75 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.899 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.813 HD22 ' HB2' ' A' ' 6' ' ' CYS . 4.0 t-20 -153.56 96.55 2.03 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -119.63 148.3 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.218 -173.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 91.8 m -101.21 114.89 29.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.046 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 27' ' ' LYS . 1.2 p -104.16 157.22 5.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.9 p -91.36 123.78 35.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.077 0.465 . . . . 0.0 111.162 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.8 -120.23 0.75 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.502 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 13.6 pt-20 -151.95 123.38 7.79 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.493 -0.416 . . . . 0.0 110.452 174.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.562 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -107.72 -151.96 17.07 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.937 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.07 144.01 51.36 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.72 135.43 67.17 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.216 1.944 . . . . 0.0 110.819 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.791 ' HE3' ' O ' ' A' ' 5' ' ' ASP . 14.6 tttm -88.41 138.56 30.19 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.755 -174.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.94 139.32 25.7 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.551 2.168 . . . . 0.0 111.222 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -132.9 -17.29 2.46 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.951 -165.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -87.04 148.41 25.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.4 m170 . . . . . 0 CA--C 1.511 -0.544 0 CA-C-O 121.376 0.608 . . . . 0.0 111.98 -168.664 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 65.6 t . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.837 0.351 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.95 110.42 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.418 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -91.02 -177.15 4.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.173 0.511 . . . . 0.0 110.816 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.638 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 82.7 p -125.4 -167.89 1.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.45 172.22 9.96 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.807 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 31.3 m -73.37 136.37 44.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.023 0.44 . . . . 0.0 111.248 -177.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 m -102.31 -21.93 14.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -139.5 156.22 47.06 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.115 0.484 . . . . 0.0 110.701 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.9 m -90.16 107.75 19.32 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.025 -0.988 . . . . 0.0 108.53 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 124.79 -0.53 8.49 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -169.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -88.15 -171.1 3.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.6 p30 -159.04 -55.2 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 74.1 mt -60.8 61.34 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.805 0.842 . . . . 0.0 112.905 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.807 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -154.03 166.91 31.53 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.14 178.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.5 OUTLIER -79.01 91.58 4.87 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.004 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.721 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 33.1 t -92.65 -65.04 1.03 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.188 0.518 . . . . 0.0 111.245 -174.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -83.69 103.79 13.28 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.793 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.36 -95.29 0.01 OUTLIER Glycine 0 C--N 1.294 -1.753 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.796 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.3 p -121.33 11.99 10.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.743 0.306 . . . . 0.0 111.236 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -73.11 126.07 29.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.07 0.462 . . . . 0.0 110.635 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 t -89.83 102.55 13.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.089 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 13' ' ' LEU . 1.3 m -85.3 162.83 18.94 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.915 0.388 . . . . 0.0 111.37 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -148.76 -140.04 3.24 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.726 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -84.8 134.73 34.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.292 0.567 . . . . 0.0 109.56 -173.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.89 -16.46 28.11 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -169.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -119.61 158.38 26.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.061 0.458 . . . . 0.0 110.786 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.629 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 4.4 tppp? -130.51 107.71 9.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.049 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 85.8 m -89.31 126.81 35.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.538 0.208 . . . . 0.0 110.77 -177.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -128.82 127.94 66.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.196 0.522 . . . . 0.0 111.163 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.56 ' HG ' ' OD1' ' A' ' 37' ' ' ASN . 5.5 mp -87.02 81.11 8.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.495 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.02 -113.0 1.71 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.158 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -164.55 176.58 8.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.84 -116.32 7.23 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.345 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -96.5 -22.78 16.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.571 0.701 . . . . 0.0 109.132 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -91.64 37.29 0.96 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.979 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.625 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -64.92 -32.25 73.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.902 -175.407 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.625 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 10.7 t30 -155.1 75.28 0.95 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -115.63 146.67 41.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -165.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 16' ' ' CYS . 69.8 m -94.26 100.55 12.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.401 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.1 p -90.84 158.48 2.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.3 p -89.13 125.69 35.15 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.623 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.97 -123.37 0.87 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.955 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -152.3 109.01 3.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.174 0.511 . . . . 0.0 110.294 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.629 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -90.2 -147.61 18.1 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.287 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.547 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -133.8 142.03 42.13 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.7 134.19 61.35 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.129 1.886 . . . . 0.0 110.851 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HD3' ' HB3' ' A' ' 14' ' ' CYS . 1.6 ttpm? -88.34 113.84 57.0 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 -171.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.24 151.08 18.05 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.115 2.544 . . . . 0.0 111.521 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -124.25 -42.98 2.09 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -168.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.9 m -102.98 -92.57 0.33 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.095 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.6 m80 . . . . . 0 CA--C 1.513 -0.446 0 CA-C-O 121.03 0.443 . . . . 0.0 110.804 -171.28 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.847 0.356 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 t -112.62 79.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.103 0.478 . . . . 0.0 110.739 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -95.0 154.93 16.94 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 4.7 p -134.91 -159.88 1.0 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.23 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.51 155.95 19.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.719 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.1 m -63.81 137.14 57.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.986 0.422 . . . . 0.0 111.621 -176.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m -107.5 -31.4 8.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.047 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.82 157.01 46.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.609 -175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 m -88.39 122.1 31.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.476 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.94 -6.5 21.97 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.8 164.97 14.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.9 p30 -136.77 -57.12 0.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.414 HD23 ' HA2' ' A' ' 23' ' ' GLY . 91.8 mt -59.55 61.39 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.111 0.965 . . . . 0.0 112.984 -176.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.719 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.77 167.29 30.7 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.394 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -81.62 105.24 12.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.726 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 34.2 t -94.57 -70.85 0.69 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.654 -172.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 20.4 tt0 -86.84 79.38 8.82 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.106 0.955 . . . . 0.0 109.68 -175.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 -91.88 0.28 Allowed Glycine 0 C--N 1.294 -1.781 0 CA-C-N 113.551 -1.659 . . . . 0.0 111.612 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 p -109.25 -3.45 17.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.658 0.266 . . . . 0.0 110.929 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 18.8 m-80 -64.84 114.79 4.73 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.184 0.516 . . . . 0.0 111.124 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.01 104.36 14.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.918 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.91 151.32 37.37 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.959 0.409 . . . . 0.0 110.233 179.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -140.14 -153.5 6.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.97 144.75 27.45 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.13 -3.42 80.28 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -165.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -135.0 156.3 49.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.6 ttpp -142.12 123.15 14.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.969 0.414 . . . . 0.0 109.981 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.726 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 14.4 t -90.04 139.48 30.57 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.911 0.386 . . . . 0.0 110.688 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.9 pt -132.38 124.04 51.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.761 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.0 mp -81.3 98.29 8.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.055 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 36' ' ' LYS . . . 99.54 114.85 3.62 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.584 -0.735 . . . . 0.0 113.463 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.539 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -169.26 114.46 0.56 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.034 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.62 -115.73 8.19 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.829 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -98.43 48.75 0.99 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.05 0.452 . . . . 0.0 109.902 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.543 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 8.0 t -148.4 156.04 41.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.354 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.562 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -129.58 -8.78 4.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.826 174.301 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.518 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 6.5 t-20 -154.7 81.71 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.539 ' HG2' ' HD2' ' A' ' 32' ' ' ARG . 27.7 tp60 -113.48 141.51 47.03 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -167.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 93.9 m -96.67 109.14 21.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.773 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.7 p -103.6 162.96 3.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 p -90.18 129.23 36.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.487 0.661 . . . . 0.0 111.198 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.51 -144.43 8.96 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.91 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -128.31 105.61 8.46 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.974 0.416 . . . . 0.0 110.267 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.81 -151.99 22.88 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.202 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.21 142.5 35.61 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.17 142.69 77.49 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.381 2.054 . . . . 0.0 111.428 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HD3' ' HB3' ' A' ' 14' ' ' CYS . 2.3 ttpm? -87.29 119.22 70.78 Favored Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -175.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.0 148.06 1.15 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.476 3.451 . . . . 0.0 114.019 -174.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.12 -24.69 3.39 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.429 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 92.1 p -88.32 -35.09 17.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.112 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 . . . . . 0 CA--C 1.501 -0.909 0 CA-C-O 121.899 0.856 . . . . 0.0 110.194 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.5 t -88.47 83.72 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -165.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -90.05 150.21 22.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 164.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.566 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -150.8 -173.18 4.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.76 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.24 150.51 24.32 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.777 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 13.3 m -62.15 128.84 38.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.024 0.44 . . . . 0.0 110.479 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -95.71 -17.17 21.47 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.868 -177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' HB2' ' OE1' ' A' ' 11' ' ' GLN . 36.1 mt-10 -138.37 151.69 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.786 -170.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.1 m -87.67 124.21 33.31 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.472 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 115.35 -6.58 21.06 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.876 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.526 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -89.84 162.48 15.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.1 p30 -132.74 -59.24 0.91 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 73.8 mt -60.29 61.47 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -174.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.777 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -155.41 172.75 17.7 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.985 177.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -85.87 80.55 8.87 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.601 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 17.5 t -60.66 -70.72 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.205 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -95.78 137.84 34.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 30.43 -96.7 0.01 OUTLIER Glycine 0 N--CA 1.467 0.708 0 O-C-N 124.733 1.271 . . . . 0.0 114.712 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 p -120.08 17.0 12.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.275 0.56 . . . . 0.0 111.46 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -85.38 103.82 14.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.554 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -87.93 102.9 13.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -74.26 153.3 39.47 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.735 -176.368 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.31 -134.88 3.26 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.127 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.65 126.88 35.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.053 0.454 . . . . 0.0 110.259 -171.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.26 -13.2 31.08 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -119.85 161.33 21.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.242 -0.479 . . . . 0.0 109.924 176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.8 ttpp -146.25 123.08 11.27 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.84 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.601 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.2 t -89.04 141.92 28.08 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.718 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.5 pt -133.42 128.75 55.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.31 0.576 . . . . 0.0 109.998 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 6' ' ' CYS . 6.6 mp -100.21 120.6 40.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.45 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 35' ' ' SER . . . 74.46 96.26 0.11 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.323 -0.853 . . . . 0.0 114.099 172.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 32' ' ' ARG . 2.5 tpt180 -159.98 94.66 1.13 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.04 -110.26 3.0 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -94.67 1.96 55.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.068 0.461 . . . . 0.0 109.984 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 9.3 t -90.03 146.15 24.56 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.992 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.647 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -135.37 -32.5 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.019 175.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.647 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 4.9 t-20 -155.64 77.7 0.98 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -115.71 146.78 41.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.953 0.406 . . . . 0.0 111.79 -171.507 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 90.3 m -99.48 106.18 18.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.516 175.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.2 p -95.99 158.99 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.1 p -88.98 126.84 35.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.8 0.333 . . . . 0.0 111.112 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.68 -119.12 0.73 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.006 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 9.2 pt-20 -147.02 117.0 7.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -102.91 -149.12 21.14 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.537 -177.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.7 144.9 19.87 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.369 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.568 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 53.0 Cg_exo -55.6 144.55 74.25 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.362 2.041 . . . . 0.0 110.436 173.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 1.8 ttpm? -87.99 107.7 17.35 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 7.6 Cg_exo -73.09 152.0 50.47 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.692 2.261 . . . . 0.0 111.607 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.25 -66.23 0.2 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 t -145.15 -172.77 3.93 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.4 m170 . . . . . 0 CA--C 1.505 -0.756 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 175.231 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.8 t -114.75 124.16 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.23 162.75 26.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.148 0.499 . . . . 0.0 110.464 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -147.96 -177.51 5.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.632 176.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.458 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 4.8 m-20 -86.93 148.05 25.51 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.704 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 21.9 m -60.8 133.58 56.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.502 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -109.91 -29.62 8.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.877 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 159.43 30.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.347 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -87.52 117.2 26.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.569 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.98 -6.82 9.42 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.214 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -89.42 160.44 16.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.639 0.257 . . . . 0.0 110.426 177.29 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.4 p30 -133.79 -57.28 0.88 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 78.9 mt -61.47 60.58 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.003 0.921 . . . . 0.0 112.886 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.704 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -155.05 162.33 41.08 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.448 179.154 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.68 85.36 5.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.1 0.476 . . . . 0.0 109.953 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.628 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 26.1 t -66.28 -73.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.429 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.08 144.12 26.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.116 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 22.76 -90.53 0.01 OUTLIER Glycine 0 N--CA 1.47 0.918 0 O-C-N 125.028 1.455 . . . . 0.0 114.699 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 p -121.6 -1.7 9.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.794 0.331 . . . . 0.0 111.197 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -70.29 104.06 2.56 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.629 0.728 . . . . 0.0 110.997 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 21.3 t -88.84 101.05 11.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.922 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -65.82 156.92 31.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.972 -175.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -134.71 -152.92 6.7 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -85.96 139.15 31.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.28 -15.63 50.28 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -120.48 166.22 13.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.4 ttpp -149.99 117.4 6.09 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.628 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.5 t -88.92 136.31 33.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.887 0.375 . . . . 0.0 110.266 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.2 pt -127.01 128.35 70.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.299 0.571 . . . . 0.0 110.243 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 5.8 mp -107.71 104.36 13.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.871 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 35' ' ' SER . . . 85.74 77.5 1.2 Allowed Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.76 176.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -136.69 66.97 1.46 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.11 -100.38 2.32 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.763 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.57 12.47 22.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.338 0.59 . . . . 0.0 109.707 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.442 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 3.1 t -113.25 144.62 42.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.777 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -132.71 -38.21 1.02 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.784 0.326 . . . . 0.0 110.253 174.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -155.12 97.35 1.91 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -144.01 138.89 28.69 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.135 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 91.8 m -89.41 96.03 10.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.916 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.6 p -90.23 160.13 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 p -88.88 132.0 34.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.285 0.564 . . . . 0.0 111.368 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.91 -128.6 1.68 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.876 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -143.14 112.85 6.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.344 0.593 . . . . 0.0 110.28 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.444 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -93.53 -148.09 23.03 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.419 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.93 142.71 22.81 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.83 139.4 78.19 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.198 1.932 . . . . 0.0 110.676 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.556 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 16.5 tttm -86.46 123.97 70.42 Favored Pre-proline 0 N--CA 1.432 -1.352 0 CA-C-O 120.99 0.424 . . . . 0.0 110.493 -173.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 32.5 Cg_exo -58.49 142.53 98.1 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.791 2.327 . . . . 0.0 112.27 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.774 ' HG3' ' H ' ' A' ' 50' ' ' SER . 4.7 pt20 -160.94 -69.86 0.06 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.07 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.774 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 4.9 t -112.6 63.19 0.63 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.804 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 . . . . . 0 CA--C 1.503 -0.845 0 CA-C-O 121.33 0.586 . . . . 0.0 110.366 178.941 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 81.9 t . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 33.2 t -125.1 84.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 110.391 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -88.76 156.5 18.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.47 0.652 . . . . 0.0 109.886 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.612 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -151.32 -157.54 0.82 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.953 -177.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.77 147.76 26.17 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 10.2 m -59.35 129.87 44.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.117 0.484 . . . . 0.0 110.796 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 m -103.08 -27.08 12.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.601 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.36 159.36 36.42 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.403 -176.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 46.5 m -87.05 118.66 26.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.292 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.88 -4.72 11.54 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.12 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.506 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -89.06 161.82 16.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.706 0.288 . . . . 0.0 110.402 175.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 14' ' ' CYS . 6.1 p30 -135.66 -56.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.126 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 88.9 mt -62.15 63.13 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.375 1.047 . . . . 0.0 112.161 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -153.94 162.6 41.09 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.332 177.575 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.73 81.46 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.388 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.739 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 43.2 t -67.87 -79.87 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.385 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 11.1 tp10 -72.86 157.59 37.17 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -3.38 -78.3 0.01 OUTLIER Glycine 0 N--CA 1.472 1.094 0 O-C-N 125.284 1.615 . . . . 0.0 115.446 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.0 p -126.64 15.03 7.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.009 0.433 . . . . 0.0 111.125 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 4.9 m-20 -83.85 111.2 18.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.755 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.9 t -87.92 103.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -74.94 163.82 27.22 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.081 -176.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.77 -138.34 2.83 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.849 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -85.91 125.8 33.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.195 0.521 . . . . 0.0 109.917 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -19.54 11.38 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -172.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -124.33 161.38 26.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' O ' HG12 ' A' ' 40' ' ' VAL . 25.6 ttpp -141.9 117.92 10.61 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.739 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 32.8 t -91.05 135.27 33.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.095 0.474 . . . . 0.0 110.572 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 23.3 pt -132.38 144.81 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.137 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.674 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.1 mp -97.15 98.06 9.72 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.327 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.8 -120.19 4.42 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.456 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -149.13 174.07 12.74 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.14 -132.45 42.66 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.299 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -89.34 -2.25 58.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.182 0.515 . . . . 0.0 109.696 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -104.88 47.44 0.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.799 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.77 -16.94 49.4 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.504 -177.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.566 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 26.2 t-20 -155.14 94.56 1.64 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -134.14 137.81 44.77 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.359 -172.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 92.8 m -89.7 96.02 10.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.152 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.1 p -89.8 166.12 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.9 p -88.52 127.4 35.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.263 0.554 . . . . 0.0 111.178 -176.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.5 -135.54 3.57 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.985 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -141.36 110.3 6.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.448 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -92.68 -149.74 25.23 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.261 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.31 144.87 29.93 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 51.3 Cg_exo -55.3 140.35 81.74 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.387 2.058 . . . . 0.0 111.408 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.506 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 11.3 tttm -87.65 138.57 31.56 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.164 -176.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD2' ' HG2' ' A' ' 47' ' ' LYS . 83.7 Cg_exo -49.15 142.2 21.59 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.304 2.669 . . . . 0.0 113.419 177.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB2' ' HB ' ' A' ' 2' ' ' VAL . 5.7 pt20 -148.59 -10.77 0.35 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.557 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.3 m -151.51 35.17 0.56 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.486 -172.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.2 m170 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.271 0.557 . . . . 0.0 110.734 177.543 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.917 0.389 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.67 97.21 6.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.084 0.468 . . . . 0.0 110.014 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -89.68 160.5 16.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.033 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.6 -178.02 5.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.252 -174.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.1 155.55 20.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.782 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 3.8 m -61.18 134.26 56.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.366 0.603 . . . . 0.0 111.592 -173.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 m -100.13 -18.17 17.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.711 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -145.46 157.85 43.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.591 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 m -89.37 120.22 30.52 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.489 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.07 -2.9 14.43 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.532 -170.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.16 172.39 9.11 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.9 p30 -143.52 -55.81 0.39 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 74.6 mt -61.61 66.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.925 0.869 . . . . 0.0 112.478 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.782 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -153.83 168.93 24.68 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.112 -1.403 . . . . 0.0 109.592 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.71 84.41 4.05 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 92.5 m -72.77 -80.21 0.07 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.473 -175.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -88.0 121.01 29.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.358 -173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.47 -90.31 0.01 OUTLIER Glycine 0 C--N 1.304 -1.235 0 O-C-N 123.985 0.803 . . . . 0.0 111.436 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.84 10.54 4.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.7 0.286 . . . . 0.0 111.561 173.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -71.17 126.11 28.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.164 0.506 . . . . 0.0 110.718 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 3.7 t -88.61 93.85 4.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.882 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.664 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -65.97 154.82 38.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 -176.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.01 -156.23 8.66 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -87.39 132.74 33.87 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.55 -22.26 8.86 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -168.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -117.6 159.95 22.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.09 171.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.551 ' O ' HG12 ' A' ' 40' ' ' VAL . 19.2 ttpp -133.62 113.97 12.99 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.303 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 51.7 t -90.22 130.51 36.34 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.6 pt -123.76 127.24 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.459 0.647 . . . . 0.0 111.023 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 20.4 mt -84.08 109.91 18.06 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.023 176.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.41 -112.51 3.56 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.129 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -167.26 163.85 15.38 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.25 -119.24 8.52 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.14 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.91 -5.26 53.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.167 0.508 . . . . 0.0 109.719 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 t -114.2 34.99 4.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.643 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -63.91 -21.08 66.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.896 -178.459 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.626 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 21.5 t-20 -153.46 131.02 11.43 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -150.35 124.73 9.54 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.468 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.664 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 81.0 m -89.57 95.7 10.38 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.696 176.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 27' ' ' LYS . 5.0 p -89.03 160.33 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.0 p -89.24 126.06 35.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.227 0.537 . . . . 0.0 111.422 -175.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.9 -122.36 0.9 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 11.8 pt-20 -150.23 123.59 8.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.177 0.513 . . . . 0.0 110.417 173.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -107.52 -145.81 12.3 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.381 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.22 142.62 21.98 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 51.1 Cg_exo -57.41 144.09 92.49 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.581 2.187 . . . . 0.0 111.243 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' A' ' 14' ' ' CYS . 2.1 ttpm? -89.08 108.56 24.79 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.534 0.207 . . . . 0.0 111.445 -172.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 6.2 Cg_exo -72.22 169.68 20.96 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.04 2.493 . . . . 0.0 111.932 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -156.97 -33.02 0.08 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.987 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 t -104.42 138.63 40.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.813 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.408 . . . . 0.0 110.071 -179.17 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 121.017 0.437 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -107.56 90.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.125 0.488 . . . . 0.0 110.831 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -98.65 162.52 13.09 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p -133.57 176.2 8.75 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -87.89 152.29 22.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 11.5 m -60.0 133.24 55.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.558 -178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -113.44 -15.28 12.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.517 0.675 . . . . 0.0 110.273 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.556 ' HB2' ' OE1' ' A' ' 11' ' ' GLN . 46.1 mt-10 -134.2 151.64 51.42 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.217 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -88.11 124.36 33.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.06 -4.21 27.09 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.328 -173.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.556 ' OE1' ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -89.27 162.11 16.04 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.7 p30 -136.04 -56.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 73.6 mt -61.83 62.18 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.96 0.788 . . . . 0.0 112.918 -177.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -155.48 175.25 14.12 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.596 178.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.2 106.57 14.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 40.2 t -98.73 -65.9 0.93 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.434 0.635 . . . . 0.0 110.966 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.13 107.07 18.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.879 -175.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.73 -90.04 0.01 OUTLIER Glycine 0 C--N 1.299 -1.521 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.007 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 p -124.49 2.08 8.34 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.0 0.429 . . . . 0.0 111.424 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -70.25 125.14 25.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.782 -175.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.06 105.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.348 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -72.91 155.47 39.84 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.24 -143.22 4.38 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.636 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -86.21 139.12 31.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.486 0.66 . . . . 0.0 110.266 -176.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.71 -9.94 58.82 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.718 -172.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -125.73 160.77 28.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.033 174.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.7 ttpp -143.74 119.55 10.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.536 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 17.5 t -89.16 133.18 34.5 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.847 0.356 . . . . 0.0 110.304 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 pt -128.29 123.01 59.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.379 0.609 . . . . 0.0 110.883 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.7 mp -79.4 97.84 6.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.474 176.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.44 -120.21 3.26 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.028 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 16.0 mmt180 -147.77 160.11 43.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.59 -115.64 7.53 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.059 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -89.6 -21.98 22.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.546 0.689 . . . . 0.0 109.639 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 t -93.62 31.86 1.5 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.253 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.628 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -65.05 -28.04 69.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.559 -175.209 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.628 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 2.7 t30 -154.93 89.8 1.25 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -128.09 145.05 51.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -170.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 72.8 m -89.12 110.51 21.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.859 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.7 p -103.29 159.95 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 p -88.98 128.33 35.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.228 0.537 . . . . 0.0 111.122 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.6 -133.93 2.73 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.245 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -139.51 111.1 7.15 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.155 0.502 . . . . 0.0 109.938 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.75 -152.98 28.77 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.433 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.28 139.03 30.38 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.5 135.15 68.01 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.351 2.034 . . . . 0.0 110.907 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 18.7 tttt -87.79 113.68 55.64 Favored Pre-proline 0 N--CA 1.443 -0.801 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 16.5 Cg_exo -67.13 145.77 74.18 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.721 2.28 . . . . 0.0 112.571 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -142.95 -42.23 0.31 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.159 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -88.12 174.71 8.09 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.796 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.5 m80 . . . . . 0 CA--C 1.507 -0.699 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.31 -178.837 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.137 0.494 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.91 120.37 63.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -115.01 178.88 4.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.5 p -137.59 -161.44 1.17 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.693 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -85.24 142.61 29.28 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -174.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.727 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 35.0 m -50.28 133.15 24.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.503 0.668 . . . . 0.0 111.128 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -115.07 -10.25 12.24 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.595 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.476 ' HB2' ' OE1' ' A' ' 11' ' ' GLN . 41.8 mt-10 -143.94 151.04 39.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.631 -173.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 m -89.01 126.95 35.64 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.455 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.3 -1.03 34.98 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.789 ' HG2' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.19 164.85 14.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 8.8 p30 -139.74 -57.05 0.57 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 75.4 mt -62.1 59.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.979 0.895 . . . . 0.0 112.415 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.768 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 1.6 p -155.39 150.6 26.9 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.126 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.65 89.85 2.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.629 0.728 . . . . 0.0 109.949 177.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.791 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 34.1 t -62.66 -73.51 0.11 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.358 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 1.2 tm-20 -87.53 163.31 16.73 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -23.04 -72.53 0.01 OUTLIER Glycine 0 N--CA 1.472 1.058 0 O-C-N 124.26 0.975 . . . . 0.0 115.366 -169.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.9 p -115.72 14.72 16.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.238 0.542 . . . . 0.0 110.46 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 3.8 m-20 -80.81 92.19 6.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.889 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 41.9 t -87.91 97.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.702 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.47 158.81 32.09 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.8 -173.301 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -141.42 -146.26 4.69 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -87.0 134.72 33.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.196 0.522 . . . . 0.0 109.641 -174.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.01 -13.91 37.51 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -170.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -123.89 165.84 16.68 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.8 ttpp -148.89 118.46 6.97 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.791 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 13.7 t -89.41 132.46 34.98 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.8 pt -128.36 120.39 52.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.303 0.573 . . . . 0.0 110.707 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.2 mp -87.87 101.18 13.48 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.581 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -104.27 -118.22 4.45 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.862 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -151.38 159.68 44.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.686 0.279 . . . . 0.0 110.673 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.62 -122.21 8.36 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.301 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.04 -3.47 58.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.121 0.486 . . . . 0.0 109.856 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 t -120.38 55.95 1.0 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.988 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -100.53 -18.48 16.62 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.489 -178.53 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.451 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 27.5 t-20 -154.46 94.31 1.68 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -145.97 143.37 29.45 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.438 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.702 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 99.5 m -91.18 99.49 12.48 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.861 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 27' ' ' LYS . 5.3 p -89.69 160.77 2.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.2 p -87.62 129.99 34.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.25 0.547 . . . . 0.0 111.124 -176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.34 -135.12 3.51 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.669 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.86 108.98 7.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.034 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.57 -148.72 24.59 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.327 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.471 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -144.09 144.8 27.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 122.469 0.308 . . . . 0.0 110.299 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.511 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 33.2 Cg_exo -60.01 154.89 47.83 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.718 2.279 . . . . 0.0 111.65 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.789 ' HG2' ' HG2' ' A' ' 11' ' ' GLN . 2.0 mtmt -87.55 132.58 40.33 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-O 121.052 0.453 . . . . 0.0 110.725 -178.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 6.2 Cg_exo -71.25 146.12 50.36 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.791 2.327 . . . . 0.0 112.196 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.35 -36.41 0.99 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.999 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.5 m -89.17 111.29 22.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.455 173.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.2 m80 . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.489 -178.554 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.651 0.263 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.1 t -123.48 116.91 49.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.434 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -140.08 154.72 47.14 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.485 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 13.6 p -144.36 -176.11 4.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.358 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.0 141.85 28.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.752 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 9.1 m -59.12 137.65 57.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.473 0.178 . . . . 0.0 111.145 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -118.75 -25.48 6.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.917 0.389 . . . . 0.0 111.204 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.48 156.32 35.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.993 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 m -89.07 114.47 25.71 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.358 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.65 -0.67 9.36 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.333 -173.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.28 171.93 9.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.4 p30 -145.45 -56.73 0.32 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 65.8 mt -62.67 58.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.148 0.905 . . . . 0.0 112.492 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.752 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.05 159.33 41.51 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.957 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -73.05 102.78 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.037 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.756 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 29.6 t -89.44 -70.48 0.66 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.71 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 9.3 tp10 -79.56 158.99 27.02 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -6.93 -78.02 0.01 OUTLIER Glycine 0 N--CA 1.473 1.162 0 O-C-N 124.984 1.428 . . . . 0.0 115.241 -176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.9 p -122.5 14.43 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.843 0.354 . . . . 0.0 111.264 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 3.6 m-20 -83.97 108.05 16.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.624 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 9.2 t -92.06 104.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.811 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 1.2 m -82.32 168.85 17.15 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.187 -174.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -145.34 -149.27 4.98 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.56 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -86.79 134.28 33.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.441 0.639 . . . . 0.0 109.997 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.5 -17.17 23.74 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -165.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -118.82 163.13 17.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.903 -0.649 . . . . 0.0 109.498 172.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 24.9 ttpp -144.61 117.96 9.04 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 173.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.756 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 33.7 t -89.17 132.31 34.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.733 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 pt -129.64 127.0 63.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.274 0.559 . . . . 0.0 110.879 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.457 ' HG ' ' OD1' ' A' ' 37' ' ' ASN . 6.1 mp -89.91 122.22 32.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.32 -119.41 1.54 Allowed Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -147.55 171.78 15.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.61 -116.2 8.94 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.782 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -89.17 -15.45 33.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.527 0.679 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t -104.44 29.42 6.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.952 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 2.9 pttp -52.54 -59.52 4.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.657 -176.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.457 ' OD1' ' HG ' ' A' ' 30' ' ' LEU . 3.3 t30 -153.82 77.15 1.09 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -178.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 1.6 tp60 -117.87 150.18 39.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -163.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.811 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 70.8 m -95.43 100.38 12.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.721 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.1 p -91.58 162.17 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -89.14 127.33 35.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.554 0.693 . . . . 0.0 111.779 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.47 -134.02 2.86 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.534 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -143.83 111.19 5.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.448 0.624 . . . . 0.0 110.495 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -89.22 -138.29 6.64 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.311 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.4 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -146.9 148.0 31.39 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 122.671 0.388 . . . . 0.0 110.341 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.4 ' HD2' HG22 ' A' ' 45' ' ' THR . 31.4 Cg_exo -59.56 134.87 60.76 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.602 2.201 . . . . 0.0 111.186 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 13.7 tttt -89.97 132.66 35.61 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 -175.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.99 142.02 86.25 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.78 2.32 . . . . 0.0 112.035 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 7.7 pt20 -176.33 -18.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.332 0.587 . . . . 0.0 111.397 -169.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.9 m -88.59 66.91 8.34 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.722 0.773 . . . . 0.0 110.066 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 . . . . . 0 CA--C 1.509 -0.609 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.049 -178.42 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.96 0.41 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 51.2 t -107.71 119.66 57.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.576 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -112.26 174.83 5.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.202 0.525 . . . . 0.0 110.545 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.486 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.2 p -133.82 -163.32 1.35 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -87.66 153.83 21.07 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.111 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.755 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 17.0 m -65.64 135.87 55.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.574 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 m -103.93 -23.03 13.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.071 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.98 162.77 34.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.241 0.544 . . . . 0.0 110.942 -173.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.0 m -87.12 122.0 30.35 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.151 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.86 -5.92 18.15 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.901 -173.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 1.025 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.86 161.04 15.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 175.793 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' CYS . 6.8 p30 -136.05 -55.93 0.76 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.402 HD23 ' HA2' ' A' ' 23' ' ' GLY . 89.0 mt -61.07 55.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.247 0.967 . . . . 0.0 112.893 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.755 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 1.2 p -155.36 160.48 40.74 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.845 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -77.6 97.24 5.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.364 0.602 . . . . 0.0 109.393 177.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.617 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 13.0 t -72.65 -77.31 0.1 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.703 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -86.85 162.11 17.95 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 3.29 -87.99 0.0 OUTLIER Glycine 0 N--CA 1.474 1.174 0 O-C-N 124.964 1.415 . . . . 0.0 114.969 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.1 p -123.07 22.05 9.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.463 0.649 . . . . 0.0 110.237 172.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -78.57 99.04 6.35 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.209 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 31.0 t -88.32 99.94 9.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.014 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.668 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -73.07 155.98 39.21 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.651 -176.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -139.67 -154.05 6.23 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.643 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -85.78 135.13 33.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.434 0.617 . . . . 0.0 109.52 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.25 -9.35 53.92 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -127.34 164.15 22.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.557 -0.822 . . . . 0.0 109.278 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.3 ttpp -150.28 121.46 7.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.211 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.617 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.9 t -89.23 138.0 31.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.956 0.408 . . . . 0.0 110.232 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -128.08 124.47 62.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.436 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.726 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.6 mp -92.88 80.67 4.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.374 176.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.87 -109.05 2.41 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.752 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -155.93 160.81 40.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.394 -0.225 . . . . 0.0 110.394 -175.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.86 -121.58 7.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.869 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.11 -10.74 29.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.398 0.618 . . . . 0.0 109.434 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.4 t -99.57 22.85 10.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.145 0.974 . . . . 0.0 109.413 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.726 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 14.3 pttp -66.81 -27.01 67.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.662 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -153.3 91.09 1.47 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 56.4 tp60 -127.65 139.63 52.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.108 0.48 . . . . 0.0 111.694 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.668 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 59.7 m -90.83 92.89 8.99 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.868 171.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.7 p -90.16 159.76 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.9 p -88.65 127.03 35.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.387 0.613 . . . . 0.0 110.685 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.67 -148.44 11.92 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.895 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -122.22 106.34 11.04 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.28 -144.14 12.47 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.091 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 1.025 HG22 ' HG3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -150.04 146.18 19.91 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.167 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.39 119.77 7.15 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.375 2.05 . . . . 0.0 111.841 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 8.4 tmtt? -84.5 117.04 67.78 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.52 154.02 67.42 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.278 2.652 . . . . 0.0 115.405 -168.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -113.25 -20.02 11.56 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.901 -1.954 . . . . 0.0 108.734 173.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 m -89.47 -65.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.675 175.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.074 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 121.203 0.525 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 67.5 t -89.39 115.64 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -89.67 174.58 7.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.545 0.688 . . . . 0.0 111.628 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.3 p -121.55 -176.52 3.33 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.138 -175.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.56 152.14 22.43 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 4.8 m -63.01 133.36 54.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.205 0.526 . . . . 0.0 111.225 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -105.45 -23.11 12.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.692 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' HB2' HE22 ' A' ' 11' ' ' GLN . 2.3 mm-40 -130.52 153.98 48.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.339 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 51.5 m -88.27 112.0 22.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.1 -0.13 7.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.004 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.568 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -88.64 171.84 9.72 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.746 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.6 p30 -142.41 -57.44 0.45 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 82.8 mt -62.87 61.62 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.815 0.846 . . . . 0.0 112.354 -178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -153.51 171.23 19.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.821 -179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 4' ' ' THR . 2.5 mt -83.45 88.36 6.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.546 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 41.9 t -80.49 -61.53 1.95 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.875 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.99 113.7 25.34 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.976 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 46.33 -97.32 0.01 OUTLIER Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.754 -175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -115.1 0.99 13.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -70.3 123.05 20.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.978 0.418 . . . . 0.0 110.607 -175.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.26 97.39 6.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.486 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.6 OUTLIER -74.69 167.29 22.09 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.541 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.02 -124.76 0.72 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.802 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -86.26 124.46 32.67 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.174 0.511 . . . . 0.0 110.312 -169.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.44 -2.7 37.02 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.045 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -130.89 154.35 48.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.323 0.582 . . . . 0.0 110.867 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.589 ' O ' HG12 ' A' ' 40' ' ' VAL . 5.2 ttpp -129.57 111.63 12.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.174 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 61.7 m -91.56 124.33 35.64 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.162 0.506 . . . . 0.0 111.09 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 16.3 pt -128.0 139.3 52.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.819 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 8.6 mp -59.27 121.16 10.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.776 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -65.26 -45.48 90.94 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.527 -1.215 . . . . 0.0 113.313 -175.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 73.33 153.79 0.14 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.302 0.641 . . . . 0.0 111.058 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.36 -104.32 1.18 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.844 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -93.32 15.24 16.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.63 0.729 . . . . 0.0 109.573 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 t -143.7 171.9 13.56 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.674 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.61 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -139.66 -33.47 0.6 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.112 176.015 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.61 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 0.5 OUTLIER -154.83 140.99 18.49 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 176.239 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -141.4 140.67 33.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.854 0.359 . . . . 0.0 110.755 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 70.8 m -90.68 95.76 10.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.944 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.5 p -90.23 159.67 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -88.83 130.51 35.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.216 0.531 . . . . 0.0 111.464 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.69 -132.29 2.53 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.705 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -137.41 112.69 9.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.009 0.433 . . . . 0.0 110.335 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -100.99 -146.89 19.87 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.205 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.475 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -147.11 148.43 32.16 Favored Pre-proline 0 C--N 1.324 -0.533 0 C-N-CA 122.18 0.192 . . . . 0.0 110.664 -178.474 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.475 ' HD2' HG22 ' A' ' 45' ' ' THR . 51.1 Cg_exo -55.8 148.76 54.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.196 1.931 . . . . 0.0 110.785 173.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 9.5 tttm -89.31 113.06 54.94 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-O 120.691 0.281 . . . . 0.0 111.481 -171.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 19.5 Cg_endo -62.34 163.47 20.4 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.599 2.2 . . . . 0.0 112.294 176.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -155.03 -44.01 0.08 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.991 -177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -86.93 -51.08 6.25 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.445 0.641 . . . . 0.0 109.699 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.4 m170 . . . . . 0 CA--C 1.508 -0.637 0 CA-C-O 121.35 0.595 . . . . 0.0 109.905 -179.312 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 121.001 0.429 . . . . 0.0 111.42 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.3 t -116.78 109.82 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.062 0.458 . . . . 0.0 110.822 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.452 ' CD1' HG11 ' A' ' 21' ' ' VAL . 97.2 m-85 -103.27 177.4 4.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.733 176.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 p -136.26 166.46 23.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.268 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.22 139.99 29.94 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.827 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 28.2 m -60.24 130.8 48.43 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 109.937 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -113.08 -28.58 7.62 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.208 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.461 ' HB3' HE22 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -121.49 153.02 38.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.844 -177.006 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 58.9 m -88.44 114.56 25.19 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.392 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.14 -9.56 6.64 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.94 -173.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.461 HE22 ' HB3' ' A' ' 8' ' ' GLU . 0.6 OUTLIER -86.61 168.31 13.75 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.32 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 6.1 p30 -140.15 -55.24 0.54 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 67.8 mt -62.76 56.24 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.249 0.968 . . . . 0.0 112.854 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.827 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.33 160.78 41.9 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.444 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -71.77 108.14 4.93 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.645 0.736 . . . . 0.0 109.371 174.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 53.3 t -89.47 -71.34 0.61 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.168 -176.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 8.8 tp10 -82.42 161.18 22.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -8.55 -78.03 0.01 OUTLIER Glycine 0 N--CA 1.473 1.147 0 O-C-N 124.905 1.378 . . . . 0.0 115.483 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.3 p -121.16 15.23 11.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 0.0 111.232 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 4.1 m-20 -87.06 103.81 15.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.6 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.68 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 37.0 t -89.53 105.14 15.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.778 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -78.44 169.74 17.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.382 -177.181 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -153.39 -133.69 1.89 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.823 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -85.3 141.31 30.16 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.274 0.559 . . . . 0.0 110.536 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.12 -10.26 69.87 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.184 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -120.15 160.11 23.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.971 0.415 . . . . 0.0 110.497 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.575 ' O ' HG12 ' A' ' 40' ' ' VAL . 19.3 ttpp -142.45 108.54 5.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.295 176.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.49 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 67.7 m -89.46 135.09 33.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.137 -174.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 19.0 pt -131.72 138.08 53.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.375 0.607 . . . . 0.0 110.543 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.1 mp -95.38 101.85 13.61 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.549 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.97 -113.41 3.5 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.95 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.405 ' N ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -155.6 162.75 40.58 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.65 -139.5 17.27 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.098 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.55 -4.48 59.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 170.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 14.3 m -94.38 30.58 1.93 Allowed 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 113.139 -1.846 . . . . 0.0 110.158 175.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.646 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 1.3 pptp? -64.76 -31.32 72.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.863 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.646 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -154.98 95.73 1.77 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.145 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -110.79 139.83 45.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.037 0.446 . . . . 0.0 111.293 -172.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.778 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 77.7 m -90.43 101.09 13.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.767 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -96.08 158.98 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.0 p -88.31 128.63 35.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.774 0.321 . . . . 0.0 111.124 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.7 -121.28 0.88 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.673 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.542 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 6.9 pt-20 -149.79 125.95 10.68 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 173.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.52 -147.49 11.34 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.611 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.35 144.53 50.01 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.453 -0.374 . . . . 0.0 110.569 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.449 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 26.1 Cg_exo -62.65 141.68 86.69 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.009 1.806 . . . . 0.0 109.924 171.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -88.14 111.93 46.2 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.676 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 18.2 Cg_exo -68.2 176.73 5.17 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.175 2.584 . . . . 0.0 111.641 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -107.3 -37.09 6.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.814 -174.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -103.82 -57.9 1.96 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.511 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.6 m80 . . . . . 0 CA--C 1.509 -0.603 0 CA-C-O 121.049 0.452 . . . . 0.0 110.451 177.272 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 121.288 0.565 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.6 t -89.34 147.1 5.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -87.84 155.51 19.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.27 0.557 . . . . 0.0 110.313 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 3.0 p -138.42 -176.56 4.5 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.542 -177.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.28 146.25 26.03 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.768 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 33.7 m -59.34 129.65 43.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.183 0.516 . . . . 0.0 110.185 175.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -102.36 -13.93 17.12 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.37 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.449 ' HB2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -150.17 163.76 37.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.209 0.528 . . . . 0.0 110.913 -174.277 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m -86.11 122.33 29.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.329 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.914 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 120.88 -7.89 10.83 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.531 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.597 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.8 169.06 11.94 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 122.868 -0.196 . . . . 0.0 110.575 178.125 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.47 -57.29 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.35 56.62 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.345 1.028 . . . . 0.0 113.095 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.768 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.77 161.91 41.32 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.833 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.03 89.02 2.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.375 173.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 36.4 t -57.2 -78.04 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.635 175.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 29.2 tt0 -87.56 161.92 17.48 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -16.0 -71.52 0.01 OUTLIER Glycine 0 N--CA 1.471 0.984 0 O-C-N 124.661 1.225 . . . . 0.0 115.665 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 p -116.66 5.96 13.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.063 0.458 . . . . 0.0 111.339 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 3.3 m-20 -80.42 93.87 6.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.471 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 46.2 t -88.54 97.74 7.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -70.7 160.72 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.224 -175.12 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.92 -141.78 3.76 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.852 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -87.13 135.3 33.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.165 0.507 . . . . 0.0 109.953 -172.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.51 -7.59 59.76 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -122.66 156.71 33.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.036 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.914 ' HD2' ' HA2' ' A' ' 10' ' ' GLY . 4.7 ttpp -138.59 121.41 16.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.831 176.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 30.0 t -89.94 130.74 36.11 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.38 137.2 54.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.423 0.63 . . . . 0.0 110.462 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.667 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -113.83 103.3 11.06 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.793 -172.088 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.92 -122.53 2.51 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.385 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -153.13 -170.45 3.62 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.356 0.263 . . . . 0.0 110.45 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.58 -112.07 4.62 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.087 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -113.21 4.03 16.3 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.7 t -109.52 32.5 4.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.384 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.667 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 68.8 mttt -60.45 -50.31 74.09 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 121.704 0.764 . . . . 0.0 110.123 -177.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -154.25 100.82 2.33 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.595 -172.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 51.3 tp60 -135.73 143.65 45.45 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.203 -174.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 86.5 m -90.46 104.46 17.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.586 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.8 p -97.26 164.92 2.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 p -95.25 116.27 28.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.074 0.464 . . . . 0.0 111.156 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.52 -126.95 0.97 Allowed Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.001 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 111.2 6.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.481 0.657 . . . . 0.0 110.769 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.669 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -97.4 -151.87 28.04 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.725 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.412 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -150.11 147.46 22.21 Favored Pre-proline 0 C--N 1.321 -0.64 0 C-N-CA 122.511 0.325 . . . . 0.0 110.679 -176.264 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.511 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 52.5 Cg_exo -54.49 148.71 41.93 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.425 2.083 . . . . 0.0 110.497 170.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 2.2 ttpm? -88.62 115.49 63.55 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -165.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 10.5 Cg_exo -72.55 -170.54 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.135 2.557 . . . . 0.0 110.117 167.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -168.89 -54.96 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.612 0.244 . . . . 0.0 111.402 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.1 m -146.25 -57.83 0.3 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.123 0.487 . . . . 0.0 110.473 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.0 m80 . . . . . 0 CA--C 1.508 -0.64 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.163 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.3 t . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.45 109.36 21.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 120.752 0.31 . . . . 0.0 110.666 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -104.22 174.06 6.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.131 0.491 . . . . 0.0 110.355 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p -130.07 -164.09 1.38 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.656 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.32 157.66 18.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.772 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 2.7 m -67.25 133.92 50.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.321 0.581 . . . . 0.0 111.688 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -106.52 -22.57 12.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.859 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -139.98 157.83 45.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.031 0.443 . . . . 0.0 110.729 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 m -88.28 118.88 28.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.016 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.86 -5.53 10.53 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.805 -173.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.8 176.49 7.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.0 p30 -148.81 -54.14 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 98.0 mt -60.55 65.95 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.898 0.856 . . . . 0.0 112.256 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.772 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 1.2 p -154.1 165.91 34.71 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.317 -1.311 . . . . 0.0 109.451 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.3 85.54 3.09 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 99.6 m -74.85 -78.48 0.1 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.037 -174.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -85.61 115.09 23.09 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.317 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 48.75 -94.7 0.01 OUTLIER Glycine 0 C--N 1.298 -1.552 0 O-C-N 124.136 0.897 . . . . 0.0 112.006 -173.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -117.88 0.13 11.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.0 111.737 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -72.15 123.04 22.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.96 0.41 . . . . 0.0 110.64 -176.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 t -88.68 106.01 16.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.656 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -75.3 161.94 28.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.581 -177.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.9 -143.78 3.88 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.833 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -86.75 138.36 31.68 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.282 0.563 . . . . 0.0 110.151 -172.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.17 -10.23 58.19 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -169.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -127.06 153.42 45.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 120.96 0.41 . . . . 0.0 110.202 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 40' ' ' VAL . 14.2 ttpp -134.21 113.2 11.76 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.279 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 15.0 t -89.51 130.7 35.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.906 0.384 . . . . 0.0 110.439 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -129.46 130.22 67.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.574 0.702 . . . . 0.0 111.276 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 24.5 mt -82.26 94.25 7.28 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.609 176.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.54 -111.77 1.33 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.731 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -163.94 153.02 13.91 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.67 -139.5 14.66 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.177 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -87.94 -4.25 58.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 166.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 m -94.58 30.11 2.1 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.166 -1.834 . . . . 0.0 110.448 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 1.9 pptp? -77.5 -10.74 59.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.764 -176.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -154.26 108.42 3.0 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -135.2 141.66 45.9 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.176 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.635 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 81.0 m -89.48 97.19 11.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.702 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.3 p -89.73 160.97 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.4 p -88.84 128.68 35.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.469 0.652 . . . . 0.0 111.37 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.43 -142.64 7.44 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.542 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -128.19 113.96 16.37 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.747 0.308 . . . . 0.0 110.779 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -100.87 -146.16 18.55 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.004 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.95 144.86 22.97 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 122.641 0.376 . . . . 0.0 110.701 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.446 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 41.9 Cg_exo -58.35 145.22 94.55 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.289 1.993 . . . . 0.0 110.067 171.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -89.04 110.37 37.58 Favored Pre-proline 0 C--N 1.32 -0.675 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.549 -174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 31.3 Cg_exo -58.71 155.66 36.29 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 122.978 2.452 . . . . 0.0 112.099 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -132.46 -37.29 1.08 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.309 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.8 p -125.75 138.02 53.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.464 0.65 . . . . 0.0 112.504 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.9 m170 . . . . . 0 CA--C 1.513 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.639 177.04 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.36 155.65 19.59 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.809 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 9.6 m -65.11 133.68 52.13 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.2 m -106.02 -28.65 10.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.003 0.43 . . . . 0.0 111.089 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.488 ' HB2' HE22 ' A' ' 11' ' ' GLN . 3.4 mm-40 -125.31 158.21 34.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.0 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -87.85 125.96 34.76 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 116.4 -5.74 19.2 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.064 -173.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.975 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -91.16 157.87 16.95 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.507 0.194 . . . . 0.0 110.917 176.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 14' ' ' CYS . 3.0 p30 -127.61 -59.26 1.22 Allowed 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 87.1 mt -60.64 59.5 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.482 1.114 . . . . 0.0 113.635 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.809 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -155.15 169.27 24.54 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.264 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.5 103.13 10.15 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 12.8 t -86.56 -72.87 0.48 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.617 0.723 . . . . 0.0 110.624 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -91.38 107.46 19.22 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.334 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.85 -82.41 0.01 OUTLIER Glycine 0 C--N 1.307 -1.038 0 O-C-N 124.694 1.246 . . . . 0.0 113.296 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.4 p -127.21 -3.16 6.3 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.534 0.334 . . . . 0.0 111.418 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -66.75 116.18 7.37 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.219 0.533 . . . . 0.0 111.27 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 t -88.68 93.83 4.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.871 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.711 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -63.37 145.79 54.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.803 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.87 -132.22 3.21 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.783 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -88.43 139.97 29.95 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.17 0.51 . . . . 0.0 110.525 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.29 -11.73 71.14 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.791 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -121.54 164.61 16.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.033 0.444 . . . . 0.0 110.286 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 40' ' ' VAL . 24.9 ttpp -150.67 124.91 9.42 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.734 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.6 t -89.62 135.82 33.39 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.947 0.403 . . . . 0.0 110.503 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -125.05 120.86 59.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.561 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 6' ' ' CYS . 5.9 mp . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.573 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 35.3 tp60 . . . . . 0 CA--C 1.519 -0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 111.64 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.711 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 79.3 m -91.65 92.76 8.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.852 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 27' ' ' LYS . 6.2 p -89.57 155.72 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -88.23 132.26 34.44 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.459 0.647 . . . . 0.0 111.179 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.16 -128.09 1.65 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.09 117.62 13.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.223 0.535 . . . . 0.0 110.033 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -93.8 -146.64 20.5 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.596 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.741 HG22 ' HG3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -150.42 145.67 18.84 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.89 118.83 5.74 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.364 2.042 . . . . 0.0 110.969 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.975 ' HG3' HE21 ' A' ' 11' ' ' GLN . 15.9 tttt . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.097 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.538 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 2.5 p . . . . . 0 N--CA 1.441 -0.892 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.425 ' H ' ' HB ' ' A' ' 4' ' ' THR . 1.8 m-20 -86.98 161.78 18.02 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.171 -175.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 17.7 m -64.5 137.94 58.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.721 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.484 HG23 ' HG2' ' A' ' 8' ' ' GLU . 6.2 t -106.76 -16.73 14.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.2 0.524 . . . . 0.0 110.444 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.619 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 4.9 mm-40 -138.26 154.99 49.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.741 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -88.07 127.2 35.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.608 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.43 -6.68 31.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.619 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.16 157.28 18.34 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.9 p30 -129.23 -60.02 1.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.66 60.65 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.306 1.042 . . . . 0.0 113.511 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.78 169.76 23.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.005 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -81.26 112.49 18.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.764 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 36.4 t -98.12 -79.42 0.47 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.651 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.92 111.09 18.93 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.414 -172.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.17 -92.33 0.01 OUTLIER Glycine 0 C--N 1.297 -1.596 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.327 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 p -121.16 2.06 10.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.709 0.29 . . . . 0.0 111.343 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -68.09 125.72 27.25 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.534 0.683 . . . . 0.0 111.381 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.26 108.64 19.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.496 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.743 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -74.6 149.77 39.94 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.123 176.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.33 -149.35 5.09 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.571 -0.611 . . . . 0.0 111.571 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -87.33 133.01 33.76 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.04 -8.24 38.63 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -133.57 166.84 21.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.611 -0.795 . . . . 0.0 109.253 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.55 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 24.3 ttpp -149.41 117.9 6.52 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.764 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 16.0 t -89.39 125.53 35.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.206 0.527 . . . . 0.0 110.865 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.5 pt -121.07 124.18 71.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.851 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.318 -0.784 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.292 179.085 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.582 ' HA ' HE21 ' A' ' 38' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.733 0.301 . . . . 0.0 111.343 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.743 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 97.5 m -90.14 86.96 6.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.949 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.2 p -88.02 165.89 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 p -88.97 132.22 34.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.67 0.748 . . . . 0.0 111.271 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.8 -140.39 6.4 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -138.82 111.31 7.55 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.55 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -86.5 -155.28 26.57 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.941 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.22 141.8 43.19 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.2 140.82 71.38 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.996 1.797 . . . . 0.0 109.931 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 42.0 tttt . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 120.706 0.289 . . . . 0.0 111.334 -169.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.444 -0.733 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.11 144.41 26.51 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.776 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 20.3 m -60.2 132.3 53.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 m -111.37 -12.99 13.97 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.195 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.676 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 37.4 mt-10 -136.05 156.01 49.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.892 -172.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.8 m -89.24 118.8 29.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.117 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.62 1.41 24.47 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.779 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.72 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -92.93 158.9 15.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.6 p30 -134.31 -57.38 0.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 76.6 mt -63.26 59.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.103 0.877 . . . . 0.0 112.587 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.776 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -154.43 164.9 37.93 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.778 177.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.95 98.69 7.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.787 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 14.6 t -74.16 -77.83 0.11 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.435 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 28.2 tt0 -84.13 154.52 23.09 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 11.44 -89.75 0.0 OUTLIER Glycine 0 N--CA 1.471 1.023 0 O-C-N 125.003 1.439 . . . . 0.0 115.062 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.0 p -120.07 16.96 12.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.268 0.556 . . . . 0.0 111.074 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 24.2 m-80 -79.03 98.21 6.39 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.531 0.681 . . . . 0.0 110.578 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 40.7 t -88.43 98.04 7.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.933 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -78.71 160.22 27.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.149 -174.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -143.3 -136.95 3.22 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.042 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -87.8 133.77 33.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.201 0.524 . . . . 0.0 109.86 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.7 -8.76 51.5 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.287 -173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -125.99 164.06 21.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.444 -0.378 . . . . 0.0 110.12 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HD3' ' O ' ' A' ' 43' ' ' GLU . 27.4 ttpp -148.23 120.43 8.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.745 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.787 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 10.4 t -88.84 136.96 32.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.856 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 pt -127.78 134.5 65.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.239 0.543 . . . . 0.0 110.28 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 mt . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.412 -179.53 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.734 HE21 ' HA ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.166 0.508 . . . . 0.0 111.666 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 89.4 m -92.02 97.95 11.26 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.135 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.8 p -89.67 161.8 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.2 p -89.11 129.39 35.73 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.368 0.604 . . . . 0.0 111.58 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.87 -132.33 2.62 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.183 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 5.8 pt-20 -136.95 119.24 15.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.266 0.555 . . . . 0.0 110.756 175.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.86 -143.87 15.64 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.208 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.22 142.71 17.21 Favored Pre-proline 0 C--N 1.324 -0.514 0 C-N-CA 122.507 0.323 . . . . 0.0 110.399 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 32.0 Cg_exo -59.0 132.79 49.37 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.655 2.237 . . . . 0.0 111.159 174.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.72 ' HG3' HE21 ' A' ' 11' ' ' GLN . 1.8 ttpm? . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.77 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.521 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 5.5 p . . . . . 0 N--CA 1.444 -0.757 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.32 145.52 26.31 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.7 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 26.1 m -59.54 134.14 56.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.959 0.409 . . . . 0.0 110.941 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 m -110.61 -31.67 7.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.61 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.6 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 25.6 mp0 -115.1 152.52 32.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.717 -176.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 m -88.88 119.91 29.8 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 117.46 -5.85 16.89 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.999 -173.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.758 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.08 166.33 13.93 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' CYS . 8.6 p30 -135.62 -58.19 0.78 Allowed 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.75 60.56 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.119 0.887 . . . . 0.0 112.944 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.7 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -153.76 161.28 42.22 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.359 178.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -81.77 100.03 9.3 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.85 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 30.8 t -82.34 -74.93 0.32 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.843 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 2.0 tm-20 -78.38 148.16 33.8 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 10.02 -85.87 0.0 OUTLIER Glycine 0 N--CA 1.471 1.016 0 O-C-N 124.972 1.42 . . . . 0.0 115.372 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.9 p -119.81 5.36 10.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.967 0.413 . . . . 0.0 111.248 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -71.38 107.64 4.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.227 0.537 . . . . 0.0 110.502 -177.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.9 t -89.09 98.55 8.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.497 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -66.88 153.72 42.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.211 -178.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -148.71 -128.17 1.69 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.095 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.67 134.45 33.65 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.207 0.527 . . . . 0.0 109.956 -174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.66 0.63 66.62 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.644 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.43 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 51.9 m-80 -133.96 164.48 27.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.126 0.488 . . . . 0.0 110.794 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 25.0 ttpp -150.61 123.34 8.6 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.494 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.85 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 27.8 t -89.94 133.08 34.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.986 0.422 . . . . 0.0 110.6 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.69 112.42 33.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.431 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.569 178.104 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 33.1 tp60 . . . . . 0 CA--C 1.517 -0.302 0 CA-C-O 120.979 0.418 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 60.3 m -89.36 87.93 7.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.946 172.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.9 p -89.23 159.31 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -88.9 130.62 35.39 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.258 0.551 . . . . 0.0 111.186 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.91 -134.83 3.3 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.5 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.526 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 8.8 pt-20 -133.8 113.86 12.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.099 0.476 . . . . 0.0 109.888 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.555 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -96.18 -149.75 26.02 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.523 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.39 142.47 26.68 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 122.568 0.347 . . . . 0.0 110.324 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.42 129.55 33.2 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.301 2.0 . . . . 0.0 110.851 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.758 ' HG3' HE21 ' A' ' 11' ' ' GLN . 15.2 tttt . . . . . 0 N--CA 1.446 -0.67 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.349 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.482 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.7 p . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.531 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 7.4 m-20 -87.72 149.53 24.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.674 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 25.9 m -61.45 134.75 57.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.858 0.361 . . . . 0.0 110.755 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -112.1 -20.85 11.78 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.265 0.555 . . . . 0.0 110.406 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -134.92 154.99 51.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.333 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -86.63 124.44 32.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.8 -10.05 16.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.663 -172.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.761 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.95 154.05 20.14 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.1 p30 -126.79 -61.85 1.16 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.427 HD23 ' HA2' ' A' ' 23' ' ' GLY . 94.4 mt -58.99 63.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.011 0.925 . . . . 0.0 113.05 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.674 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.15 162.32 41.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.871 177.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -78.37 87.84 4.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.602 ' HA ' ' SG ' ' A' ' 6' ' ' CYS . 13.9 t -61.3 -77.55 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.253 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 6.8 tp10 -82.56 164.91 20.53 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -8.41 -71.86 0.01 OUTLIER Glycine 0 N--CA 1.472 1.089 0 O-C-N 124.88 1.363 . . . . 0.0 115.269 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.4 p -127.67 4.38 6.11 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.697 -0.296 . . . . 0.0 111.392 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.509 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -78.8 110.64 14.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 110.737 -179.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 40.6 t -89.88 106.78 17.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.74 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.76 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -68.42 146.98 52.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.92 177.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -131.98 -156.98 8.51 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.039 -1.076 . . . . 0.0 113.454 -177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.82 117.44 24.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.739 0.78 . . . . 0.0 109.607 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.34 -4.24 23.5 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -165.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.494 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 6.6 m120 -122.25 164.49 17.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.651 -0.774 . . . . 0.0 108.987 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 40' ' ' VAL . 26.4 ttpp -149.98 118.25 6.41 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.479 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.7 t -89.51 130.48 35.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.039 0.447 . . . . 0.0 110.624 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -123.65 112.95 35.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.132 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.474 -179.725 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 11.9 tp60 . . . . . 0 N--CA 1.445 -0.702 0 CA-C-O 121.271 0.558 . . . . 0.0 111.871 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.76 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 54.6 m -89.62 89.85 7.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.112 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.8 p -88.79 153.2 3.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 p -89.78 119.73 30.43 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.175 0.512 . . . . 0.0 110.57 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.86 -130.99 1.51 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.63 110.76 7.32 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.118 0.485 . . . . 0.0 110.132 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.501 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -99.14 -145.06 17.81 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.225 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.37 136.14 11.32 Favored Pre-proline 0 C--N 1.317 -0.812 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.79 135.88 42.66 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.442 2.095 . . . . 0.0 111.038 171.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.761 ' HG3' HE21 ' A' ' 11' ' ' GLN . 24.5 tttm . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.791 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 3.4 m-20 -89.04 149.0 23.43 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.734 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 61.2 m -58.57 144.35 43.12 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.234 0.54 . . . . 0.0 112.082 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.624 ' OG1' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -114.26 -23.87 9.22 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.676 176.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.671 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 43.1 mt-10 -136.15 153.69 51.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.304 -170.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.8 m -88.46 120.86 30.23 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.7 -11.56 13.77 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -172.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.671 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -88.01 164.34 15.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.2 p30 -134.93 -58.0 0.81 Allowed 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.415 HD23 ' HA2' ' A' ' 23' ' ' GLY . 87.2 mt -58.16 61.81 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.383 1.073 . . . . 0.0 113.42 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.734 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.6 166.3 33.8 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.233 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.78 94.16 6.36 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.552 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . 49.3 t -73.79 -74.49 0.18 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.356 -172.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -91.92 150.16 21.18 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 27.15 -91.5 0.01 OUTLIER Glycine 0 N--CA 1.472 1.07 0 O-C-N 124.548 1.155 . . . . 0.0 114.535 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.01 32.73 4.0 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.413 0.625 . . . . 0.0 110.948 173.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -82.06 112.91 19.55 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.694 177.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.8 t -88.37 91.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -69.14 146.64 52.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.39 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -136.29 -152.51 6.32 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.07 137.02 32.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.489 0.644 . . . . 0.0 109.357 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.17 -9.93 46.78 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -167.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -126.93 158.63 36.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.861 -0.669 . . . . 0.0 109.892 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 18.3 ttpp -139.55 121.21 15.29 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 74.1 m -89.76 143.38 26.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.724 0.297 . . . . 0.0 111.13 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.8 pt -135.36 131.12 51.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.289 0.566 . . . . 0.0 110.768 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--N 1.316 -0.85 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.372 176.17 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.815 HE21 ' HA ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 120.591 0.234 . . . . 0.0 111.218 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 91.8 m -101.21 114.89 29.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.046 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 27' ' ' LYS . 1.2 p -104.16 157.22 5.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.9 p -91.36 123.78 35.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.077 0.465 . . . . 0.0 111.162 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.8 -120.23 0.75 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.502 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 13.6 pt-20 -151.95 123.38 7.79 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.493 -0.416 . . . . 0.0 110.452 174.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.562 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -107.72 -151.96 17.07 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.937 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.07 144.01 51.36 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.72 135.43 67.17 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.216 1.944 . . . . 0.0 110.819 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.791 ' HE3' ' O ' ' A' ' 5' ' ' ASP . 14.6 tttm . . . . . 0 N--CA 1.435 -1.18 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.755 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.638 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 82.7 p . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.45 172.22 9.96 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.807 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 31.3 m -73.37 136.37 44.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.023 0.44 . . . . 0.0 111.248 -177.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 m -102.31 -21.93 14.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -139.5 156.22 47.06 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.115 0.484 . . . . 0.0 110.701 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.9 m -90.16 107.75 19.32 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.025 -0.988 . . . . 0.0 108.53 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.566 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 124.79 -0.53 8.49 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -169.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -88.15 -171.1 3.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.6 p30 -159.04 -55.2 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 74.1 mt -60.8 61.34 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.805 0.842 . . . . 0.0 112.905 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.807 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -154.03 166.91 31.53 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.14 178.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.5 OUTLIER -79.01 91.58 4.87 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.721 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 33.1 t -92.65 -65.04 1.03 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.188 0.518 . . . . 0.0 111.245 -174.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -83.69 103.79 13.28 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.793 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.36 -95.29 0.01 OUTLIER Glycine 0 C--N 1.294 -1.753 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.796 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.3 p -121.33 11.99 10.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.743 0.306 . . . . 0.0 111.236 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.472 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -73.11 126.07 29.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.07 0.462 . . . . 0.0 110.635 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 t -89.83 102.55 13.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.089 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 13' ' ' LEU . 1.3 m -85.3 162.83 18.94 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.915 0.388 . . . . 0.0 111.37 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -148.76 -140.04 3.24 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.726 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -84.8 134.73 34.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.292 0.567 . . . . 0.0 109.56 -173.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.89 -16.46 28.11 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -169.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -119.61 158.38 26.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.061 0.458 . . . . 0.0 110.786 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.629 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 4.4 tppp? -130.51 107.71 9.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.049 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 85.8 m -89.31 126.81 35.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.538 0.208 . . . . 0.0 110.77 -177.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -128.82 127.94 66.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.196 0.522 . . . . 0.0 111.163 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 30' ' ' LEU . 5.5 mp . . . . . 0 C--N 1.322 -0.59 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.495 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 . . . . . 0 C--O 1.231 0.1 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 16' ' ' CYS . 69.8 m -94.26 100.55 12.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.401 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.1 p -90.84 158.48 2.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.3 p -89.13 125.69 35.15 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.623 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.97 -123.37 0.87 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.955 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -152.3 109.01 3.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.174 0.511 . . . . 0.0 110.294 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.629 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -90.2 -147.61 18.1 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.287 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.547 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -133.8 142.03 42.13 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.7 134.19 61.35 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.129 1.886 . . . . 0.0 110.851 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.502 ' HG3' HE21 ' A' ' 11' ' ' GLN . 1.6 ttpm? . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 -171.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 4.7 p . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.51 155.95 19.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.719 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.1 m -63.81 137.14 57.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.986 0.422 . . . . 0.0 111.621 -176.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m -107.5 -31.4 8.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.047 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.82 157.01 46.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.609 -175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 m -88.39 122.1 31.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.476 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.94 -6.5 21.97 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.8 164.97 14.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.9 p30 -136.77 -57.12 0.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.414 HD23 ' HA2' ' A' ' 23' ' ' GLY . 91.8 mt -59.55 61.39 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.111 0.965 . . . . 0.0 112.984 -176.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.719 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.77 167.29 30.7 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.394 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -81.62 105.24 12.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.704 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 34.2 t -94.57 -70.85 0.69 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.654 -172.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 20.4 tt0 -86.84 79.38 8.82 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.106 0.955 . . . . 0.0 109.68 -175.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 -91.88 0.28 Allowed Glycine 0 C--N 1.294 -1.781 0 CA-C-N 113.551 -1.659 . . . . 0.0 111.612 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 p -109.25 -3.45 17.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.658 0.266 . . . . 0.0 110.929 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 18.8 m-80 -64.84 114.79 4.73 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.184 0.516 . . . . 0.0 111.124 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.01 104.36 14.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.918 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.91 151.32 37.37 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.959 0.409 . . . . 0.0 110.233 179.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -140.14 -153.5 6.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.97 144.75 27.45 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.13 -3.42 80.28 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -165.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -135.0 156.3 49.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.6 ttpp -142.12 123.15 14.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.969 0.414 . . . . 0.0 109.981 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.704 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 14.4 t -90.04 139.48 30.57 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.911 0.386 . . . . 0.0 110.688 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.9 pt -132.38 124.04 51.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.761 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--N 1.318 -0.786 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.055 -176.677 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.427 HE21 ' H ' ' A' ' 39' ' ' CYS . 27.7 tp60 . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 93.9 m -96.67 109.14 21.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.773 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.7 p -103.6 162.96 3.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 p -90.18 129.23 36.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.487 0.661 . . . . 0.0 111.198 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.51 -144.43 8.96 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.91 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -128.31 105.61 8.46 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.974 0.416 . . . . 0.0 110.267 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.81 -151.99 22.88 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.202 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.21 142.5 35.61 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.17 142.69 77.49 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.381 2.054 . . . . 0.0 111.428 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HD3' ' HB3' ' A' ' 14' ' ' CYS . 2.3 ttpm? . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.566 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.24 150.51 24.32 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.777 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 13.3 m -62.15 128.84 38.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.024 0.44 . . . . 0.0 110.479 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -95.71 -17.17 21.47 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.868 -177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.67 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 36.1 mt-10 -138.37 151.69 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.786 -170.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.1 m -87.67 124.21 33.31 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.472 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 115.35 -6.58 21.06 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.876 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.67 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.84 162.48 15.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.1 p30 -132.74 -59.24 0.91 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 73.8 mt -60.29 61.47 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -174.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.777 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -155.41 172.75 17.7 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.985 177.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -85.87 80.55 8.87 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.601 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 17.5 t -60.66 -70.72 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.205 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -95.78 137.84 34.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 30.43 -96.7 0.01 OUTLIER Glycine 0 N--CA 1.467 0.708 0 O-C-N 124.733 1.271 . . . . 0.0 114.712 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 p -120.08 17.0 12.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.275 0.56 . . . . 0.0 111.46 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.603 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -85.38 103.82 14.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.554 -178.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -87.93 102.9 13.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -74.26 153.3 39.47 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.735 -176.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.31 -134.88 3.26 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.127 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.65 126.88 35.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.053 0.454 . . . . 0.0 110.259 -171.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.26 -13.2 31.08 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -119.85 161.33 21.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.242 -0.479 . . . . 0.0 109.924 176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.8 ttpp -146.25 123.08 11.27 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.84 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.601 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.2 t -89.04 141.92 28.08 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.718 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.5 pt -133.42 128.75 55.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.31 0.576 . . . . 0.0 109.998 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 6' ' ' CYS . 6.6 mp . . . . . 0 C--N 1.319 -0.753 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.45 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.46 0.06 0 CA-C-O 120.953 0.406 . . . . 0.0 111.79 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 90.3 m -99.48 106.18 18.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.516 175.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.2 p -95.99 158.99 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.1 p -88.98 126.84 35.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.8 0.333 . . . . 0.0 111.112 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.68 -119.12 0.73 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.006 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 9.2 pt-20 -147.02 117.0 7.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -102.91 -149.12 21.14 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.537 -177.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.7 144.9 19.87 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.369 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.6 144.55 74.25 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.362 2.041 . . . . 0.0 110.436 173.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 1.8 ttpm? . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -170.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.458 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 4.8 m-20 -86.93 148.05 25.51 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.704 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 21.9 m -60.8 133.58 56.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.502 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -109.91 -29.62 8.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.877 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 159.43 30.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.347 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -87.52 117.2 26.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.569 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.98 -6.82 9.42 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.214 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.62 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.42 160.44 16.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.639 0.257 . . . . 0.0 110.426 177.29 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.4 p30 -133.79 -57.28 0.88 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 78.9 mt -61.47 60.58 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.003 0.921 . . . . 0.0 112.886 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.704 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -155.05 162.33 41.08 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.448 179.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.68 85.36 5.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.1 0.476 . . . . 0.0 109.953 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.712 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 26.1 t -66.28 -73.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.429 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.08 144.12 26.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.116 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 22.76 -90.53 0.01 OUTLIER Glycine 0 N--CA 1.47 0.918 0 O-C-N 125.028 1.455 . . . . 0.0 114.699 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 p -121.6 -1.7 9.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.794 0.331 . . . . 0.0 111.197 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -70.29 104.06 2.56 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.629 0.728 . . . . 0.0 110.997 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 21.3 t -88.84 101.05 11.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.922 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -65.82 156.92 31.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.972 -175.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -134.71 -152.92 6.7 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -85.96 139.15 31.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.28 -15.63 50.28 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -120.48 166.22 13.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.4 ttpp -149.99 117.4 6.09 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.712 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 16.5 t -88.92 136.31 33.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.887 0.375 . . . . 0.0 110.266 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.2 pt -127.01 128.35 70.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.299 0.571 . . . . 0.0 110.243 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.318 -0.761 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.871 -176.926 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.032 0.444 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 91.8 m -89.41 96.03 10.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.916 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.6 p -90.23 160.13 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 p -88.88 132.0 34.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.285 0.564 . . . . 0.0 111.368 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.91 -128.6 1.68 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.876 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -143.14 112.85 6.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.344 0.593 . . . . 0.0 110.28 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.444 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -93.53 -148.09 23.03 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.419 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.93 142.71 22.81 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.83 139.4 78.19 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.198 1.932 . . . . 0.0 110.676 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.62 ' HG3' HE21 ' A' ' 11' ' ' GLN . 16.5 tttm . . . . . 0 N--CA 1.432 -1.352 0 CA-C-O 120.99 0.424 . . . . 0.0 110.493 -173.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.612 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.77 147.76 26.17 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 10.2 m -59.35 129.87 44.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.117 0.484 . . . . 0.0 110.796 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 m -103.08 -27.08 12.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.601 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.423 ' HB2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -129.36 159.36 36.42 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.403 -176.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 46.5 m -87.05 118.66 26.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.292 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.88 -4.72 11.54 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.12 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.506 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.06 161.82 16.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.706 0.288 . . . . 0.0 110.402 175.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 14' ' ' CYS . 6.1 p30 -135.66 -56.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.126 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 88.9 mt -62.15 63.13 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.375 1.047 . . . . 0.0 112.161 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -153.94 162.6 41.09 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.332 177.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.73 81.46 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.738 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 43.2 t -67.87 -79.87 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.385 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 11.1 tp10 -72.86 157.59 37.17 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -3.38 -78.3 0.01 OUTLIER Glycine 0 N--CA 1.472 1.094 0 O-C-N 125.284 1.615 . . . . 0.0 115.446 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.0 p -126.64 15.03 7.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.009 0.433 . . . . 0.0 111.125 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.585 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -83.85 111.2 18.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.755 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.9 t -87.92 103.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -74.94 163.82 27.22 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.081 -176.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.77 -138.34 2.83 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.849 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -85.91 125.8 33.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.195 0.521 . . . . 0.0 109.917 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -19.54 11.38 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -172.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -124.33 161.38 26.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' O ' HG12 ' A' ' 40' ' ' VAL . 25.6 ttpp -141.9 117.92 10.61 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.738 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 32.8 t -91.05 135.27 33.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.095 0.474 . . . . 0.0 110.572 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 23.3 pt -132.38 144.81 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.137 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 C--N 1.311 -1.093 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.327 176.786 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? . . . . . 0 C--O 1.233 0.23 0 CA-C-O 121.034 0.445 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 92.8 m -89.7 96.02 10.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.152 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.1 p -89.8 166.12 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.9 p -88.52 127.4 35.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.263 0.554 . . . . 0.0 111.178 -176.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.5 -135.54 3.57 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.985 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -141.36 110.3 6.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.448 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -92.68 -149.74 25.23 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.261 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.31 144.87 29.93 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 51.3 Cg_exo -55.3 140.35 81.74 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.387 2.058 . . . . 0.0 111.408 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.506 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 11.3 tttm . . . . . 0 N--CA 1.438 -1.064 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.164 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.1 155.55 20.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.782 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 3.8 m -61.18 134.26 56.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.366 0.603 . . . . 0.0 111.592 -173.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 m -100.13 -18.17 17.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.711 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.42 ' HB2' HE22 ' A' ' 11' ' ' GLN . 4.8 mm-40 -145.46 157.85 43.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.591 -177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 m -89.37 120.22 30.52 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.489 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.07 -2.9 14.43 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.532 -170.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.42 HE22 ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.16 172.39 9.11 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.9 p30 -143.52 -55.81 0.39 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 74.6 mt -61.61 66.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.925 0.869 . . . . 0.0 112.478 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.782 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -153.83 168.93 24.68 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.112 -1.403 . . . . 0.0 109.592 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.71 84.41 4.05 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 92.5 m -72.77 -80.21 0.07 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.473 -175.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -88.0 121.01 29.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.358 -173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.47 -90.31 0.01 OUTLIER Glycine 0 C--N 1.304 -1.235 0 O-C-N 123.985 0.803 . . . . 0.0 111.436 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.84 10.54 4.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.7 0.286 . . . . 0.0 111.561 173.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -71.17 126.11 28.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.164 0.506 . . . . 0.0 110.718 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 3.7 t -88.61 93.85 4.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.882 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.664 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -65.97 154.82 38.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 -176.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.01 -156.23 8.66 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -87.39 132.74 33.87 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.55 -22.26 8.86 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -168.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -117.6 159.95 22.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.09 171.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.551 ' O ' HG12 ' A' ' 40' ' ' VAL . 19.2 ttpp -133.62 113.97 12.99 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.303 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 51.7 t -90.22 130.51 36.34 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.6 pt -123.76 127.24 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.459 0.647 . . . . 0.0 111.023 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.023 176.137 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.469 0 CA-C-O 121.295 0.569 . . . . 0.0 110.468 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.664 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 81.0 m -89.57 95.7 10.38 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.696 176.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 27' ' ' LYS . 5.0 p -89.03 160.33 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.0 p -89.24 126.06 35.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.227 0.537 . . . . 0.0 111.422 -175.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.9 -122.36 0.9 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 11.8 pt-20 -150.23 123.59 8.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.177 0.513 . . . . 0.0 110.417 173.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -107.52 -145.81 12.3 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.381 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.22 142.62 21.98 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 51.1 Cg_exo -57.41 144.09 92.49 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.581 2.187 . . . . 0.0 111.243 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' A' ' 14' ' ' CYS . 2.1 ttpm? . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.534 0.207 . . . . 0.0 111.445 -172.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -87.89 152.29 22.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 11.5 m -60.0 133.24 55.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.558 -178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -113.44 -15.28 12.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.517 0.675 . . . . 0.0 110.273 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.706 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 46.1 mt-10 -134.2 151.64 51.42 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.217 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -88.11 124.36 33.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.06 -4.21 27.09 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.328 -173.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.706 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.27 162.11 16.04 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.7 p30 -136.04 -56.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 73.6 mt -61.83 62.18 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.96 0.788 . . . . 0.0 112.918 -177.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -155.48 175.25 14.12 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.596 178.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.2 106.57 14.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 40.2 t -98.73 -65.9 0.93 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.434 0.635 . . . . 0.0 110.966 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.13 107.07 18.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.879 -175.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.73 -90.04 0.01 OUTLIER Glycine 0 C--N 1.299 -1.521 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.007 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 p -124.49 2.08 8.34 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.0 0.429 . . . . 0.0 111.424 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.489 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -70.25 125.14 25.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.782 -175.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.06 105.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.348 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -72.91 155.47 39.84 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.24 -143.22 4.38 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.636 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -86.21 139.12 31.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.486 0.66 . . . . 0.0 110.266 -176.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.71 -9.94 58.82 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.718 -172.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -125.73 160.77 28.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.033 174.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.7 ttpp -143.74 119.55 10.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.536 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 17.5 t -89.16 133.18 34.5 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.847 0.356 . . . . 0.0 110.304 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 pt -128.29 123.01 59.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.379 0.609 . . . . 0.0 110.883 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 30' ' ' LEU . 6.7 mp . . . . . 0 C--N 1.319 -0.758 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.474 176.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 72.8 m -89.12 110.51 21.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.859 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.7 p -103.29 159.95 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 p -88.98 128.33 35.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.228 0.537 . . . . 0.0 111.122 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.6 -133.93 2.73 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.245 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -139.51 111.1 7.15 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.155 0.502 . . . . 0.0 109.938 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.75 -152.98 28.77 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.433 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.28 139.03 30.38 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.5 135.15 68.01 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.351 2.034 . . . . 0.0 110.907 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.669 ' HG3' HE21 ' A' ' 11' ' ' GLN . 18.7 tttt . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.5 p . . . . . 0 N--CA 1.443 -0.788 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -85.24 142.61 29.28 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -174.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.727 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 35.0 m -50.28 133.15 24.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.503 0.668 . . . . 0.0 111.128 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -115.07 -10.25 12.24 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.595 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.626 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 41.8 mt-10 -143.94 151.04 39.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.631 -173.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 m -89.01 126.95 35.64 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.455 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.3 -1.03 34.98 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.789 ' HG2' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.19 164.85 14.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 8.8 p30 -139.74 -57.05 0.57 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 75.4 mt -62.1 59.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.979 0.895 . . . . 0.0 112.415 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.768 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 1.6 p -155.39 150.6 26.9 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.126 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.65 89.85 2.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.629 0.728 . . . . 0.0 109.949 177.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.791 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 34.1 t -62.66 -73.51 0.11 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.358 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 1.2 tm-20 -87.53 163.31 16.73 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -23.04 -72.53 0.01 OUTLIER Glycine 0 N--CA 1.472 1.058 0 O-C-N 124.26 0.975 . . . . 0.0 115.366 -169.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.9 p -115.72 14.72 16.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.238 0.542 . . . . 0.0 110.46 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.542 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -80.81 92.19 6.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.889 177.179 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 41.9 t -87.91 97.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.702 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.47 158.81 32.09 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.8 -173.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -141.42 -146.26 4.69 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -87.0 134.72 33.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.196 0.522 . . . . 0.0 109.641 -174.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.01 -13.91 37.51 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -170.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -123.89 165.84 16.68 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.8 ttpp -148.89 118.46 6.97 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.791 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 13.7 t -89.41 132.46 34.98 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.8 pt -128.36 120.39 52.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.303 0.573 . . . . 0.0 110.707 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 N--CA 1.443 -0.811 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.581 178.449 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 . . . . . 0 C--O 1.233 0.236 0 CA-C-O 121.002 0.43 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.702 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 99.5 m -91.18 99.49 12.48 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.861 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 27' ' ' LYS . 5.3 p -89.69 160.77 2.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.2 p -87.62 129.99 34.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.25 0.547 . . . . 0.0 111.124 -176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.34 -135.12 3.51 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.669 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.86 108.98 7.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.034 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.57 -148.72 24.59 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.327 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.471 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -144.09 144.8 27.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 122.469 0.308 . . . . 0.0 110.299 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.511 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 33.2 Cg_exo -60.01 154.89 47.83 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.718 2.279 . . . . 0.0 111.65 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.789 ' HG2' ' HG2' ' A' ' 11' ' ' GLN . 2.0 mtmt . . . . . 0 N--CA 1.446 -0.644 0 CA-C-O 121.052 0.453 . . . . 0.0 110.725 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.485 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 13.6 p . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.0 141.85 28.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.752 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 9.1 m -59.12 137.65 57.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.473 0.178 . . . . 0.0 111.145 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -118.75 -25.48 6.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.917 0.389 . . . . 0.0 111.204 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.425 ' HB2' HE22 ' A' ' 11' ' ' GLN . 0.6 OUTLIER -123.48 156.32 35.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.993 -177.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 m -89.07 114.47 25.71 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.358 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.65 -0.67 9.36 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.333 -173.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.656 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.28 171.93 9.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.4 p30 -145.45 -56.73 0.32 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 65.8 mt -62.67 58.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.148 0.905 . . . . 0.0 112.492 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.752 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.05 159.33 41.51 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.957 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -73.05 102.78 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.755 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 29.6 t -89.44 -70.48 0.66 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.71 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 9.3 tp10 -79.56 158.99 27.02 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -6.93 -78.02 0.01 OUTLIER Glycine 0 N--CA 1.473 1.162 0 O-C-N 124.984 1.428 . . . . 0.0 115.241 -176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.9 p -122.5 14.43 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.843 0.354 . . . . 0.0 111.264 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.559 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -83.97 108.05 16.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.624 -178.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 9.2 t -92.06 104.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.811 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 1.2 m -82.32 168.85 17.15 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.187 -174.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -145.34 -149.27 4.98 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.56 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -86.79 134.28 33.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.441 0.639 . . . . 0.0 109.997 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.485 ' C ' HD22 ' A' ' 26' ' ' ASN . . . 112.5 -17.17 23.74 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -165.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.485 HD22 ' C ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -118.82 163.13 17.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.903 -0.649 . . . . 0.0 109.498 172.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 24.9 ttpp -144.61 117.96 9.04 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 173.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.755 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 33.7 t -89.17 132.31 34.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.733 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 pt -129.64 127.0 63.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.274 0.559 . . . . 0.0 110.879 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 30' ' ' LEU . 6.1 mp . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 1.6 tp60 . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.811 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 70.8 m -95.43 100.38 12.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.721 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.1 p -91.58 162.17 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -89.14 127.33 35.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.554 0.693 . . . . 0.0 111.779 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.47 -134.02 2.86 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.534 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -143.83 111.19 5.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.448 0.624 . . . . 0.0 110.495 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -89.22 -138.29 6.64 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.311 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.4 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -146.9 148.0 31.39 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 122.671 0.388 . . . . 0.0 110.341 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.4 ' HD2' HG22 ' A' ' 45' ' ' THR . 31.4 Cg_exo -59.56 134.87 60.76 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.602 2.201 . . . . 0.0 111.186 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.656 ' HG3' HE21 ' A' ' 11' ' ' GLN . 13.7 tttt . . . . . 0 N--CA 1.448 -0.574 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.486 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.2 p . . . . . 0 N--CA 1.444 -0.742 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -87.66 153.83 21.07 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.111 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.755 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 17.0 m -65.64 135.87 55.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.574 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 m -103.93 -23.03 13.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.071 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.98 162.77 34.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.241 0.544 . . . . 0.0 110.942 -173.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.0 m -87.12 122.0 30.35 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.151 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.86 -5.92 18.15 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.901 -173.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 1.025 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.86 161.04 15.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 175.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' CYS . 6.8 p30 -136.05 -55.93 0.76 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.402 HD23 ' HA2' ' A' ' 23' ' ' GLY . 89.0 mt -61.07 55.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.247 0.967 . . . . 0.0 112.893 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.755 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 1.2 p -155.36 160.48 40.74 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.845 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -77.6 97.24 5.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.364 0.602 . . . . 0.0 109.393 177.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.617 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 13.0 t -72.65 -77.31 0.1 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.703 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -86.85 162.11 17.95 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 3.29 -87.99 0.0 OUTLIER Glycine 0 N--CA 1.474 1.174 0 O-C-N 124.964 1.415 . . . . 0.0 114.969 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.1 p -123.07 22.05 9.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.463 0.649 . . . . 0.0 110.237 172.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -78.57 99.04 6.35 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.209 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 31.0 t -88.32 99.94 9.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.014 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.668 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -73.07 155.98 39.21 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.651 -176.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -139.67 -154.05 6.23 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.643 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -85.78 135.13 33.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.434 0.617 . . . . 0.0 109.52 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.25 -9.35 53.92 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -127.34 164.15 22.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.557 -0.822 . . . . 0.0 109.278 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.3 ttpp -150.28 121.46 7.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.211 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.617 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.9 t -89.23 138.0 31.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.956 0.408 . . . . 0.0 110.232 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -128.08 124.47 62.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.436 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.374 176.475 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 56.4 tp60 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.0 111.694 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.668 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 59.7 m -90.83 92.89 8.99 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.868 171.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.7 p -90.16 159.76 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.9 p -88.65 127.03 35.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.387 0.613 . . . . 0.0 110.685 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.67 -148.44 11.92 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.895 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -122.22 106.34 11.04 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.28 -144.14 12.47 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.091 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 1.025 HG22 ' HG3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -150.04 146.18 19.91 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.167 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.39 119.77 7.15 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.375 2.05 . . . . 0.0 111.841 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 8.4 tmtt? . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.3 p . . . . . 0 N--CA 1.442 -0.844 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.56 152.14 22.43 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 4.8 m -63.01 133.36 54.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.205 0.526 . . . . 0.0 111.225 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -105.45 -23.11 12.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.692 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.451 ' HB2' HE22 ' A' ' 11' ' ' GLN . 2.3 mm-40 -130.52 153.98 48.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.339 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 51.5 m -88.27 112.0 22.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.1 -0.13 7.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.004 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.568 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.64 171.84 9.72 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.6 p30 -142.41 -57.44 0.45 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 82.8 mt -62.87 61.62 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.815 0.846 . . . . 0.0 112.354 -178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -153.51 171.23 19.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.821 -179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 4' ' ' THR . 2.5 mt -83.45 88.36 6.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.546 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 41.9 t -80.49 -61.53 1.95 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.875 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.99 113.7 25.34 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.976 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 46.33 -97.32 0.01 OUTLIER Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.754 -175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -115.1 0.99 13.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.502 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -70.3 123.05 20.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.978 0.418 . . . . 0.0 110.607 -175.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.26 97.39 6.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.486 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.6 OUTLIER -74.69 167.29 22.09 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.541 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.02 -124.76 0.72 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.802 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -86.26 124.46 32.67 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.174 0.511 . . . . 0.0 110.312 -169.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.44 -2.7 37.02 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.045 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -130.89 154.35 48.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.323 0.582 . . . . 0.0 110.867 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.589 ' O ' HG12 ' A' ' 40' ' ' VAL . 5.2 ttpp -129.57 111.63 12.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.174 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 61.7 m -91.56 124.33 35.64 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.162 0.506 . . . . 0.0 111.09 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 16.3 pt -128.0 139.3 52.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.819 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.776 178.566 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.854 0.359 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 70.8 m -90.68 95.76 10.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.944 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.5 p -90.23 159.67 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -88.83 130.51 35.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.216 0.531 . . . . 0.0 111.464 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.69 -132.29 2.53 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.705 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -137.41 112.69 9.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.009 0.433 . . . . 0.0 110.335 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.476 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -100.99 -146.89 19.87 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.205 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.475 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -147.11 148.43 32.16 Favored Pre-proline 0 C--N 1.324 -0.533 0 C-N-CA 122.18 0.192 . . . . 0.0 110.664 -178.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.475 ' HD2' HG22 ' A' ' 45' ' ' THR . 51.1 Cg_exo -55.8 148.76 54.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.196 1.931 . . . . 0.0 110.785 173.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 9.5 tttm . . . . . 0 N--CA 1.438 -1.064 0 CA-C-O 120.691 0.281 . . . . 0.0 111.481 -171.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.22 139.99 29.94 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.827 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 28.2 m -60.24 130.8 48.43 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 109.937 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -113.08 -28.58 7.62 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.208 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' HB2' HE22 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -121.49 153.02 38.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.844 -177.006 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 58.9 m -88.44 114.56 25.19 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.392 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.14 -9.56 6.64 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.94 -173.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.688 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -86.61 168.31 13.75 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 6.1 p30 -140.15 -55.24 0.54 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 67.8 mt -62.76 56.24 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.249 0.968 . . . . 0.0 112.854 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.827 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.33 160.78 41.9 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.444 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -71.77 108.14 4.93 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.645 0.736 . . . . 0.0 109.371 174.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 53.3 t -89.47 -71.34 0.61 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.168 -176.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 8.8 tp10 -82.42 161.18 22.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -8.55 -78.03 0.01 OUTLIER Glycine 0 N--CA 1.473 1.147 0 O-C-N 124.905 1.378 . . . . 0.0 115.483 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.3 p -121.16 15.23 11.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 0.0 111.232 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.586 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -87.06 103.81 15.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.6 -179.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.68 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 37.0 t -89.53 105.14 15.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.778 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -78.44 169.74 17.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.382 -177.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -153.39 -133.69 1.89 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.823 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -85.3 141.31 30.16 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.274 0.559 . . . . 0.0 110.536 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.12 -10.26 69.87 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.184 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -120.15 160.11 23.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.971 0.415 . . . . 0.0 110.497 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.575 ' O ' HG12 ' A' ' 40' ' ' VAL . 19.3 ttpp -142.45 108.54 5.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.295 176.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.49 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 67.7 m -89.46 135.09 33.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.137 -174.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 19.0 pt -131.72 138.08 53.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.375 0.607 . . . . 0.0 110.543 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 C--N 1.317 -0.827 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.549 -179.311 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.037 0.446 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.778 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 77.7 m -90.43 101.09 13.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.767 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -96.08 158.98 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.0 p -88.31 128.63 35.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.774 0.321 . . . . 0.0 111.124 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.7 -121.28 0.88 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.673 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.542 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 6.9 pt-20 -149.79 125.95 10.68 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 173.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.52 -147.49 11.34 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.611 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.35 144.53 50.01 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.453 -0.374 . . . . 0.0 110.569 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.65 141.68 86.69 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.009 1.806 . . . . 0.0 109.924 171.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.688 ' HG3' HE21 ' A' ' 11' ' ' GLN . 2.0 ttpm? . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.676 -172.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 3.0 p . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.28 146.25 26.03 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.768 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 33.7 m -59.34 129.65 43.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.183 0.516 . . . . 0.0 110.185 175.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -102.36 -13.93 17.12 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.37 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.449 ' HB2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -150.17 163.76 37.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.209 0.528 . . . . 0.0 110.913 -174.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m -86.11 122.33 29.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.329 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.914 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 120.88 -7.89 10.83 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.531 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.597 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.8 169.06 11.94 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 122.868 -0.196 . . . . 0.0 110.575 178.125 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.47 -57.29 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.35 56.62 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.345 1.028 . . . . 0.0 113.095 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.768 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.77 161.91 41.32 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.833 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.03 89.02 2.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.375 173.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 36.4 t -57.2 -78.04 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.635 175.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 29.2 tt0 -87.56 161.92 17.48 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -16.0 -71.52 0.01 OUTLIER Glycine 0 N--CA 1.471 0.984 0 O-C-N 124.661 1.225 . . . . 0.0 115.665 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 p -116.66 5.96 13.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.063 0.458 . . . . 0.0 111.339 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -80.42 93.87 6.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.471 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 46.2 t -88.54 97.74 7.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -70.7 160.72 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.224 -175.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.92 -141.78 3.76 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.852 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -87.13 135.3 33.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.165 0.507 . . . . 0.0 109.953 -172.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.51 -7.59 59.76 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -122.66 156.71 33.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.036 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.914 ' HD2' ' HA2' ' A' ' 10' ' ' GLY . 4.7 ttpp -138.59 121.41 16.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.831 176.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 30.0 t -89.94 130.74 36.11 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.38 137.2 54.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.423 0.63 . . . . 0.0 110.462 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.315 -0.912 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.793 -172.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 8.3 tp-100 . . . . . 0 C--O 1.23 0.066 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 86.5 m -90.46 104.46 17.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.586 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.8 p -97.26 164.92 2.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 p -95.25 116.27 28.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.074 0.464 . . . . 0.0 111.156 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.52 -126.95 0.97 Allowed Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.001 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 111.2 6.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.481 0.657 . . . . 0.0 110.769 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.669 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -97.4 -151.87 28.04 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.725 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.412 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -150.11 147.46 22.21 Favored Pre-proline 0 C--N 1.321 -0.64 0 C-N-CA 122.511 0.325 . . . . 0.0 110.679 -176.264 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.412 ' HD2' HG22 ' A' ' 45' ' ' THR . 52.5 Cg_exo -54.49 148.71 41.93 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.425 2.083 . . . . 0.0 110.497 170.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 2.2 ttpm? . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -165.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 N--CA 1.448 -0.567 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.32 157.66 18.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.772 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 2.7 m -67.25 133.92 50.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.321 0.581 . . . . 0.0 111.688 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -106.52 -22.57 12.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.859 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -139.98 157.83 45.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.031 0.443 . . . . 0.0 110.729 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 m -88.28 118.88 28.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.016 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.86 -5.53 10.53 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.805 -173.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.627 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -87.8 176.49 7.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.0 p30 -148.81 -54.14 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 98.0 mt -60.55 65.95 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.898 0.856 . . . . 0.0 112.256 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.772 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 1.2 p -154.1 165.91 34.71 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.317 -1.311 . . . . 0.0 109.451 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.3 85.54 3.09 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 99.6 m -74.85 -78.48 0.1 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.037 -174.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -85.61 115.09 23.09 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.317 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 48.75 -94.7 0.01 OUTLIER Glycine 0 C--N 1.298 -1.552 0 O-C-N 124.136 0.897 . . . . 0.0 112.006 -173.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -117.88 0.13 11.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.0 111.737 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.498 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -72.15 123.04 22.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.96 0.41 . . . . 0.0 110.64 -176.342 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 t -88.68 106.01 16.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.656 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -75.3 161.94 28.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.581 -177.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.9 -143.78 3.88 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.833 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -86.75 138.36 31.68 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.282 0.563 . . . . 0.0 110.151 -172.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.17 -10.23 58.19 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -169.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -127.06 153.42 45.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 120.96 0.41 . . . . 0.0 110.202 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 40' ' ' VAL . 14.2 ttpp -134.21 113.2 11.76 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.279 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 15.0 t -89.51 130.7 35.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.906 0.384 . . . . 0.0 110.439 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -129.46 130.22 67.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.574 0.702 . . . . 0.0 111.276 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--N 1.317 -0.815 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.609 176.718 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.822 0.344 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.635 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 81.0 m -89.48 97.19 11.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.702 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.3 p -89.73 160.97 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.4 p -88.84 128.68 35.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.469 0.652 . . . . 0.0 111.37 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.43 -142.64 7.44 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.542 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -128.19 113.96 16.37 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.747 0.308 . . . . 0.0 110.779 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -100.87 -146.16 18.55 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.004 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.95 144.86 22.97 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 122.641 0.376 . . . . 0.0 110.701 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.35 145.22 94.55 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.289 1.993 . . . . 0.0 110.067 171.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.627 ' HG3' HE21 ' A' ' 11' ' ' GLN . 2.0 ttpm? . . . . . 0 C--N 1.32 -0.675 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.549 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.921 0.391 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 51.5 t -122.59 106.58 17.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.873 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -93.24 157.95 16.0 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.3 p -136.37 -178.08 5.0 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.87 -176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.36 155.65 19.59 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.809 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 9.6 m -65.11 133.68 52.13 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.2 m -106.02 -28.65 10.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.003 0.43 . . . . 0.0 111.089 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.488 ' HB2' HE22 ' A' ' 11' ' ' GLN . 3.4 mm-40 -125.31 158.21 34.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.0 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 m -87.85 125.96 34.76 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 116.4 -5.74 19.2 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.064 -173.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.975 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -91.16 157.87 16.95 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.507 0.194 . . . . 0.0 110.917 176.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 14' ' ' CYS . 3.0 p30 -127.61 -59.26 1.22 Allowed 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 87.1 mt -60.64 59.5 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 O-C-N 124.482 1.114 . . . . 0.0 113.635 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.809 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -155.15 169.27 24.54 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.264 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.5 103.13 10.15 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 12.8 t -86.56 -72.87 0.48 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.617 0.723 . . . . 0.0 110.624 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -91.38 107.46 19.22 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.334 -176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.85 -82.41 0.01 OUTLIER Glycine 0 C--N 1.307 -1.038 0 O-C-N 124.694 1.246 . . . . 0.0 113.296 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.4 p -127.21 -3.16 6.3 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 122.534 0.334 . . . . 0.0 111.418 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -66.75 116.18 7.37 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.219 0.533 . . . . 0.0 111.27 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.4 t -88.68 93.83 4.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.871 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.711 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -63.37 145.79 54.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.803 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.87 -132.22 3.21 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.783 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -88.43 139.97 29.95 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.17 0.51 . . . . 0.0 110.525 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.29 -11.73 71.14 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.791 -175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -121.54 164.61 16.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.033 0.444 . . . . 0.0 110.286 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 40' ' ' VAL . 24.9 ttpp -150.67 124.91 9.42 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.734 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.61 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.6 t -89.62 135.82 33.39 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.947 0.403 . . . . 0.0 110.503 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.5 pt -125.05 120.86 59.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.561 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 5.9 mp -95.35 101.16 12.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.573 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.9 -118.29 2.87 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.81 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -152.94 164.19 38.39 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.23 -126.27 25.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.985 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.63 -13.83 36.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.149 0.5 . . . . 0.0 109.701 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 t -99.58 53.55 0.94 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -95.88 -13.56 23.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.555 -173.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.9 118.67 4.97 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 35.3 tp60 -151.29 140.15 20.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.64 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.711 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 79.3 m -91.65 92.76 8.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.852 172.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 27' ' ' LYS . 6.2 p -89.57 155.72 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.5 p -88.23 132.26 34.44 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.459 0.647 . . . . 0.0 111.179 -176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.16 -128.09 1.65 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.09 117.62 13.82 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.223 0.535 . . . . 0.0 110.033 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -93.8 -146.64 20.5 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.596 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.741 HG22 ' HG3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -150.42 145.67 18.84 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -177.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.89 118.83 5.74 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.364 2.042 . . . . 0.0 110.969 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.975 ' HG3' HE21 ' A' ' 11' ' ' GLN . 15.9 tttt -84.63 116.6 65.93 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.097 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.2 136.54 56.44 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 C-N-CA 122.384 2.056 . . . . 0.0 111.845 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -151.47 -28.18 0.19 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.195 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 p -119.55 134.25 55.31 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.497 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.5 m170 . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.023 0.439 . . . . 0.0 110.616 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.287 0.565 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.7 t -88.39 90.25 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.363 0.601 . . . . 0.0 110.477 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -114.15 -176.14 2.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.102 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.538 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 2.5 p -121.91 -159.33 0.81 Allowed 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.425 ' H ' ' HB ' ' A' ' 4' ' ' THR . 1.8 m-20 -86.98 161.78 18.02 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.171 -175.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 17.7 m -64.5 137.94 58.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.721 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.484 HG23 ' HG2' ' A' ' 8' ' ' GLU . 6.2 t -106.76 -16.73 14.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.2 0.524 . . . . 0.0 110.444 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.619 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 4.9 mm-40 -138.26 154.99 49.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.741 -175.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -88.07 127.2 35.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.608 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.43 -6.68 31.94 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.619 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.16 157.28 18.34 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.9 p30 -129.23 -60.02 1.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.66 60.65 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.306 1.042 . . . . 0.0 113.511 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.718 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.78 169.76 23.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.005 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -81.26 112.49 18.62 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.764 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 36.4 t -98.12 -79.42 0.47 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.651 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.92 111.09 18.93 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.414 -172.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.17 -92.33 0.01 OUTLIER Glycine 0 C--N 1.297 -1.596 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.327 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 p -121.16 2.06 10.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.709 0.29 . . . . 0.0 111.343 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -68.09 125.72 27.25 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.534 0.683 . . . . 0.0 111.381 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.26 108.64 19.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.496 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.743 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -74.6 149.77 39.94 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.123 176.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.33 -149.35 5.09 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.571 -0.611 . . . . 0.0 111.571 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -87.33 133.01 33.76 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.04 -8.24 38.63 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -133.57 166.84 21.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.611 -0.795 . . . . 0.0 109.253 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.55 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 24.3 ttpp -149.41 117.9 6.52 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.764 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 16.0 t -89.39 125.53 35.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.206 0.527 . . . . 0.0 110.865 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.5 pt -121.07 124.18 71.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.851 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 6.8 mp -75.78 89.03 2.84 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.292 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 35' ' ' SER . . . 124.62 115.84 2.14 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.21 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 35' ' ' SER . 16.6 tpt180 -154.09 79.82 1.12 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.26 -91.03 1.23 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.03 12.88 12.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.467 0.651 . . . . 0.0 109.553 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.497 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 22.7 t -88.58 148.63 23.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.504 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -97.04 -40.48 8.83 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.779 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 2.0 p-10 -152.35 120.02 6.08 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.582 HE21 ' HA ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -121.87 137.3 54.83 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.343 -174.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.743 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 97.5 m -90.14 86.96 6.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.949 174.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.2 p -88.02 165.89 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 p -88.97 132.22 34.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.67 0.748 . . . . 0.0 111.271 -176.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.8 -140.39 6.4 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -138.82 111.31 7.55 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.55 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -86.5 -155.28 26.57 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.941 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.22 141.8 43.19 Favored Pre-proline 0 C--N 1.31 -1.111 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.488 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 50.0 Cg_exo -54.2 140.82 71.38 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.996 1.797 . . . . 0.0 109.931 173.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 42.0 tttt -86.79 112.35 46.42 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-O 120.706 0.289 . . . . 0.0 111.334 -169.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 21.0 Cg_exo -65.76 142.39 69.74 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.827 2.351 . . . . 0.0 110.87 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.517 ' HG3' ' H ' ' A' ' 50' ' ' SER . 10.5 pt20 -164.07 -55.66 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.851 -169.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.517 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 32.9 t -150.24 148.42 28.87 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.884 0.849 . . . . 0.0 111.501 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.33 97.76 5.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.107 0.48 . . . . 0.0 110.309 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -102.54 -174.71 2.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.187 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.4 p -129.73 -175.37 3.58 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.74 -174.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.11 144.41 26.51 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.776 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 20.3 m -60.2 132.3 53.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 m -111.37 -12.99 13.97 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.195 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.676 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 37.4 mt-10 -136.05 156.01 49.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.892 -172.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.8 m -89.24 118.8 29.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.117 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.62 1.41 24.47 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.779 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.72 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -92.93 158.9 15.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.6 p30 -134.31 -57.38 0.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 46' ' ' PRO . 76.6 mt -63.26 59.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.103 0.877 . . . . 0.0 112.587 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.776 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -154.43 164.9 37.93 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.778 177.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.95 98.69 7.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.635 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 14.6 t -74.16 -77.83 0.11 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.435 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 28.2 tt0 -84.13 154.52 23.09 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 11.44 -89.75 0.0 OUTLIER Glycine 0 N--CA 1.471 1.023 0 O-C-N 125.003 1.439 . . . . 0.0 115.062 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.0 p -120.07 16.96 12.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.268 0.556 . . . . 0.0 111.074 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 24.2 m-80 -79.03 98.21 6.39 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.531 0.681 . . . . 0.0 110.578 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 40.7 t -88.43 98.04 7.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.933 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -78.71 160.22 27.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.149 -174.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -143.3 -136.95 3.22 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.042 -179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -87.8 133.77 33.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.201 0.524 . . . . 0.0 109.86 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.7 -8.76 51.5 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.287 -173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -125.99 164.06 21.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.444 -0.378 . . . . 0.0 110.12 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HD3' ' O ' ' A' ' 43' ' ' GLU . 27.4 ttpp -148.23 120.43 8.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.745 177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.635 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 10.4 t -88.84 136.96 32.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.856 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.4 pt -127.78 134.5 65.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.239 0.543 . . . . 0.0 110.28 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.69 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 44.0 mt -103.86 84.02 2.2 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.412 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.457 ' C ' ' HA ' ' A' ' 36' ' ' LYS . . . -108.77 -109.72 3.32 Favored Glycine 0 C--N 1.317 -0.501 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.647 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.426 ' HD3' ' N ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -152.87 168.2 26.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -176.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 36' ' ' LYS . . . 68.33 -118.49 9.37 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.092 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -94.83 -15.27 23.88 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.472 0.653 . . . . 0.0 109.35 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 t -100.46 26.69 6.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.947 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 3.2 ptpt -78.43 -31.28 48.04 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.296 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -153.87 80.08 1.14 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.734 HE21 ' HA ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -134.68 140.44 46.0 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.666 -171.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 89.4 m -92.02 97.95 11.26 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.135 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.8 p -89.67 161.8 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.2 p -89.11 129.39 35.73 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.368 0.604 . . . . 0.0 111.58 -174.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.87 -132.33 2.62 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.183 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 5.8 pt-20 -136.95 119.24 15.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.266 0.555 . . . . 0.0 110.756 175.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.86 -143.87 15.64 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.208 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.22 142.71 17.21 Favored Pre-proline 0 C--N 1.324 -0.514 0 C-N-CA 122.507 0.323 . . . . 0.0 110.399 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 32.0 Cg_exo -59.0 132.79 49.37 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.655 2.237 . . . . 0.0 111.159 174.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.72 ' HG3' HE21 ' A' ' 11' ' ' GLN . 1.8 ttpm? -89.6 108.23 23.82 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.77 -175.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 21.3 Cg_exo -65.07 147.54 88.8 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.589 2.193 . . . . 0.0 111.804 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -139.02 -38.59 0.5 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.565 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.3 m -90.24 -30.61 17.43 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 51.5 m80 . . . . . 0 CA--C 1.512 -0.517 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.133 173.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 120.941 0.4 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 t -100.04 76.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.582 0.706 . . . . 0.0 110.056 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -97.77 153.34 18.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.868 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.521 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 5.5 p -135.32 -164.37 1.52 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.353 -175.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.32 145.52 26.31 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.7 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 26.1 m -59.54 134.14 56.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.959 0.409 . . . . 0.0 110.941 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 m -110.61 -31.67 7.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.61 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.6 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 25.6 mp0 -115.1 152.52 32.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.717 -176.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 m -88.88 119.91 29.8 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 117.46 -5.85 16.89 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.999 -173.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.758 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.08 166.33 13.93 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 14' ' ' CYS . 8.6 p30 -135.62 -58.19 0.78 Allowed 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.75 60.56 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.119 0.887 . . . . 0.0 112.944 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.7 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -153.76 161.28 42.22 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.359 178.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -81.77 100.03 9.3 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.578 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 30.8 t -82.34 -74.93 0.32 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.843 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 2.0 tm-20 -78.38 148.16 33.8 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 10.02 -85.87 0.0 OUTLIER Glycine 0 N--CA 1.471 1.016 0 O-C-N 124.972 1.42 . . . . 0.0 115.372 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.9 p -119.81 5.36 10.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.967 0.413 . . . . 0.0 111.248 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -71.38 107.64 4.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.227 0.537 . . . . 0.0 110.502 -177.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.9 t -89.09 98.55 8.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.497 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -66.88 153.72 42.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.211 -178.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -148.71 -128.17 1.69 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.095 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.67 134.45 33.65 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.207 0.527 . . . . 0.0 109.956 -174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.66 0.63 66.62 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.644 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.43 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 51.9 m-80 -133.96 164.48 27.21 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.126 0.488 . . . . 0.0 110.794 175.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 25.0 ttpp -150.61 123.34 8.6 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.494 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 38' ' ' GLN . 27.8 t -89.94 133.08 34.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.986 0.422 . . . . 0.0 110.6 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.69 112.42 33.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.431 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 5.3 mp -86.78 80.67 8.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.569 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.17 -112.23 2.35 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.709 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 35' ' ' SER . 38.7 ttp180 -155.26 157.07 36.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -173.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.72 -137.24 13.3 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.829 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.15 -7.38 56.99 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 167.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 53.8 m -92.64 23.64 3.96 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 112.462 -2.154 . . . . 0.0 110.35 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 12.1 ptmm? -59.26 -36.88 76.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.298 -176.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 3.5 p-10 -152.87 128.93 10.37 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 171.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 33.1 tp60 -145.12 138.53 26.68 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.452 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 60.3 m -89.36 87.93 7.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.946 172.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.9 p -89.23 159.31 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -88.9 130.62 35.39 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.258 0.551 . . . . 0.0 111.186 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.91 -134.83 3.3 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.5 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.526 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 8.8 pt-20 -133.8 113.86 12.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.099 0.476 . . . . 0.0 109.888 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.555 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -96.18 -149.75 26.02 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.523 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.39 142.47 26.68 Favored Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 122.568 0.347 . . . . 0.0 110.324 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.42 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 32.5 Cg_exo -58.42 129.55 33.2 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.301 2.0 . . . . 0.0 110.851 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.758 ' HG3' HE21 ' A' ' 11' ' ' GLN . 15.2 tttt -89.11 113.29 55.64 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.349 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 9.4 Cg_exo -71.93 148.74 52.07 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.867 2.378 . . . . 0.0 111.691 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -99.21 -4.13 32.74 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.962 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.4 p -88.97 55.75 3.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.591 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.528 ' HE1' ' HE2' ' A' ' 47' ' ' LYS . 23.0 m80 . . . . . 0 CA--C 1.509 -0.607 0 CA-C-O 121.455 0.645 . . . . 0.0 110.924 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.671 0.272 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.99 104.23 16.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.823 0.344 . . . . 0.0 110.739 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -89.75 160.44 16.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.092 0.472 . . . . 0.0 110.371 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.482 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.7 p -139.38 -165.06 1.79 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.339 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.531 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 7.4 m-20 -87.72 149.53 24.17 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.726 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 25.9 m -61.45 134.75 57.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.858 0.361 . . . . 0.0 110.755 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -112.1 -20.85 11.78 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.265 0.555 . . . . 0.0 110.406 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -134.92 154.99 51.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.333 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -86.63 124.44 32.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.8 -10.05 16.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.663 -172.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.761 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.95 154.05 20.14 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.1 p30 -126.79 -61.85 1.16 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.427 HD23 ' HA2' ' A' ' 23' ' ' GLY . 94.4 mt -58.99 63.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.011 0.925 . . . . 0.0 113.05 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.726 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.15 162.32 41.27 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.871 177.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -78.37 87.84 4.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.602 ' HA ' ' SG ' ' A' ' 6' ' ' CYS . 13.9 t -61.3 -77.55 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.253 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.634 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 6.8 tp10 -82.56 164.91 20.53 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -8.41 -71.86 0.01 OUTLIER Glycine 0 N--CA 1.472 1.089 0 O-C-N 124.88 1.363 . . . . 0.0 115.269 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.4 p -127.67 4.38 6.11 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.697 -0.296 . . . . 0.0 111.392 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.509 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -78.8 110.64 14.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 110.737 -179.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 40.6 t -89.88 106.78 17.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.74 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.76 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -68.42 146.98 52.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.92 177.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -131.98 -156.98 8.51 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.039 -1.076 . . . . 0.0 113.454 -177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -85.82 117.44 24.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.739 0.78 . . . . 0.0 109.607 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.34 -4.24 23.5 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -165.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.494 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 6.6 m120 -122.25 164.49 17.77 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.651 -0.774 . . . . 0.0 108.987 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 40' ' ' VAL . 26.4 ttpp -149.98 118.25 6.41 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.479 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.7 t -89.51 130.48 35.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.039 0.447 . . . . 0.0 110.624 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -123.65 112.95 35.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.132 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 5.8 mp -80.33 79.5 6.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.474 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.14 -109.72 1.55 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.724 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.26 168.5 27.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.88 -142.26 18.3 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.378 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.96 -2.0 58.34 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 167.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 m -98.17 25.47 6.13 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.731 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.625 ' HG3' ' OD1' ' A' ' 37' ' ' ASN . 9.6 pttm -58.58 -26.88 64.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.008 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.634 ' ND2' ' HA ' ' A' ' 17' ' ' GLU . 18.3 p-10 -153.41 82.28 1.18 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 11.9 tp60 -94.57 135.67 35.76 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.871 -169.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.76 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 54.6 m -89.62 89.85 7.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.112 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.8 p -88.79 153.2 3.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 p -89.78 119.73 30.43 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.175 0.512 . . . . 0.0 110.57 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.86 -130.99 1.51 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.63 110.76 7.32 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.118 0.485 . . . . 0.0 110.132 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.501 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -99.14 -145.06 17.81 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.225 -177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.37 136.14 11.32 Favored Pre-proline 0 C--N 1.317 -0.812 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.79 135.88 42.66 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.442 2.095 . . . . 0.0 111.038 171.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.761 ' HG3' HE21 ' A' ' 11' ' ' GLN . 24.5 tttm -86.61 120.9 72.2 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -48.67 135.47 27.63 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.018 2.479 . . . . 0.0 112.505 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -133.38 -33.87 1.09 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.25 -171.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -88.9 -64.17 1.18 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.928 176.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 55.2 m80 . . . . . 0 CA--C 1.508 -0.638 0 CA-C-O 121.396 0.617 . . . . 0.0 110.219 -177.56 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.969 0.414 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.6 t -113.2 110.33 31.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.399 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -115.15 168.51 9.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.293 0.568 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 p -127.36 -172.8 2.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.815 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.791 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 3.4 m-20 -89.04 149.0 23.43 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.734 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 61.2 m -58.57 144.35 43.12 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.234 0.54 . . . . 0.0 112.082 -174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.624 ' OG1' ' HE2' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -114.26 -23.87 9.22 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.676 176.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.671 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 43.1 mt-10 -136.15 153.69 51.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.304 -170.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.8 m -88.46 120.86 30.23 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.7 -11.56 13.77 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -172.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.671 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -88.01 164.34 15.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.2 p30 -134.93 -58.0 0.81 Allowed 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.415 HD23 ' HA2' ' A' ' 23' ' ' GLY . 87.2 mt -58.16 61.81 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.383 1.073 . . . . 0.0 113.42 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.734 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.6 166.3 33.8 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.233 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.78 94.16 6.36 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.552 ' HB2' ' SG ' ' A' ' 28' ' ' CYS . 49.3 t -73.79 -74.49 0.18 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.356 -172.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -91.92 150.16 21.18 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 27.15 -91.5 0.01 OUTLIER Glycine 0 N--CA 1.472 1.07 0 O-C-N 124.548 1.155 . . . . 0.0 114.535 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.01 32.73 4.0 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.413 0.625 . . . . 0.0 110.948 173.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -82.06 112.91 19.55 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.694 177.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.8 t -88.37 91.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -69.14 146.64 52.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.39 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -136.29 -152.51 6.32 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.07 137.02 32.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.489 0.644 . . . . 0.0 109.357 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.17 -9.93 46.78 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -167.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -126.93 158.63 36.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.861 -0.669 . . . . 0.0 109.892 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 18.3 ttpp -139.55 121.21 15.29 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 16' ' ' CYS . 74.1 m -89.76 143.38 26.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.724 0.297 . . . . 0.0 111.13 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.8 pt -135.36 131.12 51.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.289 0.566 . . . . 0.0 110.768 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.7 mp -91.3 117.81 29.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.372 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.64 -115.99 2.31 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.768 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -141.67 160.56 39.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.639 0.257 . . . . 0.0 111.334 -174.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.11 -124.56 11.4 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.023 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -93.06 -10.13 37.22 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 t -90.73 30.65 1.14 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.638 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -64.86 -21.2 66.75 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.899 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.444 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -153.56 96.55 2.03 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.815 HE21 ' HA ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -119.63 148.3 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.218 -173.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 91.8 m -101.21 114.89 29.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.046 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 27' ' ' LYS . 1.2 p -104.16 157.22 5.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.9 p -91.36 123.78 35.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.077 0.465 . . . . 0.0 111.162 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.8 -120.23 0.75 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.502 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 13.6 pt-20 -151.95 123.38 7.79 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.493 -0.416 . . . . 0.0 110.452 174.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.562 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -107.72 -151.96 17.07 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.937 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.07 144.01 51.36 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.72 135.43 67.17 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.216 1.944 . . . . 0.0 110.819 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.791 ' HE3' ' O ' ' A' ' 5' ' ' ASP . 14.6 tttm -88.41 138.56 30.19 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.755 -174.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.94 139.32 25.7 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.551 2.168 . . . . 0.0 111.222 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -132.9 -17.29 2.46 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.951 -165.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -87.04 148.41 25.29 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.4 m170 . . . . . 0 CA--C 1.511 -0.544 0 CA-C-O 121.376 0.608 . . . . 0.0 111.98 -168.664 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 65.6 t . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.837 0.351 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.95 110.42 31.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.418 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -91.02 -177.15 4.84 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.173 0.511 . . . . 0.0 110.816 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.638 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 82.7 p -125.4 -167.89 1.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -87.45 172.22 9.96 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.807 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 31.3 m -73.37 136.37 44.38 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.023 0.44 . . . . 0.0 111.248 -177.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 m -102.31 -21.93 14.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -139.5 156.22 47.06 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.115 0.484 . . . . 0.0 110.701 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.9 m -90.16 107.75 19.32 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.025 -0.988 . . . . 0.0 108.53 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 124.79 -0.53 8.49 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -169.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -88.15 -171.1 3.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.6 p30 -159.04 -55.2 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 74.1 mt -60.8 61.34 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.805 0.842 . . . . 0.0 112.905 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.807 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.7 OUTLIER -154.03 166.91 31.53 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.14 178.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.5 OUTLIER -79.01 91.58 4.87 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.721 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 33.1 t -92.65 -65.04 1.03 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.188 0.518 . . . . 0.0 111.245 -174.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -83.69 103.79 13.28 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.793 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.36 -95.29 0.01 OUTLIER Glycine 0 C--N 1.294 -1.753 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.796 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.3 p -121.33 11.99 10.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.743 0.306 . . . . 0.0 111.236 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.472 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -73.11 126.07 29.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.07 0.462 . . . . 0.0 110.635 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 t -89.83 102.55 13.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.089 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 13' ' ' LEU . 1.3 m -85.3 162.83 18.94 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.915 0.388 . . . . 0.0 111.37 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -148.76 -140.04 3.24 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.726 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -84.8 134.73 34.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.292 0.567 . . . . 0.0 109.56 -173.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.89 -16.46 28.11 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -169.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -119.61 158.38 26.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.061 0.458 . . . . 0.0 110.786 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.629 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 4.4 tppp? -130.51 107.71 9.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.049 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 85.8 m -89.31 126.81 35.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.538 0.208 . . . . 0.0 110.77 -177.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -128.82 127.94 66.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.196 0.522 . . . . 0.0 111.163 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.56 ' HG ' ' OD1' ' A' ' 37' ' ' ASN . 5.5 mp -87.02 81.11 8.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.495 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.02 -113.0 1.71 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.158 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -164.55 176.58 8.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.84 -116.32 7.23 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.345 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -96.5 -22.78 16.9 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.571 0.701 . . . . 0.0 109.132 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -91.64 37.29 0.96 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.979 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.625 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -64.92 -32.25 73.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.902 -175.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.625 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 10.7 t30 -155.1 75.28 0.95 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -115.63 146.67 41.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -165.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 16' ' ' CYS . 69.8 m -94.26 100.55 12.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.401 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.1 p -90.84 158.48 2.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.3 p -89.13 125.69 35.15 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.623 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.97 -123.37 0.87 Allowed Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.955 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -152.3 109.01 3.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.174 0.511 . . . . 0.0 110.294 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.629 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -90.2 -147.61 18.1 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.287 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.547 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -133.8 142.03 42.13 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.7 134.19 61.35 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.129 1.886 . . . . 0.0 110.851 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.502 ' HG3' HE21 ' A' ' 11' ' ' GLN . 1.6 ttpm? -88.34 113.84 57.0 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 -171.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.24 151.08 18.05 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.115 2.544 . . . . 0.0 111.521 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -124.25 -42.98 2.09 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -168.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.9 m -102.98 -92.57 0.33 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.095 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.6 m80 . . . . . 0 CA--C 1.513 -0.446 0 CA-C-O 121.03 0.443 . . . . 0.0 110.804 -171.28 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.847 0.356 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 t -112.62 79.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.103 0.478 . . . . 0.0 110.739 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -95.0 154.93 16.94 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 4.7 p -134.91 -159.88 1.0 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.23 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.51 155.95 19.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.719 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.1 m -63.81 137.14 57.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.986 0.422 . . . . 0.0 111.621 -176.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m -107.5 -31.4 8.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.047 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.82 157.01 46.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.609 -175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 m -88.39 122.1 31.51 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.476 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.94 -6.5 21.97 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -171.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.8 164.97 14.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.9 p30 -136.77 -57.12 0.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.414 HD23 ' HA2' ' A' ' 23' ' ' GLY . 91.8 mt -59.55 61.39 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.111 0.965 . . . . 0.0 112.984 -176.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.719 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.77 167.29 30.7 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.394 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -81.62 105.24 12.61 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 175.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.726 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 34.2 t -94.57 -70.85 0.69 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.654 -172.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 20.4 tt0 -86.84 79.38 8.82 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.106 0.955 . . . . 0.0 109.68 -175.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 -91.88 0.28 Allowed Glycine 0 C--N 1.294 -1.781 0 CA-C-N 113.551 -1.659 . . . . 0.0 111.612 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 p -109.25 -3.45 17.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.658 0.266 . . . . 0.0 110.929 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 17' ' ' GLU . 18.8 m-80 -64.84 114.79 4.73 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.184 0.516 . . . . 0.0 111.124 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.9 t -89.01 104.36 14.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.918 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.91 151.32 37.37 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.959 0.409 . . . . 0.0 110.233 179.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -140.14 -153.5 6.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -85.97 144.75 27.45 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.13 -3.42 80.28 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -165.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -135.0 156.3 49.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.6 ttpp -142.12 123.15 14.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.969 0.414 . . . . 0.0 109.981 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.726 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 14.4 t -90.04 139.48 30.57 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.911 0.386 . . . . 0.0 110.688 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.9 pt -132.38 124.04 51.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.761 176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.0 mp -81.3 98.29 8.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.055 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 36' ' ' LYS . . . 99.54 114.85 3.62 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.584 -0.735 . . . . 0.0 113.463 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.539 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -169.26 114.46 0.56 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.62 -115.73 8.19 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.829 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -98.43 48.75 0.99 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.05 0.452 . . . . 0.0 109.902 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.543 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 8.0 t -148.4 156.04 41.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.354 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.562 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -129.58 -8.78 4.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.826 174.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.518 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -154.7 81.71 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.539 ' HG2' ' HD2' ' A' ' 32' ' ' ARG . 27.7 tp60 -113.48 141.51 47.03 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -167.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 93.9 m -96.67 109.14 21.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.773 177.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.7 p -103.6 162.96 3.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 p -90.18 129.23 36.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.487 0.661 . . . . 0.0 111.198 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.51 -144.43 8.96 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.91 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -128.31 105.61 8.46 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.974 0.416 . . . . 0.0 110.267 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.81 -151.99 22.88 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.202 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.21 142.5 35.61 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.17 142.69 77.49 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.381 2.054 . . . . 0.0 111.428 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HD3' ' HB3' ' A' ' 14' ' ' CYS . 2.3 ttpm? -87.29 119.22 70.78 Favored Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -175.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.0 148.06 1.15 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.476 3.451 . . . . 0.0 114.019 -174.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.12 -24.69 3.39 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.429 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 92.1 p -88.32 -35.09 17.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.112 176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 . . . . . 0 CA--C 1.501 -0.909 0 CA-C-O 121.899 0.856 . . . . 0.0 110.194 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.5 t -88.47 83.72 2.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -165.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -90.05 150.21 22.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 164.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.566 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -150.8 -173.18 4.4 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.76 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.24 150.51 24.32 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.777 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 13.3 m -62.15 128.84 38.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.024 0.44 . . . . 0.0 110.479 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -95.71 -17.17 21.47 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.868 -177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.67 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 36.1 mt-10 -138.37 151.69 47.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.786 -170.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.1 m -87.67 124.21 33.31 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.472 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 115.35 -6.58 21.06 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.876 -173.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.67 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.84 162.48 15.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.1 p30 -132.74 -59.24 0.91 Allowed 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 73.8 mt -60.29 61.47 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -174.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.777 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -155.41 172.75 17.7 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.985 177.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -85.87 80.55 8.87 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.601 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 17.5 t -60.66 -70.72 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.205 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -95.78 137.84 34.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 30.43 -96.7 0.01 OUTLIER Glycine 0 N--CA 1.467 0.708 0 O-C-N 124.733 1.271 . . . . 0.0 114.712 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 p -120.08 17.0 12.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.275 0.56 . . . . 0.0 111.46 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.603 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -85.38 103.82 14.63 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.554 -178.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -87.93 102.9 13.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.1 OUTLIER -74.26 153.3 39.47 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.735 -176.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -138.31 -134.88 3.26 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.127 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.65 126.88 35.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.053 0.454 . . . . 0.0 110.259 -171.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.26 -13.2 31.08 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -119.85 161.33 21.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.242 -0.479 . . . . 0.0 109.924 176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.8 ttpp -146.25 123.08 11.27 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.84 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.601 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.2 t -89.04 141.92 28.08 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.718 -177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.5 pt -133.42 128.75 55.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.31 0.576 . . . . 0.0 109.998 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 6' ' ' CYS . 6.6 mp -100.21 120.6 40.14 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.45 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 35' ' ' SER . . . 74.46 96.26 0.11 Allowed Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.323 -0.853 . . . . 0.0 114.099 172.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HD2' ' HA ' ' A' ' 32' ' ' ARG . 2.5 tpt180 -159.98 94.66 1.13 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.04 -110.26 3.0 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -94.67 1.96 55.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.068 0.461 . . . . 0.0 109.984 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 38' ' ' GLN . 9.3 t -90.03 146.15 24.56 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.992 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.647 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -135.37 -32.5 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.019 175.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.647 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -155.64 77.7 0.98 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -115.71 146.78 41.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.953 0.406 . . . . 0.0 111.79 -171.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 90.3 m -99.48 106.18 18.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.516 175.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.2 p -95.99 158.99 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.1 p -88.98 126.84 35.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.8 0.333 . . . . 0.0 111.112 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.68 -119.12 0.73 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.006 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 9.2 pt-20 -147.02 117.0 7.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -102.91 -149.12 21.14 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.537 -177.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.7 144.9 19.87 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.369 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.568 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 53.0 Cg_exo -55.6 144.55 74.25 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.362 2.041 . . . . 0.0 110.436 173.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 1.8 ttpm? -87.99 107.7 17.35 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 7.6 Cg_exo -73.09 152.0 50.47 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.692 2.261 . . . . 0.0 111.607 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -150.25 -66.23 0.2 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 t -145.15 -172.77 3.93 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.4 m170 . . . . . 0 CA--C 1.505 -0.756 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 175.231 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.8 t -114.75 124.16 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.649 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.23 162.75 26.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.148 0.499 . . . . 0.0 110.464 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -147.96 -177.51 5.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.632 176.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.458 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 4.8 m-20 -86.93 148.05 25.51 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.704 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 21.9 m -60.8 133.58 56.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.502 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -109.91 -29.62 8.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.877 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 159.43 30.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.347 -175.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.1 m -87.52 117.2 26.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.569 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.98 -6.82 9.42 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.214 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.62 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.42 160.44 16.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.639 0.257 . . . . 0.0 110.426 177.29 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 5.4 p30 -133.79 -57.28 0.88 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 78.9 mt -61.47 60.58 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.003 0.921 . . . . 0.0 112.886 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.704 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -155.05 162.33 41.08 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.448 179.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.68 85.36 5.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.1 0.476 . . . . 0.0 109.953 176.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.628 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 26.1 t -66.28 -73.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.429 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.08 144.12 26.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.116 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 22.76 -90.53 0.01 OUTLIER Glycine 0 N--CA 1.47 0.918 0 O-C-N 125.028 1.455 . . . . 0.0 114.699 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 p -121.6 -1.7 9.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.794 0.331 . . . . 0.0 111.197 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -70.29 104.06 2.56 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.629 0.728 . . . . 0.0 110.997 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 21.3 t -88.84 101.05 11.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.922 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -65.82 156.92 31.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.972 -175.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -134.71 -152.92 6.7 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.064 -0.815 . . . . 0.0 111.064 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -85.96 139.15 31.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.28 -15.63 50.28 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -167.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -120.48 166.22 13.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.4 ttpp -149.99 117.4 6.09 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.628 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.5 t -88.92 136.31 33.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.887 0.375 . . . . 0.0 110.266 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.2 pt -127.01 128.35 70.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.299 0.571 . . . . 0.0 110.243 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 5.8 mp -107.71 104.36 13.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.871 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 35' ' ' SER . . . 85.74 77.5 1.2 Allowed Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.76 176.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -136.69 66.97 1.46 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.11 -100.38 2.32 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.763 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -92.57 12.47 22.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.338 0.59 . . . . 0.0 109.707 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.442 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 3.1 t -113.25 144.62 42.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.777 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -132.71 -38.21 1.02 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.784 0.326 . . . . 0.0 110.253 174.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -155.12 97.35 1.91 Allowed 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.01 138.89 28.69 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.135 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 91.8 m -89.41 96.03 10.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.916 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.6 p -90.23 160.13 2.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 p -88.88 132.0 34.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.285 0.564 . . . . 0.0 111.368 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.91 -128.6 1.68 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.876 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -143.14 112.85 6.96 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.344 0.593 . . . . 0.0 110.28 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.444 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -93.53 -148.09 23.03 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.419 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.93 142.71 22.81 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.83 139.4 78.19 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.198 1.932 . . . . 0.0 110.676 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.62 ' HG3' HE21 ' A' ' 11' ' ' GLN . 16.5 tttm -86.46 123.97 70.42 Favored Pre-proline 0 N--CA 1.432 -1.352 0 CA-C-O 120.99 0.424 . . . . 0.0 110.493 -173.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 32.5 Cg_exo -58.49 142.53 98.1 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.791 2.327 . . . . 0.0 112.27 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.774 ' HG3' ' H ' ' A' ' 50' ' ' SER . 4.7 pt20 -160.94 -69.86 0.06 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.07 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.774 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 4.9 t -112.6 63.19 0.63 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.804 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 . . . . . 0 CA--C 1.503 -0.845 0 CA-C-O 121.33 0.586 . . . . 0.0 110.366 178.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 81.9 t . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 49' ' ' GLN . 33.2 t -125.1 84.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 110.391 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.7 m-30 -88.76 156.5 18.94 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.47 0.652 . . . . 0.0 109.886 176.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.612 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -151.32 -157.54 0.82 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.953 -177.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.77 147.76 26.17 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 10.2 m -59.35 129.87 44.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.117 0.484 . . . . 0.0 110.796 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 m -103.08 -27.08 12.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.601 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.423 ' HB2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -129.36 159.36 36.42 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.403 -176.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 46.5 m -87.05 118.66 26.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.292 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.88 -4.72 11.54 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.12 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.506 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.06 161.82 16.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.706 0.288 . . . . 0.0 110.402 175.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 14' ' ' CYS . 6.1 p30 -135.66 -56.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.126 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 88.9 mt -62.15 63.13 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.375 1.047 . . . . 0.0 112.161 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.752 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -153.94 162.6 41.09 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.332 177.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.73 81.46 5.99 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.739 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 43.2 t -67.87 -79.87 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.385 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 11.1 tp10 -72.86 157.59 37.17 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -3.38 -78.3 0.01 OUTLIER Glycine 0 N--CA 1.472 1.094 0 O-C-N 125.284 1.615 . . . . 0.0 115.446 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.0 p -126.64 15.03 7.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.009 0.433 . . . . 0.0 111.125 176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.585 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -83.85 111.2 18.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.755 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.9 t -87.92 103.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -74.94 163.82 27.22 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.081 -176.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.77 -138.34 2.83 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.849 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -85.91 125.8 33.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.195 0.521 . . . . 0.0 109.917 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.62 -19.54 11.38 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -172.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -124.33 161.38 26.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' O ' HG12 ' A' ' 40' ' ' VAL . 25.6 ttpp -141.9 117.92 10.61 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.739 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 32.8 t -91.05 135.27 33.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.095 0.474 . . . . 0.0 110.572 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 23.3 pt -132.38 144.81 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.137 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.674 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.1 mp -97.15 98.06 9.72 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.327 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.8 -120.19 4.42 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.456 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -149.13 174.07 12.74 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.14 -132.45 42.66 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.299 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -89.34 -2.25 58.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.182 0.515 . . . . 0.0 109.696 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -104.88 47.44 0.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.799 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.77 -16.94 49.4 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.504 -177.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.566 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 26.2 t-20 -155.14 94.56 1.64 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -134.14 137.81 44.77 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.359 -172.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.766 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 92.8 m -89.7 96.02 10.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.152 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.1 p -89.8 166.12 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.9 p -88.52 127.4 35.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.263 0.554 . . . . 0.0 111.178 -176.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.5 -135.54 3.57 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.985 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -141.36 110.3 6.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.448 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -92.68 -149.74 25.23 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.261 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.31 144.87 29.93 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 51.3 Cg_exo -55.3 140.35 81.74 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.387 2.058 . . . . 0.0 111.408 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.506 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 11.3 tttm -87.65 138.57 31.56 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.164 -176.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.444 ' HD2' ' HG2' ' A' ' 47' ' ' LYS . 83.7 Cg_exo -49.15 142.2 21.59 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.304 2.669 . . . . 0.0 113.419 177.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB2' ' HB ' ' A' ' 2' ' ' VAL . 5.7 pt20 -148.59 -10.77 0.35 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.557 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.3 m -151.51 35.17 0.56 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.486 -172.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.2 m170 . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.271 0.557 . . . . 0.0 110.734 177.543 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.917 0.389 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.67 97.21 6.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.084 0.468 . . . . 0.0 110.014 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -89.68 160.5 16.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.033 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.6 -178.02 5.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.252 -174.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.1 155.55 20.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.782 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 3.8 m -61.18 134.26 56.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.366 0.603 . . . . 0.0 111.592 -173.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 m -100.13 -18.17 17.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.711 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.42 ' HB2' HE22 ' A' ' 11' ' ' GLN . 4.8 mm-40 -145.46 157.85 43.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.591 -177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 m -89.37 120.22 30.52 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.489 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.07 -2.9 14.43 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.532 -170.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.42 HE22 ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.16 172.39 9.11 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.9 p30 -143.52 -55.81 0.39 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 74.6 mt -61.61 66.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.925 0.869 . . . . 0.0 112.478 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.782 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -153.83 168.93 24.68 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.112 -1.403 . . . . 0.0 109.592 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.71 84.41 4.05 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 92.5 m -72.77 -80.21 0.07 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.473 -175.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -88.0 121.01 29.9 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.358 -173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.47 -90.31 0.01 OUTLIER Glycine 0 C--N 1.304 -1.235 0 O-C-N 123.985 0.803 . . . . 0.0 111.436 -173.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.84 10.54 4.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.7 0.286 . . . . 0.0 111.561 173.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -71.17 126.11 28.73 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.164 0.506 . . . . 0.0 110.718 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 3.7 t -88.61 93.85 4.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.882 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.664 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -65.97 154.82 38.35 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 -176.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.01 -156.23 8.66 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -87.39 132.74 33.87 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.55 -22.26 8.86 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -168.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -117.6 159.95 22.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.09 171.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.551 ' O ' HG12 ' A' ' 40' ' ' VAL . 19.2 ttpp -133.62 113.97 12.99 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.303 175.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 51.7 t -90.22 130.51 36.34 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.829 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.6 pt -123.76 127.24 73.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.459 0.647 . . . . 0.0 111.023 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 20.4 mt -84.08 109.91 18.06 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.023 176.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -101.41 -112.51 3.56 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.129 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -167.26 163.85 15.38 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.25 -119.24 8.52 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.14 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -91.91 -5.26 53.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.167 0.508 . . . . 0.0 109.719 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.4 t -114.2 34.99 4.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.643 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -63.91 -21.08 66.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.896 -178.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.626 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 21.5 t-20 -153.46 131.02 11.43 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -150.35 124.73 9.54 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.468 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.664 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 81.0 m -89.57 95.7 10.38 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.696 176.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 27' ' ' LYS . 5.0 p -89.03 160.33 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.0 p -89.24 126.06 35.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.227 0.537 . . . . 0.0 111.422 -175.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.9 -122.36 0.9 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 11.8 pt-20 -150.23 123.59 8.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.177 0.513 . . . . 0.0 110.417 173.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -107.52 -145.81 12.3 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.381 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.22 142.62 21.98 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 51.1 Cg_exo -57.41 144.09 92.49 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.581 2.187 . . . . 0.0 111.243 174.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' A' ' 14' ' ' CYS . 2.1 ttpm? -89.08 108.56 24.79 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.534 0.207 . . . . 0.0 111.445 -172.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 6.2 Cg_exo -72.22 169.68 20.96 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.04 2.493 . . . . 0.0 111.932 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -156.97 -33.02 0.08 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.987 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.6 t -104.42 138.63 40.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.813 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 120.956 0.408 . . . . 0.0 110.071 -179.17 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 121.017 0.437 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -107.56 90.7 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.125 0.488 . . . . 0.0 110.831 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -98.65 162.52 13.09 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p -133.57 176.2 8.75 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -87.89 152.29 22.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 11.5 m -60.0 133.24 55.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.558 -178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -113.44 -15.28 12.63 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.517 0.675 . . . . 0.0 110.273 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.706 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 46.1 mt-10 -134.2 151.64 51.42 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.217 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -88.11 124.36 33.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.06 -4.21 27.09 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.328 -173.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.706 ' NE2' ' HB2' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -89.27 162.11 16.04 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 14' ' ' CYS . 4.7 p30 -136.04 -56.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 73.6 mt -61.83 62.18 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.96 0.788 . . . . 0.0 112.918 -177.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.723 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -155.48 175.25 14.12 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.596 178.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.2 106.57 14.19 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 40.2 t -98.73 -65.9 0.93 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.434 0.635 . . . . 0.0 110.966 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.13 107.07 18.9 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.879 -175.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 52.73 -90.04 0.01 OUTLIER Glycine 0 C--N 1.299 -1.521 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.007 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 p -124.49 2.08 8.34 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.0 0.429 . . . . 0.0 111.424 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.489 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -70.25 125.14 25.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.782 -175.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.06 105.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.348 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -72.91 155.47 39.84 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -139.24 -143.22 4.38 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.636 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -86.21 139.12 31.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.486 0.66 . . . . 0.0 110.266 -176.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.71 -9.94 58.82 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.718 -172.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -125.73 160.77 28.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.033 174.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 40' ' ' VAL . 28.7 ttpp -143.74 119.55 10.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.536 177.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 17.5 t -89.16 133.18 34.5 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.847 0.356 . . . . 0.0 110.304 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 pt -128.29 123.01 59.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.379 0.609 . . . . 0.0 110.883 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.7 mp -79.4 97.84 6.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.474 176.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.44 -120.21 3.26 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.028 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 16.0 mmt180 -147.77 160.11 43.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.59 -115.64 7.53 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.059 177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -89.6 -21.98 22.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.546 0.689 . . . . 0.0 109.639 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 t -93.62 31.86 1.5 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.253 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.628 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -65.05 -28.04 69.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.559 -175.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.628 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 2.7 t30 -154.93 89.8 1.25 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -128.09 145.05 51.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -170.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 72.8 m -89.12 110.51 21.23 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.859 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.7 p -103.29 159.95 4.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 172.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 p -88.98 128.33 35.69 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.228 0.537 . . . . 0.0 111.122 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.6 -133.93 2.73 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.245 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -139.51 111.1 7.15 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.155 0.502 . . . . 0.0 109.938 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.75 -152.98 28.77 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.433 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.28 139.03 30.38 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.5 135.15 68.01 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.351 2.034 . . . . 0.0 110.907 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.669 ' HG3' HE21 ' A' ' 11' ' ' GLN . 18.7 tttt -87.79 113.68 55.64 Favored Pre-proline 0 N--CA 1.443 -0.801 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 16.5 Cg_exo -67.13 145.77 74.18 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.721 2.28 . . . . 0.0 112.571 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -142.95 -42.23 0.31 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.159 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -88.12 174.71 8.09 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.796 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.5 m80 . . . . . 0 CA--C 1.507 -0.699 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.31 -178.837 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 121.137 0.494 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.91 120.37 63.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -115.01 178.88 4.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.5 p -137.59 -161.44 1.17 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.693 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -85.24 142.61 29.28 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -174.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.727 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 35.0 m -50.28 133.15 24.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.503 0.668 . . . . 0.0 111.128 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -115.07 -10.25 12.24 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.595 -175.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.626 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 41.8 mt-10 -143.94 151.04 39.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.631 -173.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 m -89.01 126.95 35.64 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.455 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.3 -1.03 34.98 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -173.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.789 ' HG2' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.19 164.85 14.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 8.8 p30 -139.74 -57.05 0.57 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 75.4 mt -62.1 59.43 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.979 0.895 . . . . 0.0 112.415 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.768 ' HB3' ' HG3' ' A' ' 47' ' ' LYS . 1.6 p -155.39 150.6 26.9 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.126 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.65 89.85 2.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.629 0.728 . . . . 0.0 109.949 177.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.791 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 34.1 t -62.66 -73.51 0.11 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.358 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 1.2 tm-20 -87.53 163.31 16.73 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -23.04 -72.53 0.01 OUTLIER Glycine 0 N--CA 1.472 1.058 0 O-C-N 124.26 0.975 . . . . 0.0 115.366 -169.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.9 p -115.72 14.72 16.44 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.238 0.542 . . . . 0.0 110.46 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.542 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -80.81 92.19 6.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.889 177.179 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 41.9 t -87.91 97.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.702 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -75.47 158.81 32.09 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.8 -173.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -141.42 -146.26 4.69 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -87.0 134.72 33.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.196 0.522 . . . . 0.0 109.641 -174.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.01 -13.91 37.51 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -170.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -123.89 165.84 16.68 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.8 ttpp -148.89 118.46 6.97 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.791 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 13.7 t -89.41 132.46 34.98 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.8 pt -128.36 120.39 52.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.303 0.573 . . . . 0.0 110.707 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.2 mp -87.87 101.18 13.48 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.581 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -104.27 -118.22 4.45 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.862 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -151.38 159.68 44.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.686 0.279 . . . . 0.0 110.673 -176.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.62 -122.21 8.36 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.301 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.04 -3.47 58.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.121 0.486 . . . . 0.0 109.856 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 t -120.38 55.95 1.0 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.988 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -100.53 -18.48 16.62 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.489 -178.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.451 ' N ' ' HD3' ' A' ' 36' ' ' LYS . 27.5 t-20 -154.46 94.31 1.68 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -145.97 143.37 29.45 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.438 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.702 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 99.5 m -91.18 99.49 12.48 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.861 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 27' ' ' LYS . 5.3 p -89.69 160.77 2.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.2 p -87.62 129.99 34.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.25 0.547 . . . . 0.0 111.124 -176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.34 -135.12 3.51 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.669 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.86 108.98 7.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.034 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.57 -148.72 24.59 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.327 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.471 ' O ' ' HG3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -144.09 144.8 27.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 122.469 0.308 . . . . 0.0 110.299 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.511 ' HA ' ' HB2' ' A' ' 13' ' ' LEU . 33.2 Cg_exo -60.01 154.89 47.83 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.718 2.279 . . . . 0.0 111.65 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.789 ' HG2' ' HG2' ' A' ' 11' ' ' GLN . 2.0 mtmt -87.55 132.58 40.33 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-O 121.052 0.453 . . . . 0.0 110.725 -178.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 6.2 Cg_exo -71.25 146.12 50.36 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.791 2.327 . . . . 0.0 112.196 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -133.35 -36.41 0.99 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.999 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.5 m -89.17 111.29 22.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.455 173.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.2 m80 . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.489 -178.554 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.651 0.263 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.1 t -123.48 116.91 49.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.434 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -140.08 154.72 47.14 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.485 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 13.6 p -144.36 -176.11 4.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.358 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.0 141.85 28.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.752 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 9.1 m -59.12 137.65 57.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.473 0.178 . . . . 0.0 111.145 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t -118.75 -25.48 6.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.917 0.389 . . . . 0.0 111.204 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.425 ' HB2' HE22 ' A' ' 11' ' ' GLN . 0.6 OUTLIER -123.48 156.32 35.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.993 -177.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 m -89.07 114.47 25.71 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.358 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.65 -0.67 9.36 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.333 -173.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.656 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.28 171.93 9.42 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 7.4 p30 -145.45 -56.73 0.32 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 65.8 mt -62.67 58.73 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.148 0.905 . . . . 0.0 112.492 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.752 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.05 159.33 41.51 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.957 -179.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -73.05 102.78 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.037 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.756 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 29.6 t -89.44 -70.48 0.66 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.71 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 9.3 tp10 -79.56 158.99 27.02 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -6.93 -78.02 0.01 OUTLIER Glycine 0 N--CA 1.473 1.162 0 O-C-N 124.984 1.428 . . . . 0.0 115.241 -176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.9 p -122.5 14.43 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.843 0.354 . . . . 0.0 111.264 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.559 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -83.97 108.05 16.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.624 -178.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 9.2 t -92.06 104.2 15.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.811 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 1.2 m -82.32 168.85 17.15 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.187 -174.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -145.34 -149.27 4.98 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.56 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -86.79 134.28 33.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.441 0.639 . . . . 0.0 109.997 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.485 ' C ' HD22 ' A' ' 26' ' ' ASN . . . 112.5 -17.17 23.74 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -165.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.485 HD22 ' C ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -118.82 163.13 17.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.903 -0.649 . . . . 0.0 109.498 172.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 24.9 ttpp -144.61 117.96 9.04 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 173.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.756 ' HG ' ' HG ' ' A' ' 16' ' ' CYS . 33.7 t -89.17 132.31 34.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.733 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 pt -129.64 127.0 63.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.274 0.559 . . . . 0.0 110.879 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.457 ' HG ' ' OD1' ' A' ' 37' ' ' ASN . 6.1 mp -89.91 122.22 32.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.32 -119.41 1.54 Allowed Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -147.55 171.78 15.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.61 -116.2 8.94 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.782 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -89.17 -15.45 33.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.527 0.679 . . . . 0.0 109.496 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t -104.44 29.42 6.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.952 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 2.9 pttp -52.54 -59.52 4.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.657 -176.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.457 ' OD1' ' HG ' ' A' ' 30' ' ' LEU . 3.3 t30 -153.82 77.15 1.09 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -178.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 1.6 tp60 -117.87 150.18 39.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -163.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.811 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 70.8 m -95.43 100.38 12.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.721 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.1 p -91.58 162.17 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -89.14 127.33 35.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.554 0.693 . . . . 0.0 111.779 -176.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.47 -134.02 2.86 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.534 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -143.83 111.19 5.88 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.448 0.624 . . . . 0.0 110.495 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -89.22 -138.29 6.64 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.311 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.4 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -146.9 148.0 31.39 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 122.671 0.388 . . . . 0.0 110.341 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.4 ' HD2' HG22 ' A' ' 45' ' ' THR . 31.4 Cg_exo -59.56 134.87 60.76 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.602 2.201 . . . . 0.0 111.186 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.656 ' HG3' HE21 ' A' ' 11' ' ' GLN . 13.7 tttt -89.97 132.66 35.61 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.107 -175.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.99 142.02 86.25 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.78 2.32 . . . . 0.0 112.035 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 7.7 pt20 -176.33 -18.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.332 0.587 . . . . 0.0 111.397 -169.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.9 m -88.59 66.91 8.34 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.722 0.773 . . . . 0.0 110.066 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 . . . . . 0 CA--C 1.509 -0.609 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.049 -178.42 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.96 0.41 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 51.2 t -107.71 119.66 57.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.576 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -112.26 174.83 5.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.202 0.525 . . . . 0.0 110.545 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.486 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.2 p -133.82 -163.32 1.35 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -87.66 153.83 21.07 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.111 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.755 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 17.0 m -65.64 135.87 55.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.574 178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 m -103.93 -23.03 13.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.071 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.98 162.77 34.65 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.241 0.544 . . . . 0.0 110.942 -173.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.0 m -87.12 122.0 30.35 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.151 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.86 -5.92 18.15 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.901 -173.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 1.025 ' HG3' HG22 ' A' ' 45' ' ' THR . 0.0 OUTLIER -90.86 161.04 15.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 175.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' CYS . 6.8 p30 -136.05 -55.93 0.76 Allowed 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.402 HD23 ' HA2' ' A' ' 23' ' ' GLY . 89.0 mt -61.07 55.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.247 0.967 . . . . 0.0 112.893 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.755 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 1.2 p -155.36 160.48 40.74 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.845 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -77.6 97.24 5.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.364 0.602 . . . . 0.0 109.393 177.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.617 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 13.0 t -72.65 -77.31 0.1 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.703 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -86.85 162.11 17.95 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 3.29 -87.99 0.0 OUTLIER Glycine 0 N--CA 1.474 1.174 0 O-C-N 124.964 1.415 . . . . 0.0 114.969 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.1 p -123.07 22.05 9.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.463 0.649 . . . . 0.0 110.237 172.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -78.57 99.04 6.35 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.209 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 31.0 t -88.32 99.94 9.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.014 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.668 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -73.07 155.98 39.21 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.651 -176.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -139.67 -154.05 6.23 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.643 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -85.78 135.13 33.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.434 0.617 . . . . 0.0 109.52 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.25 -9.35 53.92 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -127.34 164.15 22.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.557 -0.822 . . . . 0.0 109.278 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' O ' HG12 ' A' ' 40' ' ' VAL . 27.3 ttpp -150.28 121.46 7.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.211 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.617 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.9 t -89.23 138.0 31.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.956 0.408 . . . . 0.0 110.232 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -128.08 124.47 62.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.436 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.726 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.6 mp -92.88 80.67 4.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.374 176.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.87 -109.05 2.41 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.752 -174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -155.93 160.81 40.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.394 -0.225 . . . . 0.0 110.394 -175.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.86 -121.58 7.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.869 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.11 -10.74 29.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.398 0.618 . . . . 0.0 109.434 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.4 t -99.57 22.85 10.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.145 0.974 . . . . 0.0 109.413 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.726 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 14.3 pttp -66.81 -27.01 67.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.662 177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -153.3 91.09 1.47 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 56.4 tp60 -127.65 139.63 52.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.108 0.48 . . . . 0.0 111.694 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.668 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 59.7 m -90.83 92.89 8.99 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.868 171.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.7 p -90.16 159.76 2.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.9 p -88.65 127.03 35.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.387 0.613 . . . . 0.0 110.685 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.67 -148.44 11.92 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.895 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -122.22 106.34 11.04 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.28 -144.14 12.47 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.091 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 1.025 HG22 ' HG3' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -150.04 146.18 19.91 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.167 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.39 119.77 7.15 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.375 2.05 . . . . 0.0 111.841 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HB2' ' HG2' ' A' ' 11' ' ' GLN . 8.4 tmtt? -84.5 117.04 67.78 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.52 154.02 67.42 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.278 2.652 . . . . 0.0 115.405 -168.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -113.25 -20.02 11.56 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 112.901 -1.954 . . . . 0.0 108.734 173.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 m -89.47 -65.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.675 175.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.074 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 121.203 0.525 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 67.5 t -89.39 115.64 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -89.67 174.58 7.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.545 0.688 . . . . 0.0 111.628 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.3 p -121.55 -176.52 3.33 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.138 -175.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.56 152.14 22.43 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 4.8 m -63.01 133.36 54.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.205 0.526 . . . . 0.0 111.225 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -105.45 -23.11 12.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.692 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.451 ' HB2' HE22 ' A' ' 11' ' ' GLN . 2.3 mm-40 -130.52 153.98 48.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.339 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 51.5 m -88.27 112.0 22.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.1 -0.13 7.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.004 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.568 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.64 171.84 9.72 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 14' ' ' CYS . 5.6 p30 -142.41 -57.44 0.45 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 82.8 mt -62.87 61.62 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.815 0.846 . . . . 0.0 112.354 -178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.746 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -153.51 171.23 19.04 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.821 -179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 4' ' ' THR . 2.5 mt -83.45 88.36 6.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.546 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 41.9 t -80.49 -61.53 1.95 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.875 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.99 113.7 25.34 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.976 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 46.33 -97.32 0.01 OUTLIER Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.754 -175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -115.1 0.99 13.79 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.502 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -70.3 123.05 20.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.978 0.418 . . . . 0.0 110.607 -175.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.26 97.39 6.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.486 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.6 OUTLIER -74.69 167.29 22.09 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.541 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.02 -124.76 0.72 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.802 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -86.26 124.46 32.67 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.174 0.511 . . . . 0.0 110.312 -169.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.44 -2.7 37.02 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.045 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -130.89 154.35 48.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.323 0.582 . . . . 0.0 110.867 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.589 ' O ' HG12 ' A' ' 40' ' ' VAL . 5.2 ttpp -129.57 111.63 12.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.174 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.478 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 61.7 m -91.56 124.33 35.64 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.162 0.506 . . . . 0.0 111.09 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 16.3 pt -128.0 139.3 52.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.819 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 8.6 mp -59.27 121.16 10.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.776 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -65.26 -45.48 90.94 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.527 -1.215 . . . . 0.0 113.313 -175.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 73.33 153.79 0.14 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.302 0.641 . . . . 0.0 111.058 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.36 -104.32 1.18 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.844 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -93.32 15.24 16.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.63 0.729 . . . . 0.0 109.573 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 t -143.7 171.9 13.56 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.674 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.61 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -139.66 -33.47 0.6 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.112 176.015 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.61 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 0.5 OUTLIER -154.83 140.99 18.49 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 176.239 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -141.4 140.67 33.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.854 0.359 . . . . 0.0 110.755 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.612 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 70.8 m -90.68 95.76 10.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.944 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 27' ' ' LYS . 3.5 p -90.23 159.67 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -88.83 130.51 35.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.216 0.531 . . . . 0.0 111.464 -175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.69 -132.29 2.53 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.705 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -137.41 112.69 9.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.009 0.433 . . . . 0.0 110.335 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -100.99 -146.89 19.87 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.205 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.475 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -147.11 148.43 32.16 Favored Pre-proline 0 C--N 1.324 -0.533 0 C-N-CA 122.18 0.192 . . . . 0.0 110.664 -178.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.475 ' HD2' HG22 ' A' ' 45' ' ' THR . 51.1 Cg_exo -55.8 148.76 54.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.196 1.931 . . . . 0.0 110.785 173.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 9.5 tttm -89.31 113.06 54.94 Favored Pre-proline 0 N--CA 1.438 -1.064 0 CA-C-O 120.691 0.281 . . . . 0.0 111.481 -171.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 19.5 Cg_endo -62.34 163.47 20.4 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.599 2.2 . . . . 0.0 112.294 176.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -155.03 -44.01 0.08 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.991 -177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 m -86.93 -51.08 6.25 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.445 0.641 . . . . 0.0 109.699 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.4 m170 . . . . . 0 CA--C 1.508 -0.637 0 CA-C-O 121.35 0.595 . . . . 0.0 109.905 -179.312 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 121.001 0.429 . . . . 0.0 111.42 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.3 t -116.78 109.82 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.062 0.458 . . . . 0.0 110.822 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.452 ' CD1' HG11 ' A' ' 21' ' ' VAL . 97.2 m-85 -103.27 177.4 4.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.733 176.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 p -136.26 166.46 23.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.268 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.22 139.99 29.94 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.827 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 28.2 m -60.24 130.8 48.43 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 109.937 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -113.08 -28.58 7.62 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.208 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' HB2' HE22 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -121.49 153.02 38.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.844 -177.006 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 29' ' ' ILE . 58.9 m -88.44 114.56 25.19 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.392 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.14 -9.56 6.64 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.94 -173.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.688 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -86.61 168.31 13.75 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 6.1 p30 -140.15 -55.24 0.54 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 67.8 mt -62.76 56.24 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.249 0.968 . . . . 0.0 112.854 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.827 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -154.33 160.78 41.9 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.444 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -71.77 108.14 4.93 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.645 0.736 . . . . 0.0 109.371 174.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 28' ' ' CYS . 53.3 t -89.47 -71.34 0.61 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.168 -176.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 8.8 tp10 -82.42 161.18 22.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -8.55 -78.03 0.01 OUTLIER Glycine 0 N--CA 1.473 1.147 0 O-C-N 124.905 1.378 . . . . 0.0 115.483 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.3 p -121.16 15.23 11.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 0.0 111.232 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.586 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -87.06 103.81 15.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.6 -179.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.68 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 37.0 t -89.53 105.14 15.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.778 ' HG ' ' HG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -78.44 169.74 17.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.382 -177.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 12' ' ' ASN . . . -153.39 -133.69 1.89 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.823 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -85.3 141.31 30.16 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.274 0.559 . . . . 0.0 110.536 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.12 -10.26 69.87 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.184 -172.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -120.15 160.11 23.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.971 0.415 . . . . 0.0 110.497 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.575 ' O ' HG12 ' A' ' 40' ' ' VAL . 19.3 ttpp -142.45 108.54 5.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.295 176.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.49 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 67.7 m -89.46 135.09 33.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.137 -174.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 19.0 pt -131.72 138.08 53.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.375 0.607 . . . . 0.0 110.543 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 6.1 mp -95.38 101.85 13.61 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.549 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -99.97 -113.41 3.5 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.361 -0.924 . . . . 0.0 111.95 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.405 ' N ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -155.6 162.75 40.58 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.65 -139.5 17.27 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.098 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -86.55 -4.48 59.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 170.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 14.3 m -94.38 30.58 1.93 Allowed 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 113.139 -1.846 . . . . 0.0 110.158 175.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.646 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 1.3 pptp? -64.76 -31.32 72.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.863 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.646 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -154.98 95.73 1.77 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.145 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.79 139.83 45.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.037 0.446 . . . . 0.0 111.293 -172.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.778 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 77.7 m -90.43 101.09 13.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.767 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -96.08 158.98 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.0 p -88.31 128.63 35.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.774 0.321 . . . . 0.0 111.124 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.7 -121.28 0.88 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.673 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.542 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 6.9 pt-20 -149.79 125.95 10.68 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 173.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.52 -147.49 11.34 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.611 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.35 144.53 50.01 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.453 -0.374 . . . . 0.0 110.569 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.449 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 26.1 Cg_exo -62.65 141.68 86.69 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.009 1.806 . . . . 0.0 109.924 171.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.688 ' HG3' HE21 ' A' ' 11' ' ' GLN . 2.0 ttpm? -88.14 111.93 46.2 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.676 -172.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 18.2 Cg_exo -68.2 176.73 5.17 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.175 2.584 . . . . 0.0 111.641 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.3 -37.09 6.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.814 -174.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -103.82 -57.9 1.96 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.511 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.6 m80 . . . . . 0 CA--C 1.509 -0.603 0 CA-C-O 121.049 0.452 . . . . 0.0 110.451 177.272 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 121.288 0.565 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.6 t -89.34 147.1 5.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -87.84 155.51 19.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.27 0.557 . . . . 0.0 110.313 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 3.0 p -138.42 -176.56 4.5 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.542 -177.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.28 146.25 26.03 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.768 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 33.7 m -59.34 129.65 43.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.183 0.516 . . . . 0.0 110.185 175.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -102.36 -13.93 17.12 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.37 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.449 ' HB2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -150.17 163.76 37.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.209 0.528 . . . . 0.0 110.913 -174.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m -86.11 122.33 29.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.329 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.914 ' HA2' ' HD2' ' A' ' 27' ' ' LYS . . . 120.88 -7.89 10.83 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.531 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.597 ' HG2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -88.8 169.06 11.94 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 122.868 -0.196 . . . . 0.0 110.575 178.125 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -143.47 -57.29 0.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.35 56.62 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.345 1.028 . . . . 0.0 113.095 -176.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.768 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 0.5 OUTLIER -154.77 161.91 41.32 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.833 179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.03 89.02 2.41 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.375 173.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 36.4 t -57.2 -78.04 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.635 175.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 20' ' ' ASN . 29.2 tt0 -87.56 161.92 17.48 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -16.0 -71.52 0.01 OUTLIER Glycine 0 N--CA 1.471 0.984 0 O-C-N 124.661 1.225 . . . . 0.0 115.665 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 p -116.66 5.96 13.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.063 0.458 . . . . 0.0 111.339 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -80.42 93.87 6.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.471 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.606 ' HA ' ' HA ' ' A' ' 15' ' ' LEU . 46.2 t -88.54 97.74 7.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -70.7 160.72 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.224 -175.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.92 -141.78 3.76 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.852 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -87.13 135.3 33.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.165 0.507 . . . . 0.0 109.953 -172.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.51 -7.59 59.76 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -122.66 156.71 33.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.036 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.914 ' HD2' ' HA2' ' A' ' 10' ' ' GLY . 4.7 ttpp -138.59 121.41 16.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.831 176.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 30.0 t -89.94 130.74 36.11 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 178.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.38 137.2 54.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.423 0.63 . . . . 0.0 110.462 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.667 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -113.83 103.3 11.06 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.793 -172.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.92 -122.53 2.51 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.385 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -153.13 -170.45 3.62 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.356 0.263 . . . . 0.0 110.45 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.58 -112.07 4.62 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.087 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -113.21 4.03 16.3 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.7 t -109.52 32.5 4.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.384 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.667 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 68.8 mttt -60.45 -50.31 74.09 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 121.704 0.764 . . . . 0.0 110.123 -177.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -154.25 100.82 2.33 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.595 -172.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 8.3 tp-100 -135.73 143.65 45.45 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.203 -174.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.759 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 86.5 m -90.46 104.46 17.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.586 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 27' ' ' LYS . 2.8 p -97.26 164.92 2.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 p -95.25 116.27 28.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.074 0.464 . . . . 0.0 111.156 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.52 -126.95 0.97 Allowed Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.001 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 111.2 6.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.481 0.657 . . . . 0.0 110.769 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.669 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -97.4 -151.87 28.04 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.725 -176.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.412 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -150.11 147.46 22.21 Favored Pre-proline 0 C--N 1.321 -0.64 0 C-N-CA 122.511 0.325 . . . . 0.0 110.679 -176.264 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.511 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 52.5 Cg_exo -54.49 148.71 41.93 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.425 2.083 . . . . 0.0 110.497 170.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HA ' ' HG2' ' A' ' 11' ' ' GLN . 2.2 ttpm? -88.62 115.49 63.55 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -165.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 10.5 Cg_exo -72.55 -170.54 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.135 2.557 . . . . 0.0 110.117 167.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -168.89 -54.96 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.612 0.244 . . . . 0.0 111.402 -169.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.1 m -146.25 -57.83 0.3 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.123 0.487 . . . . 0.0 110.473 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 19.0 m80 . . . . . 0 CA--C 1.508 -0.64 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.163 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.3 t . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.45 109.36 21.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 120.752 0.31 . . . . 0.0 110.666 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -104.22 174.06 6.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.131 0.491 . . . . 0.0 110.355 174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p -130.07 -164.09 1.38 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.656 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.32 157.66 18.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.772 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 2.7 m -67.25 133.92 50.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.321 0.581 . . . . 0.0 111.688 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 m -106.52 -22.57 12.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.859 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -139.98 157.83 45.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.031 0.443 . . . . 0.0 110.729 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.0 m -88.28 118.88 28.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.016 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.86 -5.53 10.53 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.805 -173.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.627 HE21 ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -87.8 176.49 7.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 14' ' ' CYS . 7.0 p30 -148.81 -54.14 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 98.0 mt -60.55 65.95 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.898 0.856 . . . . 0.0 112.256 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.772 ' HG ' ' HG ' ' A' ' 6' ' ' CYS . 1.2 p -154.1 165.91 34.71 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.317 -1.311 . . . . 0.0 109.451 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.3 85.54 3.09 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 99.6 m -74.85 -78.48 0.1 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.037 -174.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -85.61 115.09 23.09 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.317 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 48.75 -94.7 0.01 OUTLIER Glycine 0 C--N 1.298 -1.552 0 O-C-N 124.136 0.897 . . . . 0.0 112.006 -173.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 p -117.88 0.13 11.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.924 0.392 . . . . 0.0 111.737 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.498 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER -72.15 123.04 22.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.96 0.41 . . . . 0.0 110.64 -176.342 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 t -88.68 106.01 16.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.656 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -75.3 161.94 28.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.581 -177.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.9 -143.78 3.88 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.833 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -86.75 138.36 31.68 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.282 0.563 . . . . 0.0 110.151 -172.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.17 -10.23 58.19 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -169.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -127.06 153.42 45.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 120.96 0.41 . . . . 0.0 110.202 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 40' ' ' VAL . 14.2 ttpp -134.21 113.2 11.76 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.279 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.515 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 15.0 t -89.51 130.7 35.8 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.906 0.384 . . . . 0.0 110.439 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -129.46 130.22 67.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.574 0.702 . . . . 0.0 111.276 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 24.5 mt -82.26 94.25 7.28 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.609 176.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.54 -111.77 1.33 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.731 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -163.94 153.02 13.91 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.67 -139.5 14.66 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.177 -177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -87.94 -4.25 58.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 166.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 m -94.58 30.11 2.1 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.166 -1.834 . . . . 0.0 110.448 175.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 30' ' ' LEU . 1.9 pptp? -77.5 -10.74 59.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.764 -176.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -154.26 108.42 3.0 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -135.2 141.66 45.9 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.176 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.635 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 81.0 m -89.48 97.19 11.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.702 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 27' ' ' LYS . 4.3 p -89.73 160.97 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.4 p -88.84 128.68 35.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.469 0.652 . . . . 0.0 111.37 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.43 -142.64 7.44 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.542 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -128.19 113.96 16.37 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.747 0.308 . . . . 0.0 110.779 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 27' ' ' LYS . . . -100.87 -146.16 18.55 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.004 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.95 144.86 22.97 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 122.641 0.376 . . . . 0.0 110.701 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.446 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 41.9 Cg_exo -58.35 145.22 94.55 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.289 1.993 . . . . 0.0 110.067 171.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.627 ' HG3' HE21 ' A' ' 11' ' ' GLN . 2.0 ttpm? -89.04 110.37 37.58 Favored Pre-proline 0 C--N 1.32 -0.675 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.549 -174.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 31.3 Cg_exo -58.71 155.66 36.29 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 122.978 2.452 . . . . 0.0 112.099 -178.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -132.46 -37.29 1.08 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.309 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.8 p -125.75 138.02 53.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.464 0.65 . . . . 0.0 112.504 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.9 m170 . . . . . 0 CA--C 1.513 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.639 177.04 . . . . . . . . 0 0 . 1 stop_ save_